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Thesis abstract:
Two proteins putatively involved in the persistence o f Mycobacterium 
tuberculosis infection have been investigated by heteronuclear nuclear magnetic 
resonance (NMR) spectroscopy and other methods.
The major aspect o f work describes the characterization by NMR of the Mtb thiol 
peroxidase; TPx. TPx (165 residues) is a 36 kD symmetrical homodimer that 
catalyzes the reduction o f a range o f reactive oxygen species in vitro. 
Multidimensional heteronuclear NMR spectroscopy was applied to recombinant 
wild-type (Wt) and Cys60->Ser (C60S) TPx, both o f which are clearly folded but 
display slightly different spectral characteristics. Triple resonance NMR 
experiments recorded using [2H, 13C, 15N]-labelled C60S yielded assignments for 
the majority o f the backbone resonances. 28 non-proline residues could not be 
assigned mostly due to the absence of cross peaks. TPxWt spectra showed little 
difference in peak number indicating that the C60S mutation itself does is not 
responsible for the missing signals. Consideration o f related TPx crystal structures 
indicates that the missing cross peaks correspond to a region o f the protein that 
must display conformational plasticity necessary for the mechanism of action 
suggesting that the spectrum is affected by conformational exchange processes. 
Efforts to modulate this exchange behaviour through the application o f putative 
TPx ligands and chemical modification o f the active site cysteine residues are 
described.
In a second aspect, a preliminary characterisation o f the non-canonical RNA 
polymerase sigma factor sigJ from Mtb was performed. Bioinformatic analysis 
revealed that sigJ likely contains conserved o2 and o4 DNA-binding domains 
fused to a unique C-terminal domain. NMR spectra o f recombinant sigJ recovered 
from inclusion bodies and in the soluble fraction differed, though both forms 
yielded dispersed resonances consistent with the protein containing a globular 
component. However further progress was hampered by signal overlap and 
heterogeneous line widths. sigJ has a general capability to retard the movement of 
DNA in an electrophoretic mobility shift assay, though specific target sequence 
was identified.
“If  you can't explain it simply, you don't understand it well enough”
Albert Einstein
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Chapter 1
General Introduction: Mycobacterium 
tuberculosis (Mtb)
1.1. Summary:
In this chapter, the causative agent of tuberculosis, the bacterium Mycobacterium  
tuberculosis (Mtb) is described. Details are given as to its ability to infect host 
organisms, proliferate, survive and elude cell mediated immune responses. 
Following primary infection the bacterium has the ability to enter a dormant, non­
replicating state in infected individuals that is virtually impossible to detect with 
modem laboratory techniques. During this dormant yet viable state, a series of 
specific changes to the surrounding cellular environment triggers a process of 
reactivation within the host, sometimes many years after initial infection. The 
resulting impact o f TB, particularly in developing countries, is currently a 
growing concern among many o f the world health authorities and is considered to 
be an accelerating issue with respect to increasing cases o f antibiotic resistance 
and phenotypic adaptation to BCG-vaccinated individuals.
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1.2. Tuberculosis (TB) and Mycobacterium tuberculosis (Mtb) pathogenesis.
Much like the common cold, TB is a contagious disease that spreads through the 
air. Only people who are sick with pulmonary TB are infectious (Electronic 
Source 1, 2003). To become infected, a person needs to inhale only a small 
number o f airborne bacilli.
Figure 1.1 shows the steps involved in tuberculosis infection, proliferation, 
distribution and immune response, the details o f which are described below.
On inhalation of the Mtb bacilli into the sterile environment o f the lungs, 
specifically the respiratory bronchioles and alveoli, the bacilli settle upon the 
upper epithelium (Fenton and Vermeulen, 1996). When bacilli numbers settling 
on the upper epithelium are high, the combined weight o f these inhaled particles 
tends to result in the process of sedimentation where the bacilli are no longer 
infective. Other airborne particles, such as multi-bacilli that coagulate (known as 
Pfliiger droplets measuring 5 to 10 pM in diameter), either sediment or are cleared 
by the defence mechanisms o f the airways. However, upon condensation o f these 
droplet nuclei and the loss o f part o f their water content, smaller particles 
measuring 1 to 5 pM are formed, containing approximately three tubercle bacilli 
each; these droplets are infective. The defence mechanisms o f the upper airways 
(i.e., cough reflex, mucociliary system) non-specifically prevent particles 
measuring over 5 pM from reaching the lung parenchyma. Under infective 
conditions, however, some particles measuring 1 to 5 pM reach the distal airways 
and are deposited in the alveoli. It is believed that at least 10 to 200 o f such micro­
droplets must reach the alveoli in order for infection to take place. The 
preferential zone o f arrival is the best-ventilated part o f the lungs, corresponding 
to the sub-pleural region o f the inferior lobes. Infective bacilli enter the lung 
capillaries that span the alveoli exogenous membrane where they may escape 
from the lung capillaries to the systemic arterial circulation and become deposited 
in various organs throughout the body (Harris, 2001). The main metastatic or 
target zones o f such bacterial dissemination are the highly irrigated organs and 
tissues— the central nervous system, spongy bone, liver, kidneys, and genitals. In 
each o f these zones, the arriving bacilli are phagocytosed by the local cells o f the 
mononuclear phagocyte system.
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In the first few days following infection o f a host, a strong granulomatous 
response is initiated by the host to defend against the infection. This response 
involves an accumulation o f granuloma -  a tumour like mass composed of 
actively growing fibroblasts and capillary buds, in the area o f infection. This is an 
essential process if dissemination and proliferation o f the bacilli is to be arrested 
here (Fenton and Vermeulen, 1996). Within the first two weeks, mass replication 
o f the bacilli occurs within the host (Chan et al, 2000). This process proceeds 
unabated regardless of the attempts made by the presence o f the macrophages 
fighting to remove them. Subsequent infection o f other host cells commences 
throughout a number o f tissues (Fenton and Vermeulen, 1996). It is only after 
approximately two weeks that infected host antigen-specific defence develops 
(delayed-type hypersensitivity, DTH) and proceeds to bacilli eradication (Orme, 
1993).
Over the next four to five weeks progressive infection o f granulomatous focal 
lesions, composed o f macrophage-derived epithelioid giant cells and lymphocytes, 
begin to form. These focal lesions envelope and contain the pathogen, 
immediately subduing any further growth and replication. The process for bacilli 
eradication is hence administered and predominantly involves the alteration o f the 
immediate environment o f engulfed bacilli, resulting in low oxygen conditions 
and high peroxide concentrations. The eradication o f phagocytosed bacilli 
however is not always the end result in infected hosts. Infected macrophages in 
the interior o f each granuloma are killed as the periphery becomes fibrotic and 
caseated (a form o f coagulation necrosis in which the necrotic tissue resembles 
cheese and contains a mixture o f protein and fat that is absorbed very slowly) due 
to the development o f anaerobic and toxic fatty acid conditions. A proportion of 
such macrophage-infected granulomas may result in the latent, non-replicating 
form of the bacterium being triggered. It is at this point that a host’s cell-mediated 
immunity (CMI) (Orme, 1993) response determines whether an infection is 
arrested here or progresses to the next stages (Fenton and Vermeulen, 1996). With 
a good CMI response, the infection may be arrested permanently at this point. If 
however the CMI response is insufficient or ineffective, macrophages containing 
ingested but viable Mtb bacilli may escape from the granuloma via the 
intrapulmonary lymphatic channels. Mycobacterial defensive mechanisms include 
the production o f glycolipids that inhibit phagosome-lysosome fusion, while other
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mechanisms alter lysosomal acid pH, thereby complicating enzyme action. 
Catalase is produced which destroys hydrogen peroxide, and different 
mycobacterial components inhibit superoxide production. This phase concludes 
with destruction o f the alveolar macrophages by proliferating intracellular bacilli. 
The bacilli thereafter spread throughout the body o f the host to places where CMI 
is inadequate resulting in pulmonary damage and further spreading o f the 
organism until eventually effective antibiotic treatment must be administered if 
the patient is to survive (Fenton and Vermeulen, 1996).
There are at present a number o f tuberculostatic antibiotic treatments available 
including a vaccine known as the Bacille Calmette-Guerin (BCG) which involves 
the introduction o f an attenuated non-virulent form o f Mycobacterium bovis 
(bovine TB) into the body of the recipient thereby initiating a cell-mediated 
immune response (Coates and Hu, 2001a; Chan et al, 2000 and Electronic Source 
2 , 2002).
Individuals from developing countries are at a higher risk o f TB infection and 
reactivation because they go without the BCG vaccine or have neglected the 
correct antibiotic treatment regimen. This is a result o f poor health care 
monitoring facilities, where invariably the correct antibiotic treatments may be 
either unavailable or poorly supported. The following sections will discuss the 
consequences o f untreated TB-infected patients, and the strategies required to 
ensure that available and correct antibiotic treatment programs are provided.
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1.3. The consequences of untreated patients with TB.
Left untreated, each person with active TB will infect on average between 10 and 
15 people every year. When someone's immune system is weakened, the chances 
o f an infected individual becoming sick are greater (Electronic source 3, 2002 and 
Electronic Source 2, 2002). HIV infection, malnutrition, drug use, cancer, 
diabetes, chronic renal insufficiency and immunosuppressive drug therapy are 
each believed to increase the risk of reactivation TB (Bishai et al, 1998). The 
emergence o f multi-drug resistant Mtb strains is becoming more and more 
prevalent, especially in much of Eastern Europe where both new TB infection and 
reactivation cases are closely monitored and documented (Figure 1.2).
1.4. Antibiotic resistance.
Tuberculous reactivation is defined as the development of tuberculous disease in a 
patient who had already been infected with the tubercle bacillus in the past. 
Although there are well-documented cases of exogenous re-infection, it is 
currently accepted that most cases of re-infection are attributable to endogenous 
reactivation.
The ability o f Mtb to become tolerant to certain antimicrobial treatments could be 
due to a process known as phenotypic adaptation which enables bacteria to 
develop drug resistant phenotypes in response to the prolonged use o f antibiotics 
(Handwerger and Tomasz, 1985). The ability o f Mtb bacilli to adapt to 
administration o f antimicrobial drugs could be achieved by moving into a 
persistent state (viable but not culturable, also known as a paucibacillary state) 
and therefore would explain unusually long treatment durations that are required 
for successful pharmacotherapy of active TB (Bishai et al, 1998).
In resistant individuals, the immune control o f haematogenous seeding sites is 
dependent on local as well as systemic factors. Some systemic factors (e.g., HIV 
infection, corticotherapy, malnutrition) may account for tuberculous reactivation, 
although it is less clear how other local factors affect reactivation. It has been 
speculated that a decrease in interferon production and the intervention of
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arabinomanans may be involved in this reduction or in the generation o f a specific 
suppressor response. One o f the known important pathogenic phenomena of 
reactivation is caseum liquefaction. Although not all the factors implicated in such 
liquefaction are known, the phenomenon has been attributed to lysosomal 
enzymes released by the macrophages, and to a delayed hypersensitivity reaction 
to mycobacterial products. The immediate consequence o f caseum liquefaction is 
the production o f an excellent growth medium for the bacteria, which begin to 
multiply and release products similar to tuberculin that have great toxic potential. 
In the case o f the lungs, these released products rupture the adjacent bronchi, 
forming cavities and spreading the bacteria via the bronchogenic route.
Until 50 years ago, there were no medicines to cure TB. Now, strains that are 
resistant to a single drug have been documented in every country surveyed; what 
is more, strains o f TB resistant to all major anti-TB drugs have emerged. Drug- 
resistant TB is caused by inconsistent or partial treatment, when patients do not 
take all their medicines regularly for the required period because they start to feel 
better, because doctors and health workers prescribe the wrong treatment 
regimens, or because the drug supply is unreliable.
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Figure 1.2: A: Global estimate of new TB cases, as shown by colour coding, and an indication upon 
current case trends. B: European scale of multi-drug resistant (MDR) cases of TB in both new and 
retreated patients, represented as a colour-coded % of MDR cases. Obtained from W.H.O. Global 
Tuberculosis Control Report 2007.
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A particularly dangerous form o f drug-resistant TB is multidrug-resistant (MDR) 
TB, which is defined as the disease caused by TB bacilli resistant to at least 
isoniazid and rifampicin, the two most powerful anti-TB drugs. Rates of MDR TB 
are high in some countries, especially in the former Soviet Union, and threaten TB 
control efforts.
While drug-resistant TB is generally treatable, it requires extensive chemotherapy 
(up to two years o f treatment) with second-line anti-TB drugs which are more 
costly than first-line drugs, and which produce adverse drug reactions that are 
more severe, though manageable.
The emergence o f MDR TB, particularly in settings where many TB patients are 
also infected with HIV, poses a serious threat to TB control, and confirms the 
urgent need to strengthen basic TB control and to apply the new W.H.O. 
guidelines for the programmatic management o f drug-resistant TB.
1.5. Mtb dormancy.
Wayne and Sramek showed that abrupt exposure to anaerobic conditions of 
actively growing cultures o f Mtb leads to cell death. However, incubation under 
conditions in which oxygen is depleted gradually causes Mtb to shift down from 
active replication to dormancy (Wayne and Sramek, 1994). It is in this dormant 
state that the bacilli are resistant to bactericidal effects o f anaerobiosis and also 
exhibit partial or complete resistance to the bactericidal effects o f the drugs 
isoniazid and rifampicin. Mtb bacilli can persist for decades in a dormant state 
inside a granuloma, particularly in the apical regions o f the lung (Fenton and 
Vermeulen, 1996). Although the precise nature o f the environment inside the 
granuloma is unknown, many factors including oxygen deprivation, nutrient 
depletion, low pH, toxic oxygen species, and other adverse conditions o f this 
environment, could potentially contribute to the induction and maintenance of 
mycobacterial dormancy (Barry, Crane and Yuan 1996). In this state, alternate 
biosynthetic pathways generate cell-wall components such as mycolic acids, 
mycocerosic acid, phenolthiocerol, lipoarabinomannan and arabinogalactan, and 
the action o f several o f these may contribute to mycobacterial longevity, as well
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as triggering inflammatory host reactions and acting in pathogenesis (Cole et al, 
1998).
1.6. Location of latent Mtb in infected human hosts.
For intrapulmonary re-infection o f host tissue, latent bacilli are harboured in the 
old pulmonary lymph nodes that comprise the Ghon complex (a scar in the lungs 
o f TB patients who have successfully controlled the infection, where calcified 
lesions corresponding to the initial site o f pulmonary infection are present). In the 
extrapulmonary cases, bacilli have been found in bones, brain, lymph nodes and 
other tissues. The presence o f bacilli in these regions represents 15 % of latent TB 
reactivation cases (Bishai et al, 1998; Bishai, 2000 and Harris, 2001). Hence, a 
hypothesis by Bishai proposed that latency is maintained in widely disseminated 
sites and that the bacilli are seeded to these locations during the early bacteremic 
phase o f initial exposure (Bishai et al, 1998). Apart from pulmonary involvement, 
the most common extrapulmonary locations o f the disease are (in decreasing 
order): pleural, lymphatic, urogenital, osteoarticular, and meningeal tissues—  
although as has been pointed out, any organ or tissue can be affected. In 
immunocompetent patients, the frequency of presentation of extrapulmonary TB 
is no greater than 15 % to 20 %, with this figure increasing in situations of 
immune deficiency, as in the case of patients with AIDS, in whom 
extrapulmonary disease accounts for 50 % to 60 % of all TB cases.
1.7. Microscopic detection of latent TB bacilli.
Bishai et al. make reference to autopsy and surgical investigations into patient 
deaths that were a result o f initial TB infection that failed to reveal, via 
microscopic examination, any acid-fast bacilli (Bishai et al, 1998). Acid-fast 
bacilli are a characteristic bacterial form associated with active infectious TB and 
is a physical property o f some bacteria referring to their resistance to de- 
colorization by acids during staining procedures. Latent bacilli remained acid fast 
but were present in such low numbers that they defied microscopic detection. A
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hypothetical reasoning for this phenomenon is that the bacilli enter a different 
developmental state such that they were no longer acid fast yet still viable.
1.8. Physiological state of the Mtb bacilli during latency.
The physiological state of Mtb bacilli during latency has, as yet, no definitive 
description. One view, in light o f the evidence suggesting that Mtb is in a non­
acid-fast form during latency, along with the presence o f regulatory gene 
homologs o f sporulation (DeMaio et al, 1996) and the ability o f latent bacilli to 
remain essentially invisible to the immune system for such long periods o f time, is 
that they exists in a spore-like state. There is also data suggesting that latent 
bacilli are metabolically active. Trials involving the use of chemoprophylaxis (the 
administration o f an antibiotic agent to prevent an infection or to prevent an 
incubating infection from progressing to disease) have demonstrated that 
asymptomatic, non-infectious individuals have a significantly reduced risk of 
developing reactivation TB when treated with the antimycobacterial drugs 
isonazid or rifampin, as compared with their untreated counterparts (Bishai et al, 
1998).
1.9. Reactivation of latent Mtb.
Work carried out by DeWit et al. utilising a mouse model concluded that the 
irregularities in bacilli numbers recovered (with respect to the Mtb DNA extracted 
from them) relative to the acid-fast forms o f the bacilli seen by microscopy may 
be linked to the possibility that reactivation originates from non-acid-fast forms o f 
Mtb (DeWit et al, 1995). Reactivation o f these latent organisms can also lead to 
post-primary disease, even in people who successfully fought their initial battle 
against Mtb. One o f the major causes o f TB is thought to be through such 
reactivation (Harris, 2001). One in three individuals worldwide has latent Mtb 
infection, with a 5-10 % lifetime risk o f progression to active disease (Bishai, 
2000 and Electronic Source 2, 2002). The cavitary stage (the rapidly growing Mtb 
bacilli from within the Ghon complex), as a result o f reactivation, is the major
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milestone in the development of virulent and drug-resistant strains. The increased 
oxygen concentration within the Ghon complex allows large numbers of the 
organisms to multiply and is the major contributing factor leading to the 
evolutionary steps needed for the development of drug resistant mutants (Nardell, 
1993).
1.10. Treatment regimens for human patients infected with TB.
A number o f antibiotics are effective against tuberculosis. There are ten drugs 
currently approved by the U.S. Food and Drug Administration (FDA) for treating 
tuberculosis. O f the approved drugs, the first-line anti-TB agents that form the 
core of treatment regimens include isoniazid (INH), rifampin (RIF), ethambutol 
(EMB), and pyrazinamide (PZA).
It is common for TB infected individuals to be administered two or more types o f 
antibiotics. This is because treatment with only one drug can sometimes be 
inefficient, resulting in residual bacilli becoming resistant to that drug. This kind 
o f drug resistance attributed to adaptive bacilli to a one-drug regimen is rarely 
found in other bacteria. Often, a third and fourth drug are used during the initial, 
intensive phase o f treatment to shorten the duration o f treatment and to ensure 
success even if  drug resistance exists at the outset (Beer et al, 2003 and Thacker, 
2003).
Tuberculosis bacteria are very slow-growing; the antibiotics must be taken for a 
long time (usually for six months or longer), which includes two treatment phases. 
The ‘initial phase’ lasting two months is followed by the ‘continuation phase’ 
lasting either four or seven months. The continuation phase is normally extended 
to 28 weeks for patients who have cavitation on the initial chest film and positive 
sputum cultures after two months of treatment. Treatment is stopped dependent on 
the number o f doses ingested during the treatment cycle.
Although basic TB regimens are broadly applicable, there are modifications that 
should be made under special circumstances (i.e. HIV infection, drug resistance, 
pregnancy, or treatment o f children fewer than 1 2  years of age). Table 1. 1  lists the 
basic regimens most commonly applied to treat immune-compromised TB 
infected human patients.
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Preferred Regimen Alternative Regimen Alternative Regimen
Initial Phase:
Daily INH, RIF, PZA, and 
EMB for 56 doses ( 8  weeks)
Initial Phase:
Daily INH, RIF, PZA, and 
EMB for 14 doses (2 weeks), 
then twice weekly for 1 2  
doses ( 6  weeks)
Initial Phase:
Thrice-weekly INH, RIF, 
PZA, and EMB for 24 
doses ( 8  weeks)
Continuation Phase:
Daily INH and RIF for 126 
doses (18 weeks) 
or
Twice-weekly INH and RIF 
for 36 doses (18 weeks)
Continuation Phase:
Twice-weekly INH and RIF 
for 36 doses (18 weeks)
Continuation Phase:
Thrice-weekly INH and 
RIF for 54 doses (18 
weeks)
Table 1.1: The basic antibiotic regimens, presented as preferred and alternative treatments, 
implemented on the Initial and Continuation phase strategy of TB treatment.
A continuation phase of once-weekly INH/RIF can be used for HIV-negative 
patients who do not have cavities on the chest film and who have negative acid- 
fast bacilli smears at the completion o f the initial phase o f treatment (Beer et al, 
2003).
1.11. Directly Observed Therapy (DOT).
Many patients find it difficult to remember to take their drugs every day. Other 
people, for various reasons, discontinue treatment as soon as they feel better. 
Because o f these problems, many experts recommend that people with 
tuberculosis receive their drugs from a health care worker under a patient-centred 
case management system. This is called directly observed therapy (DOT). 
Because DOT ensures that the person takes every dose, DOT treatments are often
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less than seven days, with drugs administered two or three times during the seven 
days (Thacker, 2003).
In extreme cases surgery is required to remove a portion o f the lung unless the 
patient faithfully adheres to the drug treatment plan. However, for very drug- 
resistant infections surgery is sometimes needed. When tuberculous pericarditis 
causes significant restriction of the motion of the heart, the pericardium may need 
to be removed surgically. A tuberculoma in the brain may also need to be 
surgically removed (Beers et al, 2003).
1.12. The global plans to control the spread of TB -  targets 2006-2015.
In 2006, the World Health Organisation (W.H.O) launched the new ‘Stop TB 
Strategy’ (Thomas, 2007). The core of the TB control approach is the DOT 
regimen, launched by W.H.O. in 1995. Since its inception, more than 22 million 
patients have been treated under DOT-based services. The six components o f the 
‘Stop TB Strategy’ are summarized in Table 1.2.
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The six components of the ‘Stop TB Strategy’
1. The pursuit of 2. Addressing 3. Contributing to 4. Engaging all care 5. Empowering 6. Enabling and
high-quality DOT TB/HIV, MDR-TB health system providers. people with TB and promoting
expansion and and other challenges. strengthening. communities. research.
enhancement.
The targeting of the poorest Supplementing DOT The implementation of TB To ensure all patients Providing communities While current tools
and most vulnerable implementation with control programmes to receive high-quality care. with the ability to perform can control TB.
individuals for access to individual patient care and oversee spending, regimen requiring the need of all TB control tasks. Thereby improved practices
widely available high- support, essential to and treatment planning. participating health-care mobilizing civil societies and elimination will
quality services where the providing the best patient- together with competent providers. and also ensuring political depend on new
requirement for DOT care possible. and informed management support and long-term diagnostics, drugs and
expansion is needed, even to disseminate information sustainability for TB vaccines.
to the remotest areas. and supply. control programmes.
Table: 1.2: The six components of the ‘Stop TB Strategy' as outlined by the World Health Organisation (W.H.O) in 2006 (Thomas. 2007).
1.13. An outline of this thesis.
TB is an ongoing and continually developing area o f scientific research. With 
many issues concerned with the bacterium’s ability to elicit disease in humans 
with ever more increasing evidence of BCG-vaccination resistance strains, which 
are proving even more difficult to treat with antibiotics, understanding the 
mechanisms that underpin this bacterium’s ever developing advantageous arsenal 
is proving to be a fast developing area o f research. This thesis encompasses 4 
years o f research focused on obtaining structural and biochemical information on 
Mtb protein targets through the application o f nuclear magnetic resonance (NMR) 
spectroscopy and use of various other biochemical techniques.
This thesis is divided into a further seven chapters as follows.
Chapter 2 describes various techniques and protocols applied throughout this 
project.
Chapter 3 describes a review of for the first protein investigated during this Ph.D, 
Mtb thiol peroxidase (TPx wild-type, i.e. TPxWt) (Rvl932), including its mutated 
C —► S variant (TPxC60S). The review will include all up-to-date structural 
research and biochemical details explaining the TPx protein group classification 
and providing a comparative examination into its protein fold. This chapter looks 
at the protein data base (PDB) deposited crystal structures o f TPxWt and 
TPxC60S and outlines the differences that exist between the two proteins. The 
chapter concludes by raising the point that both TPxWt and TPxC60S apparently 
mimic the oxidised and reduced states respectively, which is the result of 
substantial local rearrangement o f secondary structure elements proximal to the 
active site. Such as has been suggested for a homologous peroxiredoxin.
Chapter 4 begins by detailing the early biochemical analyses carried out by 
independent groups to produce the two crystal structures of TPxWt and its 
mutated variant. A look at the two crystal forms and the differences between them 
is developed here in greater detail. ID []H], ['H, 15N]-HSQC and [2 H, 15N, 13C]- 
labelled-HSQC-NMR of TPxWt and TPxC60S is described with reference to the 
spectral differences between the two variants and the impact this had on obtaining
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the back-bone resonance assignment for the Cys60 —► Ser mutant o f TPx, 
TPxC60S.
Chapter 5 describes the efforts applied to resolve issues of incomplete back-bone 
assignment through the use of NMR spectroscopy. These efforts included varying 
experimental conditions such as temperature, sample pH and DTT concentration 
and the use of ligands to stabilise putative dynamic protein motion.
Chapter 6  details a summary discussion and conclusion on the results obtained 
from Mtb TPx during the course of this project and highlights the possible 
avenues o f research that may be undertaken in resolving the issue o f the 
incomplete back-bone assignment of TPxC60S as described in Section 5.
Chapter 7 details the background information for the final protein analysed in this 
thesis; an RNA polymerase sigma factor J (sigJ) (Rv3328c), a protein important in 
Mtb replication most notably in the process o f bacterial transcription. The protein
70family (a  ), and sub-division (ECF) to which sigJ belongs is described, 
highlighting similarities and differences between the various sigma factor groups 
in terms o f the domain homology and organization.
Chapter 8  details the various steps taken to optimize recombinant sigJ expression 
and the examination into low temperature stability. The use o f biochemical 
techniques to investigate the secondary structure of sigJ using circular dichroism 
(CD) and analytical size exclusion chromatography (ASEC) is also described. An 
NMR analysis on sigJ is also discussed with respect to the soluble and refolded 
forms o f the protein in 1D-[!H] and 2D [15N]-HSQC spectra. Chapter 8  concludes 
with details o f the various efforts applied in trying to resolve the ‘poor’ NMR 
spectra o f natively folded sigJ and in the use o f electrophoretic mobility shift 
assays (EMSA) to examine the potential for DNA binding.
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Chapter 2
Materials and Methods
2.1. Chapter summary:
The proteins described in this thesis -  TPxWt, TPxC60S and sigJ -  have all been 
subject to a variety o f experimental protocols and biophysical techniques. In each 
case the methods have been applied in essentially similar ways. Therefore, the 
following gives in-depth details for the experimental methodologies applied 
throughout the course o f this project, indicating where applicable instances where 
the details have varied between the application to TPxWt and TPxC60S. The 
methods include DNA amplification and DNA sequencing preparations, bulk cell 
culture, protein purification and quantitation techniques, secondary structure 
determination and analysis tools which include circular dichroism (CD) and 
nuclear magnetic resonance (NMR) spectroscopy, and a variety o f methods to 
assess potential ligand- or pH-induced structural changes that involve both NMR 
and short-wavelength spectrophotometry. The methods applied using sigJ are also 
presented and include the use of PCR, electrophoretic mobility shift assays 
(EMSA), limited proteolysis experiments and freeze/thaw studies.
This chapter concludes with a look at NMR spectroscopy and some o f the many 
ways in which this powerful technology has been diversified and developed to 
aspects o f protein structure in solution.
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2.2. General chemicals and lab equipment.
Reagents were obtained from either Sigma-Aldrich® or Invitrogen™ unless 
otherwise stated. All solutions were made with the Elga® Maxima Ultra™ pure 
water purification system.
For all centrifugation steps, either bench-top scale or large-preparation culture 
scale, the following centrifuges were used: an MSE® microcentaur™ (all 
microfuge tubes); Eppendorf™ 5810 or Heraeus® Labofuge™ 400R (15 mL and 50 
mL Falcon™ tubes); and Sorvall® RC5B centrifuges (e.g. 1L bottles).
All protein concentration steps were performed with Amicon® Centriprep®, or 
Vivaspin6 ® and Vivaspin5000® sample concentrators.
Sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed using Invitrogen™ pre-cast 1.0 mm, 15 well NuPAGE™ Novex® 4-12
TM
% Bis-Tris Gels. Electrophoresis was carried out in an Xcell SureLock Mini- 
Cell. Samples were prepared and loaded onto the gel according to the 
manufacturer’s protocol for denaturing reduced samples. 10 pL (including 2 pL 
loading buffer) o f sample was loaded into each gel-well following a period of 
heating for 5 mins at 100 °C (Invitrogen™ NuPage™ Technical Guide). Gels were 
stained using Coomassie blue (see Recipe 1) for 45 mins.
Recipe 1: Coomassie blue stain ingredients.
0.25 g Coomassie blue powder
75 mL Glacial acetic acid
500 mL 95-100 % ethanol
Double distilled water (ddFUO) added to total volume of 1 L.
Following electrophoresis the gels were drained and left in destaining solution (10 
% ethanol, 7.5 % acetic acid, made up with ddFfO) for 30 mins on a bench-top 
orbital shaker, before imaging. Imaging was carried out using an UVi DOC™ gel 
documentation system.
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Protein concentrations were established using a Biomate-4™ spectrophotometer at 
280 nm in a 1 mL quartz cuvette. Readings for each protein sample were taken 
twice, using two different dilutions. Protein dilutions were chosen to give an 
absorbance at 280 nm measurement between 0.01 and 0.5 to reflect the accurate 
dynamic range o f such a measurement. Protein concentrations were calculated 
using the Beer-Lambert law, stating that the absorbance = e.c.l (where / is the 
path length, c is the protein concentration, and e is the molar extinction 
coefficient). The theoretical extinction coefficients at 280 nm were obtained from 
the Expasy® Protparam tool (Gill and von Hippel, 1989), predicted for each 
protein using its primary amino acid sequence.
For preparative and analytical size exclusion chromatography an AKTA™ 
purification system was used. For the preparative size exclusion chromatography 
a Superdex™-75 column (Amersham® Biosciences) was employed; an analytical- 
Superdex™-75 was used for the analytical size exclusion chromatography.
In this thesis all references to the genetic code and amino acid nomenclature 
during this project are made in accordance with the details listed in Appendices 
A l and A3.
2.3. General protocols.
The two main proteins described in this thesis, TPxWt and TPxC60S (including 
sigJ), were prepared from E .coli cells (BL21 -  Invitrogen™) transformed with the 
pET22B(+) plasmid (Novagen®) containing the relevant cDNA insert in frame 
with the T7 promoter and including the lac repressor and ampicillin and 
kanamycin resistance genes. All proteins expressed contain an N-terminal 
polyhistidine (6 -His) affinity tag. The details o f the vector used and the relevant 
insert location for each of the proteins used in this project, including amino acid 
sequence, are provided in Appendices A2-A4 and A9. The German Research 
Centre for Biotechnology (GBF) supplied sigJ-, TPxWt- and TPxC60S-expressing 
cells on Luria broth (LB) agar. As is good practice, before expression o f the 
protein we took steps to check the gene inserts by amplifying the relevant plasmid
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DNA for nucleotide sequencing. For the sake of completeness this procedure is 
described below in Sections 2.3.1-2.3.1.3.
Cells from each plasmid were streaked individually onto an LB prepared agar 
plate (see Recipe 2), treated with the appropriate antibiotic, and incubated 
overnight. The resulting colonies were picked and again grown overnight in liquid 
culture in antibiotic-treated LB. Glycerol stocks were subsequently prepared (1 
mL volume and 10 % glycerol v/v) and stored at -80 °C.
Recipe 2: Luria-Bertani (LB) media.
For 1 L o f medium in double-distilled water (ddFLO)*:
5 g Yeast extract
5 g Sodium chloride (NaCl)
1 0 g T ryptone
* 1 L sample subsequently autoclaved and treated with the appropriate antibiotic
(1 mL from a lOOOx stock).
2.3.1. DNA sequencing - sample preparation.
The following (sections 2.3.1.1-2.3.1.4) describes the methodology applied in 
obtaining an isolated plasmid, containing the DNA coding region o f the protein of 
interest, required for subsequent nucleotide sequencing.
2.3.1.1. Plasmid extraction.
A 250 pL volume o f  BL21 (DE3) E. coli cells harbouring the desired expression 
vector were added to 25 mL antibiotic-treated LB (100 mg/mL carbenicillin - an 
analogue o f ampicillin with increased stability) and incubated at 37 °C in a 
mechanical shaker overnight. The cells were spun down to a pellet in a bench-top 
centrifuge at 3500 rpm for 10 mins. The supernatant was discarded and the 
plasmid vector was isolated from the cells using a Qiagen® Qiaprep Spin 
Miniprep kit in accordance with the supplied protocol.
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2.3.1.2. Plasmid identification and transformation.
Because recovery o f plasmid DNA from BL21 (DE3) cells is known to be 
inefficient, amplification in a separate non-expression strain is typically required 
prior to DNA sequencing. Thus positive identification for the presence o f a BL21 
(DE3)-derived plasmid putatively containing the protein-encoding DNA insert 
was obtained by 0.75 % agarose gel electrophoresis (see Recipe 3), with and 
without restriction endonuclease digestion (see Recipe 4). The small amount of 
vector was transformed into E. coli DH5a cells (Invitrogen™) by means of heat- 
shock treatment and spread onto a solid LB-agarose plate. The plate was then 
incubated at 37 °C overnight.
Recipe 3: Agarose gel electrophoresis (0.75% agarose):
0.375 g molecular grade agarose was dissolved into 50 mL TAE buffer (see 
Recipe 5) and poured into 5x6 cm gel mould with a 20 pL comb in place, and left 
to set for 30 mins.
DNA samples for electrophoresis were prepared by adding 5 pL o f sample to 2 
pL bromophenol blue (1:1 ratio glycerol: water and bromophenol blue sodium 
crystals to give opaque brown) -  migrates at same rate as 200-400 bp nucleic acid. 
Glycerol adds density to make sample sink to bottom of well. An additional 
sample o f DNA marker was made; 3 pL 1 Kb DNA marker to 2 pL bromophenol 
blue. All references to DNA ladder refer to the 1 kDa DNA ladder obtained from 
Invitrogen™ composed o f 12 DNA fragments ranging from 1,018 bp to 12,216 
bp. The prepared gel was then submerged in the centre of the electrophoresis gel 
tank containing TAE buffer and the prepared samples, including DNA marker 
were subsequently loaded.
Electrophoresis at 50 V was then carried out and stopped once the dye front 
reached three quarters down the length o f the gel. Staining o f the gel was done 
with ethidium bromide for 30 mins, washed with ddEEO, and imaged under long­
wave ultra-violet (UV) light.
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Recipe 4: Restriction endonuclease reaction:
Hindlll reagent (1 pL HindiII enzyme, 2 pL Hindlll buffer, 7 pL ddH2 0 ) was 
added to 10 pL plasmid vector and incubated in a 37°C water bath for 1 hour 30 
mins, before cooling on ice. The resultant samples were then analysed by agarose 
gel electrophoresis (Recipe 3).
Recipe 5: TAE (Tris Acetate EDTA) buffer -  50x:
For 1 L buffer:
242 g Tris base
57.1 mL Acetic acid
100 mL 0.5 M EDTA
ddl-EO added to 1 L and pH adjusted to 8.5.
2.3.1.3. Transformation by heat shock protocol.
50 pL o f E. coli DH5a cells was pipetted into each of 2 Eppendorf^ tubes 
labelled: + (nuclease reaction) and -  (control). 5 pL of isolated plasmid DNA was 
then added to the + Eppendorf™ tube and left on ice for 30 mins. Both 
Eppendorf™ tubes were then placed in a pre-set 42°C water bath for 60 seconds 
and then transferred onto ice for 2 mins. 250 pL o f LB (no antibiotic included) 
was then added to each tube, which were then placed into a pre-set 37 °C water 
bath for 1 hour. 50 pL from each Eppendorf^ tube was then spread onto a 
separate LB-agarose plate. The plates were then left to incubate at 37 °C 
overnight.
2.3.1.4. Plasmid extraction from DH5a cells.
A colony was picked and grown up as before, but this time in two separate falcon 
tubes containing LB medium. A Qiagen® miniprep was carried out on one batch 
o f cells and the other was stored at -80°C in cryo-vials™ with 10 % v/v glycerol
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added for future use. The plasmid DNA was incubated on the kit miniprep spin 
column for 5 mins before being eluted with water. A restriction endonuclease 
digestion was performed and a DNA gel was run to ensure correct plasmid 
purification. The purified plasmid DNA was submitted for forward and reverse
TMinsert sequencing by the external company, MWG-Biotech using standard T7
TM
promoter and terminator oligonucleotide primers (supplied by MWG-Biotech ). 
The standard genetic code and nucleotide/amino acid sequences o f TPxWt and 
TPxC60S are provided in Appendices A l, A3, and A4 respectively and Appendix 
A9 for sigJ. A translation of the amino acid abbreviations is also provided in 
Appendix A5.
2.3.2. Bulk protein production by Escherichia coli cell culture.
The following describes procedures adopted for the preparation o f milligram 
quantities o f TPx and sigJ proteins for NMR and other studies.
As a generic first step 250 pL o f expression strain BL21 (DE3) E. coli cells from 
glycerol stocks were incubated and shaken overnight at 37 °C in 25 mL 
ampicillin-treated LB media.
2.3.2.I. Unlabelled protein.
The initial 25 mL culture was scaled-up to three litres of LB medium by the 
addition o f 4 mL to each of 6  x 500 mL media in autoclaved, baffled conical 
flasks. (No intermediate culture size was required due to rapid E. coli growth in 
LB media.) Alternatively, for smaller scale cultures, i.e. 1 L preparations, 8  mL 
was added to 2 x 500 mL media in autoclaved, baffled conical flasks.
2.3 .2 .2 .15N-labelled protein.
For the generation o f single isotope-labelled protein 2 mL of the initial 25 ml LB 
culture of the E. coli expression strain was removed and added to 100 mL o f feed 
source loaded minimal M9 media (see Recipe 6 ) containing 99 % 15N-ammonium
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sulphate (Cambridge Isotopes™). The culture was then incubated with shaking 
overnight at 37 °C. 4 mL aliquots o f this starter culture were added to each of six 
baffled conical flasks containing 500 mL labelled M9 media (total culture 
volume: 6  L)
Recipe 6 : M9 minimal media ingredients**.
For 1 L o f medium in ddLLO*:
6 . 0  g NaH2 P 0 4
3-0 g k 2 h p o 4
0.5 g NaCl
l.Og (NH4 )2 S 0 4*
Feed source added:
2 mL 1 M MgCl
10 pL 1 M CaCl2
1 mL 0.01 M FeS0 4
1 mL 1000 x Vitamins (see Recipe 7)
1 mL 1000 x Micronutrients (see Recipe 8 )
1 mL 1000 x Carbenicillin
10 mL 20 % w/v Glucose*
* Isotope-labelling for NMR spectroscopy was obtained by replacing (NH4 )2 S 0 4
with ( 15NH4 )2 S0 4, glucose with 13C6 -glucose, and ddFLO with 2 H20  (D20 )  as
appropriate.
** The media was sterilised by autoclaving prior to the addition o f the feed source
components.
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Recipe 7: M9 Vitamins.
1000 x Vitamins solution/L:
0.4 g Choline chloride
0.5 g Folic acid
0-5 g Pantothenic acid
0-5 g Nicotinamide
1 - 0  g Myo-inositol
0-5 g Pyridoxal HC1
0-5 g Thiamine HC1
0.05 g Riboflavin
l.Og Biotin
Recipe 8: M9 micronutrients.
1000 x micronutrient solution/L:
3 pM Ammonium molybdate
400 pM H 3 B O 3
30 pM CoCL
10 pM C uS0 4
80 pM MnCL
10 pM Z nS0 4
2.3.2.3. [15N, 13C, 2H]-labelled protein.
For the generation o f triple isotope-labelled protein 2 mL o f the initial 25 ml LB 
culture of the E. coli expression strain was removed and added to 100 mL of feed 
source loaded minimal M9 media (see Recipe 6 ) containing 99 % 15N-ammonium 
sulphate and 13C6 -glucose (Cambridge Isotopes™) prepared in 99 % D2O (Goss 
Chemicals™) . The culture was then incubated with shaking overnight at 37 °C. 4
- 4 4 -
mL aliquots of the overnight starter culture were added to each o f four baffled 
conical flasks containing 500 mL labelled M9 D2O media (total culture volume: 2 
L ).
2.3.2.4. Induction of protein expression.
Large-scale cultures were carried out in a mechanical shaker operating at 37 °C. 
Protein expression was induced with 1 mM isopropyl P-D-l- 
thiogalactopyranoside (IPTG) (600 pL per 500 mL culture volume) once the 
optical density recorded at 600 nm (OD6 0 0) had reached between 0 . 6  and 0 .8 . 
Expression was carried out for 12 hours for the single 15N-labelled cultures and 
for 2 0  hours for the triple isotope-labelled culture.
2.3.2.5. Harvesting and homogenisation.
Following induction, cells were harvested by centrifugation for 20 mins at 6000 
rpm. Protein expression was assessed by SDS-PAGE (methodology as described 
previously). The proteins o f interest were expressed in the cytoplasm; thus the 
supernatant was subsequently removed and retained for sterilization and 
subsequent disposal, and the cell pellet retained for further processing. For 
purification the cell pellet were then removed from the centrifuge tube and re­
suspended in 15 mL aliquots of PBS buffer (see Recipe 9).
Recipe 9: PBS Buffer.
For 1L buffer in ddH2 0 :
8 g NaCl
0 . 2 0  g KC1
1.44 g NaH2 P 0 4
0.24 g K2HPO4
Buffer adjusted to pH 7.4 and autoclaved.
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The suspension was passed through a French Press (American Instrument 
Company™), five times, at a pressure o f 1000 psi. The resultant liquid, containing 
ruptured cells, was centrifuged at 15000 rpm for 40 mins. The pellet fraction was 
sterilized and subsequently discarded, whilst the supernatant was retained for 
further fractionation as described in Section 2.3.3.
2.3.3. Ni-NTA affinity chromatography.
Uncharged nickel-nitrilotriacetic acid (Ni-NTA) agarose beads (Qiagen®) were 
prepared as follows: fresh resin was washed three times with 10 mL ddFLO then 
incubated with 10 mL of 100 mM NiSC>4 for 30 mins to charge the matrix with 
nickel(II) ions. The charged resin was then washed three times with 10 mL ddFLO 
before being equilibrated in 10 mL elution buffer (Recipe 10). Between each 
washing step the resin was centrifuged for 3 mins at 1250 g and the supernatant 
carefully removed and discarded.
The clarified cell supernatant was added to 5 mL Ni-NTA agarose beads in a 50 
mL Falcon tube and rolled for 1 hour and 30 mins. The resin was pelleted by low 
speed centrifugation. Sequential washes o f the protein-bound resin were 
performed using ten different elution buffers containing increasing concentrations 
o f imidazole (see Recipe 10). Imidazole competes with the 6 -His tag o f the target 
protein for Ni-NTA binding and results in the eventual elution o f the protein from 
the Ni-NTA beads. For each wash step the Ni-NTA resin was left to incubate at 
4°C on a mechanical roller for 5 min before being centrifuged at 3000 rpm for 5 
mins and the liquid above the settled beads subsequently removed and stored for 
further analysis.
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Recipe 10: Affinity chromatography elution buffers.
For 1 L o f each buffer in ddFFO:
6.90 g 50 mM NaH 2 P 0 4
5.84 g 100 mM NaCl
0.154 g 1 mM DTT
0.037 g 0.1 mM EDTA
0.292 g Imidazole (Buffer A)
29.2 g Imidazole (Buffer B)
Elution buffers comprised different proportions o f stock phosphate buffers, buffer 
A (5 mM imidazole) and buffer B (500 mM imidazole). pH adjusted to 7.4.
Elution buffer Buffer A (v/v) Buffer B (v/v)
E2 1 0 0 % 0 %
E2.5 90% 1 0 %
E3 (applied twice) 80% 2 0 %
E3.5 70% 30%
E4 (applied twice) 60% 40%
E5 40% 60%
E 6 2 0 % 80%
E7 0 % 1 0 0 %
50 mL of elution buffers made up in 50 mL Falcon tubes.
Wash fractions were assessed by SDS-PAGE and those which contained the 
protein o f interest were concentrated to a final volume o f 5 mL using a 
Vivaspin5000® molecular weight cut-off tube centrifuged at 3500 rpm.
2.3.4. Size exclusion chromatography.
Preparative scale size exclusion chromatography (SEC) was carried out using an 
Amersham Biosciences Superdex™-75 HR16/70 column in conjunction with an 
AKTA™ Purifier 10 system o f the same manufacturer. The column was
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equilibrated with 2.5 column volumes (-300 mL) o f SEC phosphate buffer (see 
Recipe 11) using a method file constructed using the UNICORN™ software 
provided with the AKTA™ system.
The concentrated protein sample was injected (5 mL) and the column was washed 
with 2.5 column volumes SEC buffer at a flow rate o f 0.5 mL/min, collecting 5 
mL fractions. The column eluate was continuously monitored by UV absorption at 
260 nm and 280 nm.
Fractions giving UV absorbance at 280 nm were run on an SDS-PAGE gel. The 
fractions containing the protein o f interest were pooled and concentrated to 500 
pL using a Vivaspin5000® molecular weight cut-off tube centrifuged at 3500 rpm.
Recipe 11: SEC phosphate buffer.
For 1 L o f each buffer:
6.90 g 50 mM NaH 2 P 0 4
5.84 g 100 mM NaCl
0.154 g 1 mM DTT
0.037 g 0.1 mM EDTA
Made up to 1 L with ddH20  and pH adjusted to 7.4.
2.3.5. Analytical size exclusion chromatography.
Analytical SEC was performed using a 10/30 Superdex-75 column (Amersham 
Biosciences) connected to an AKTA™ Purifier 10 system. 100 pL o f sample was 
injected and eluted at a flow rate of 0.5 ml/min using the SEC buffer (Recipe 11). 
Protein elution was monitored by UV absorption at 260 nm and 280 nm. For 
assessment o f TPx proteins the chromatogram was separately recorded for four 
different dilutions o f the stock protein solution in SEC buffer: undiluted (ca. 6  
mM), 1-in-2, 1-in-4, and l-in - 6  (1 mM).
Note: Ion exchange chromatography (IEC) was performed using an XK 16/0 Q- 
Sepharose™ column (Amersham Biosciences) connected to an AKTA™ Purifier
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10 system. The column was run in a similar manner to the SEC column with 
Recipe 11 being the basis for two buffers with varying salt concentration (200-650 
mM) to create a linear elution gradient.
2.3.6. Circular dichroism spectropolarimetry.
Circular dichroism spectropolarimetry (CD) was performed on an Aviv™ Model 
62DS CD spectrophotometer equipped using a thermoelectric cell holder and with 
a Hamilton™ microlab™ 500 series automatic titrator. Far-UV CD spectra were 
collected from 210 nm to 310 nm using a 1 mm path-length cell and a 3 second 
averaging time. Thermal unfolding data were collected at 222 nm from 20 °C to 
95 °C. Samples were placed in a 2 mm path-length cuvette and heated in 
increments o f 1 °C, using an equilibration time o f 1 min and a 5 second 
measurement averaging time. Protein concentrations were kept constant at 40 pM, 
unless otherwise stated.
All CD measurements were corrected by subtracting the buffer spectra prior to 
conversion to molar ellipticity. All experiments were carried out in the same 
buffer at pH 7.4, unless stated otherwise: 50 mM NaH2PC>4 , 50 mM NaCl, 1 mM 
DTT and 0.1 mM EDTA. Data was processed using Aviv™ Software Systems 
V2.76. Data fitting o f the CD thermal titration data was performed using Origin™ 
v5.0 from Microcal™ inc. USA.
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2.3.7. Nuclear magnetic resonance spectroscopy.
The following (Sections 2.3.7.1-2.3.7.6 ) describes the methodology applied in 
producing a protein sample o f adequate concentration fit for analysis by NMR 
spectroscopy. A brief description of the various NMR-based experiments is also 
provided below.
2.3.7.1. Sample preparation.
500 pL o f protein sample was transferred to a 5 mm NMR tube and 50 pL of 
deuterium oxide (D2O) was added. The addition o f 10 % v/v D2 O provides a 
reference signal for the spectrophotometer field-frequency lock system.
2.3.7.2. NMR spectrometers.
NMR spectroscopy was carried out using Varian UnityPLUS™ spectrometers 
operating at nominal !H frequencies o f 500 MHz and 600 MHz, each equipped 
with a triple resonance Z-axis pulse field gradient (PFG) probe and four radio 
frequency channels. Experiments were carried out at 25 °C, unless otherwise 
stated.
2.3.7.3. Two-dimensional [*11, lsN]-heteronuclear single quantum coherence 
spectroscopy.
Two-dimensional (2D) ['H^NJ-heteronuclear single quantum coherence (HSQC) 
spectroscopy was carried out using a pulse sequence with combined gradient 
coherence selection and sensitivity enhancement elements (Kay et al, 1992). 
Solvent peak suppression was carried out by using low power water flip-back 
pulses (Zhang et al, 1994). All experiments performed on the UCL NMR 
spectrometers were previously adapted from cited pulse sequences by staff 
members and were set up according to the standard guidance of Dr. R. Harris. All
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spectra were recorded with 1024 complex points in the direct dimension and 1 GO- 
256 complex points in the indirect dimension (unless otherwise stated). On the 
500 (600) MHz spectrometer, frequency sweep widths of 4000 (4200) Hz in the 
fH direct and 1650 (2000) Hz in the 15N indirect dimensions were employed (*H 
transmitter set to the middle o f the NH region o f the spectrum). The number of 
scans recorded for each ti increment was varied depending on the protein 
concentration. ‘Folded-in’ or aliased signals such as those arising from arginine 
side chain NH groups were identified by manipulation o f the ‘fl 180 flag’ macro 
(developed in-house by Dr. R. Harris). The macro can be set to manipulate the ti 
increment timing and thereby the first order phase correction in the indirect 
dimension, such that the aliased peaks appear either in-phase (positive; fl 180 = 
’n ’) or 180° out o f phase (i.e. negative; f l l8 0 = ,y’), was used with all HSQC 
experiments to ‘fold in’ Arg residues that would otherwise be located beyond the 
display parameters for most HSQC spectra during data processing.
2.3.7.4. Chemical shift perturbation analysis by [*H, 15N]-HSQC NMR  
titrations.
All ligands used for the titration experiments were purchased from either Sigma- 
Aldrich™ or Invitrogen™ and were all supplied as lyophilised powders which were 
dissolved into solution using the following buffer made up in ddH2 0 : 50 mM 
NaH2 PC>4 , 100 mM NaCl, 1 mM DTT (unless otherwise stated) and 0.1 mM 
EDTA, pH 7.4.
The interactions o f the TPx proteins with putative ligands was assessed by NMR- 
based titrations using 2D [!H,15N]-HSQC spectroscopy using spectrometer 
parameters identical, or very similar to those described above. The temperature 
was kept constant at 25 °C and the sample pH maintained, before and after the 
addition o f each aliquot o f a given ligand, at pH 7.4. The experimental details for 
the titration series performed are listed in Table 2.1.
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Table 2.1: Details of the NMR titration experiments performed with various proteins and ligands.
Ligand used Supplier Protein used 
{Mtb)
Total protein 
concentration1 
(mM)
Max. ligand 
concentration2 
(mM)
Titration
points3
% Protein 
dilution4
DTT
concentration5
(mM)
(CH3C00)2Mg.4H20  
(Magnesium Acetate)
,  I'M
Invitrogen TPxC60S and 
TPxWt
0.50 2 0 0 . 0 0 4 1 0 1 . 0 0
4, 4 ’-dithiodipyridine 
(DTDP)
Sigma-
Aldrich™
TPxC60S 1 . 0 0 4.60 7 1 2 0 . 0 0
2 -[(2 ,6 -dichlorophenyl) 
amino] benzeneacetic acid 
(Diclofenac sodium salt -  
“compound-40”)
Sigma-
Aldrich™
TPxC60S 1 . 0 0 4.00 8 1 0 1 . 0 0
Key: 1 : Refers to the protein concentration prior to the first titration point, 2: refers to the maximal concentration of ligand reached after the final titration point, 3: refers to 
the number of titration points acquired, 4: refers to the % of protein diluted following the final titration point, 5: refers to the total DTT concentration in the sample during the 
titration experiment.
2.3.7.5. 2D [*H, 15N]-transverse relaxation optimised spectroscopy.
2D [’H, 15N]-transverse relaxation optimised spectroscopy (TROSY) (Pervushin 
et al., 1997), including WATERGATE solvent suppression, followed an in-house 
implementation by Dr. R. Harris o f the pulse sequences downloaded with 
permission from Prof. L. E. Kay (http://pound.med.utoronto.ca/pulse_reg.html) at 
the University o f Toronto, Canada. All TROSY-based NMR experiments were 
carried out on the 600 MHz spectrometer. Acquisition parameters were essentially 
identical between the HSQC and TROSY experiments with the frequency sweep 
widths o f 4200 Hz in the ]H direct, and 2000 Hz in the 15N indirect, dimension. 
The number o f scans per increment varied depending on the protein concentration.
2.3.7.6. NMR triple resonance experiments for sequence specific resonance 
assignment.
A 1 mM [2 H, 13C, 15N]-TPxC60S sample (pH 7.4) was used for all heteronuclear 
2D and 3D NMR experiments and recorded at 25 °C at a proton frequency o f 500 
MHz. The following experiments were obtained with locally implemented 
‘standard’ pulse sequences: HNCA, HNCO, HN(CO)CA, HNCB, HN(CA)CB 
and CB(CACO)NH (Yamazaki et al, 1994A). The acquisition parameter details 
for each experiment are listed in Table 2.2.
Combined analysis o f these 3D spectra allowed the correlation o f N and HN with 
CO, Ca and C(3 chemical shifts, to identify connected amino acid segments. The 
Ca and C|3 chemical shift distributions o f each residue type, coupled with the 
probabilistic method set-up by Grzesiek and Bax (Grzesiek and Bax, 1993) 
facilitated the identification of connected spin systems with corresponding regions 
o f the target amino acid sequence, thereby yielding sequence-specific resonance 
assignments. Section 2.10 details the general practical aspects of the assignment 
process while Section 4.6 describes the results o f the application o f this procedure 
to Mtb TPxC60S.
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Experiment Points Sweep Width Points Sweep Width Points Sweep Width Transients
HSQC 1024 (116 ms) 4400 N/A N/A 256(150 ms) 1700 8
HNCA 1024 (116 ms) 4200 64 (18 ms) 3600 32 (19 ms) 1700 8
HN(CO)CA 1024 (116 ms) 4200 64 (18 ms) 3600 32 (19 ms) 1700 8
HNCB 1024 (116 ms) 4200 64 (9 ms) 7100 32 (19 ms) 1700 16
HN(CA)CB 1024 (116 ms) 4200 64 (9 ms) 7100 32 (19 ms) 1700 16
CB(CACO)NH 1024 (116 ms) 4200 64 (8.5 ms) 7500 32 (19 ms) 1700 1 2
HNCO 1024 (116 ms) 4200 64 (27 ms) 1800 32 (19 ms) 1700 8
Table 2.2: Experimental details of 2D and 3D NMR experiments applied upon Mtb TPxC60S at 25°C using; Varian UnityPlus™ spectrometers operating at a ’H frequency of 
500 MHz.
2.3.8. Processing NMR data.
All raw NMR data were processed using the nmrPipe program o f Delaglio and co­
workers (Delaglio et al, 1995). Standard manipulations of data sets included application 
of apodization functions, zero-filling to the nearest 2n points, Fourier transformation, 
first and second order phase corrections, and base-line corrections. The precise 
processing steps varied between data sets. Processed spectra were initially visualised in 
nmrDraw™ (Delaglio et al, 1995).
Following processing, spectra were exported into AZARA (Boucher, 2002) format. 
Multiple spectra were visualised and referenced in PLOT2 (Boucher, 2002). The 
sequential resonance assignment was performed using the ANSIG™ analysis package 
(Kraulis, 1991) using the contour and cross peak files generated in AZARA.
2.3.9. Measurement of protein sulfhydryls by reaction with DTDP.
The thiol group-reactive compound 4, 4 ’-dithiodipyridine (DTDP) was used in a series 
of titration experiments with TPxC60S monitored by NMR spectroscopy with 
concurrent UV/visible spectral analysis by absorbance changes at 250 nm and 324 nm 
(see Chapter 5). In the latter case the method described below was to quantify the 
number o f reacting thiol groups within a given protein sample.
First, 5 g DTDP was mixed into 200 mL o f 50 mM Na2HPC>4 , 100 mM NaCl, and 0.1 
mM EDTA (pH 7.4) and allowed to stir over-night. The concentration o f the dissolved 
mixture was then checked in a 1 mL quartz cuvette in Biomate-4™ spectrophotometer, 
using the same buffer as a blank. Using the Beer-Lambert law and an extinction 
coefficient o f 21400 M ' 1 cm*1, the final concentration o DTDP was assessed to be 140 
mM. This stock solution was diluted as required.
To a 1 mM TPxC60S NMR sample, containing no dithiothreitol (DTT), DTDP was 
added sequentially to yield the following final concentrations: 200 pM, 400 pM, 1000 
pM, 1600 pM, 2600 pM, 3600 pM and 4600 pM. Small aliquots (20 pL) were 
withdrawn from the NMR sample and analysed on the Biomate-4 spectrophotometer at 
two wavelengths -  250 nm and 324 nm -  to determine the extent of DTDP reaction. The 
two wavelengths correspond to the intact DTDP chromophore, absorbing at 250 nm, 
and the free reacted by-product (4-thiopyridone) absorbing at 324 nm.
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The following equation was used to estimate the number o f reacting thiol groups for the 
targeted protein (Riener et al, 2002):
molSH (in 0.00105 L) = ( A3 2 4S -  A3 2 4r -  A3 2 4P) / (AE324 * 1 cm)
Where:
A 3 2 4S -  A3 2 4r -  A32 4P yields the difference in absorbance due to reacted DTDP 
devoid o f systematic errors;
A3 2 4S = absorbance reading o f 1 ml 40 pM protein plus 50 pL 0.5 mM DTDP 
read against H2 O;
A3 2 4r = absorbance reading o f 1ml protein buffer plus 50 pL 0.5 mM DTDP read 
against H2 O;
A3 2 4P = absorbance reading o f 1ml 40 pM protein plus 50 pL H2 O read against 
H2 O; and
A8 3 2 4  = 21,400 M^cnT1 (effective molar absorptivity change upon reaction of 
cysteine with DTDP at pH 7.0; Riener et al, 2002).
The result o f this calculation was normalised to the protein concentration determined by 
absorbance at 280 nm, using the predicted extinction coefficient as described above.
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2.4. Polymerase chain reaction (PCR).
PCR mixtures (Recipe 12) were prepared on ice in thin-walled 200 pL PCR tubes: 
Recipe 12: PCR reaction mixture.
Mixture component: Amount added
Plasmid DNA template (50-100 ng) 30 pL
dNTP1 mix (2 mM) 15 pL
5’ primer (1 mM) 10 pL
3’ Primer (1 mM) 10 pL
Pfu1 DNA polymerase (80 pM) 3 pL
1 Ox Pfu buffer2 10 pL
ddH20 To a final volume o f 100 pL
1. An equimolar mixture o f dATP, dCTP, dTTP and dGTP (Promega™) 
2. Obtained from Promega™
PCR was carried out using a Primus™ thermocycler (MWG-Biotech™). The heating 
block o f the thermocycler was pre-heated to 95 °C and the PCR samples added to the 
block straight from ice (a technique known as ‘hot start’ PCR) to improve the efficiency 
o f the initial primer annealing event.
Samples were subjected to 30 rounds o f thermal cycling (95 °C for 30 seconds, 95 °C 
for 30 seconds and 72 °C for 90 seconds) to amplify the required stretch o f DNA.
All DNA was purchased from Invitrogen™ unless otherwise stated.
2.4.1. Primer sequences used.
HNS-Salmonella Typhimurium 300 bp-DNA stretch amplification,
Forward primer: 5’ ATGAGCGAAGCACTTAAAATTCTGA 3’
Reverse primer: 5’ TCAGAATTTTGAATGCTTCTCGCAT 3’
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Upstream 300 bp-DNA sequence from sigF-Mtb amplification,
Forward primer: 5’ GGATTTCGACGCCGTGGCCGACCTG 3’
Reverse primer: 5’ CAGGTCGGCCACGGCGTCGAAATCC 3’
4 DNA constructs, OLR’s (Overlapping Region), were then made from the 300 bp 
upstream DNA sequence from sigF-M/6.
OLR1; 1 -  200 bp of 300 bp upstream DNA sequence from sigF -Mtb,
Forward primer: 5’ GGATTTCGACGCCGTGGCCGACCTG 3’
Reverse primer: 5’ GCGGTCAGGACATGCCAGCTAAAGC 3’
OLR2; 100 -  300 bp of 300 bp upstream DNA sequence from sigF-M/6,
Forward primer: 5’ CCGGATGCCACCCTGCGCCTGGTGG 3’
Reverse primer: 5’ GCGGTCAGGACATGCCAGCTAAAGC 3’
OLR3; 1 -  120 bp o f 300 bp upstream DNA sequence from sigF -Mtb,
Forward primer: 5’ GGATTTCGACGCCGTGGCCGACCTG 3’
Reverse primer: 5’ ACTTCGTCTTTTCGCGGATCGACCA 3*
OLR4; 80 -  200 bp o f 300 bp upstream DNA sequence from sigF -M/6,
Forward primer: 5’ CCCGGTTGATTCGCTCGGCCTTGCC 3’
Reverse primer: 5’ GCGGTCAGGACATGCCAGCTAAAGC 3’
2.5. Electrophoretic mobility shift assay (EMSA) experiments.
These experiments were carried out using DNA from two sources: 300 bp DNA 
sequence upstream of sigF (M/6) (amplified and isolated from genomic Mtb DNA using 
a Midi-prep® gel extraction kit obtained from MWG-Biotech™ and carried out using the 
recommended protocol provided), and 300 bp fragment of Salmonella Typhimurium 
HNS (obtained from an in-house source). OLR fragments 1-4 were also used in the 
same manner described below. For the EMSA experiments carried out, 6 % agarose 
Novex® DNA precast retardation gels were used. From a 1 mM stock o f sigJ, six 
dilutions were made; 1 mM, 0.8 mM, 0.6 mM, 0.5 mM, 0.4 mM, 0.3 mM and 0.1 mM.
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The DNA concentration used for addition to each sample o f the seven different protein 
concentrations was kept consistent (~40 ng/pL). Therefore the following initial scale 
volumes used for the PCR reaction mixtures are, sigJ (5 pL), DNA (5 pL), ddfbO  (2 
pL), and loading dye (bromophenol blue -  Invitrogen™) (3 pL) made up the final 
volume (15 pL) for each reaction mixture added to the 6 % agarose gel. A 1 Kb DNA 
ladder was also run concurrently with the samples already added to the 6 % agarose gel. 
A control o f only DNA and no protein present was also run, with the protein replaced 
by 5 pL o f ddfhO  in the final volume. Electrophoresis was carried out in an Xcell 
SureLock™ Mini-Cell at 50 V with variable amplitude for 3 hours in TBE buffer 
(Recipe 13). At this point the dye-front would have reached almost 1 cm before the end 
o f the gel. The gel was then placed in ethidium bromide for staining for 10 mins and 
then visualised under UV detection.
Recipe 13: Tris-Borate-EDTA (TBE) buffer.
lOx Tris-Borate-EDTA (TBE):
Component: Amount added:
Tris base 108 g
Boric acid 55 g
Na4EDTA 9.3 g
Made up to 1 L using ddEhO; no pH adjustment required
2.6. Limited proteolysis.
Initially a ‘range finding’ experiment is conducted with differing protease enzymes at 
varying dilutions to determine the best protease type and concentration to use in the 
following ‘time course’ experiment.
All proteases were obtained from Sigma-Aldrich® and made up to 1 mg/mL in the 
manufacturer’s recommended buffers (Recipe 14) and freeze-dried in liquid nitrogen. 
The subsequent samples are then kept frozen at -80 °C.
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Recipe 14: Proteases (Sigma-Aldrich®) and the buffers used:
Storage and dilution buffer:
Protease: Final concentration and storage buffer:
Chymotrypsin 1 mM Tris, pH 8.0
Trypsin 1 mM HCL
Elastase 1 mM HCL
2.7. Limited proteolysis ‘range finding’ experiment.
Final sample concentrations and dilutions o f proteases used:
- Chymotrypsin 1 mg/mL (1:1), 0.1 mg/mL (1:10), 0.01 mg/mL (1:100)
- Trypsin 1 mg/mL (1:1), 0.1 mg/mL (1:10), 0.01 mg/mL (1:100)
- Elastase 1 mg/mL (1:1), 0.1 mg/mL (1:10), 0.01 mg/mL (1:100)
The protein concentration was held fixed (1 mM) throughout each sample preparation.
Therefore, for each reaction mixture 3 pL of protease was added to 10 pL o f protein. 
Each reaction was left on ice for 5 mins before the protease is inactivated by adding 2 
pL o f loading dye (bromophenol blue -  Invitrogen) and the addition o f the samples to a 
heating block set to 100 °C.
Samples are then loaded onto an SDS-PAGE Invitrogen pre-cast NuPAGE™ Novex® 4- 
12 % Bis-Tris Gel 1.0 mm, 15 well gel, with protein standard markers with a control 
consisting o f the protein minus protease. All references to ‘protein marker’ refer to 
Marker 12 obtained from Invitrogen™ composed o f Myosin (200 kDa), p-galactosidase 
(116.3 kDa), Phosphorylase B (97.4 kDa), BSA (66.3 kDa), Glutamic dehydrogenase 
(55.4 kDa), Lactate dehydrogenase (36.5 kDa), Carbonic anhydrase (31 kDa), Trypsin 
inhibitor (21.5 kDa), Lysozyme (14.4 kDa), Aprotinin (6 kDa), Insulin B-chain (3.5 
kDa) and Insulin A-chain (2.5 kDa).
Electrophoresis was carried out according to the manufacturer’s protocol in an Xcell 
SureLock™ Cell as previously referenced. Gels were stained using Coomassie blue for 
45 mins. Gels were then drained and left in de-staining solution (10 % ethanol, 7.5 % 
acetic acid) for 30 mins on an orbital shaker, before imaging.
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2.8. Limited proteolysis ‘time course’ experiment.
On choosing the most effective protease, a ‘time course’ experiment was then 
conducted to determine the optimum length o f time to yield the most efficient digest 
pattern, as well as to provide details as to any fragments which may appear consistently 
undigested throughout the course o f the experiment.
For the ‘range finding’ experiment the same protocol was followed as outlined above; 
the difference being the time at which the protease was ‘deactivated’ by adding loading 
dye (Marker 12 -  Invitrogen™, containing P-mercaptoethanol) to the sample and placing 
it in a heating block at 100 °C.
The entire ‘time course’ experiment was run over a two hour period, with samples 
containing protease being ‘deactivated’ after the following intervals: 5 mins, 10 mins, 
20 mins, 30 mins, 1 hour and 2 hours. Electrophoresis followed by staining o f the SDS- 
PAGE gel was then carried out, in a method as described previously for the ‘range 
finding’ experiment.
2.9. Freeze-thaw experiment.
The sensitivity o f sigJ to degradation/precipitation to varying temperatures and glycerol 
concentrations, thereby determining the parameters by which purified sigJ could be 
stored under, was examined by qualitative visual assessment by SDS-PAGE (method as 
described above).
The glycerol percentage to store sigJ at sub-zero temperatures (-80 °C) was examined 
by adding the following glycerol percentages to three separate Eppendorf™ tubes, each 
containing 0.5 mM sigJ; 0 %, 10 % and 20 % v/v. All three Eppendorf™ tubes were then 
placed into a -80°C freezer for one week. Concurrently, a separate Eppendorf™ tube 
containing 0.5 mM sigJ containing 20 % glycerol v/v was left at room temperature (-25 
°C), also for one week. All four samples were then examined by SDS-PAGE to visually 
determine the extent to which any degradation may have occurred.
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2.10. Obtaining sigJ protein from inclusion bodies.
The process o f extracting protein from E. coli expressed inclusion bodies, found in the 
insoluble cell fraction, and subsequent refolding is essentially the same as the method 
described in the Sections 2.3.2-2.3.4 but with the following differences.
After processing o f the cell extract using the French Press and the subsequent second 
centrifugation step, the resulting supernatant is set aside and the cell pellet recovered. 
The cell pellet is re-suspended in PBS buffer containing 2 % v/v Triton X-100 and the 
resulting solution centrifuged at 15000 rpm for 40 mins. Following this step, the cell 
pellet is washed in PBS buffer only and then completely re-suspended in Buffer A 
(Recipe 15). The solution is then manually homogenised using a homogenising tube and 
pestle and then centrifuged at 15000 rpm for 40 mins.
Ni-NTA affinity chromatography is then applied in the same way as described in 
section 2.3.3 but using Buffer A and Buffer B (Recipe 15) to create the linear imidazole 
gradient. Wash fractions were assessed by SDS-PAGE and those which contained sigJ 
were concentrated to a final volume of 5 mL using a Vivaspin5000 molecular weight 
cut-off tube centrifuged at 3500 rpm. The refolding aspect o f sigJ requires that the 5 mL 
concentrate is diluted (1:5) with Buffer A containing 1 mM DTT is then ‘slow- 
exchanged’ using a dialysis membrane against 50 mM 2-Amino-2- 
(hydroxymethyl)propane-l,3-diol-HCL (Tris-HCL), 300 mM NaCl and 1 mM DTT and 
adjusted to pH 8.0.
Recipe 15: Buffer A - sigJ refolding buffer.
For 1 L o f each buffer in d d ^ O :
6.05 g 50 mM Tris-HCL
17.52 g 300 mM NaCl
480.48 g 8 M Urea
0.292 g Imidazole (Buffer A)
29.2 g Imidazole (Buffer B)
Elution buffers comprised different proportions o f stock phosphate buffers, buffer 
A (5 mM imidazole) and buffer B (500 mM imidazole). pH adjusted to 8.0.
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2.11. NMR spectroscopy structural and functional analysis of proteins.
NMR spectroscopy is the name given to the technique which exploits the magnetic 
properties o f nuclei. A magnetic moment is intrinsic to all nuclei having either an odd or 
even number o f nucleons. In simple terms the application of NMR exploits the 
alignment o f such nuclei in a powerful externally-applied magnetic field and perturbing 
this alignment using radiofrequency electromagnetic radiation. The resulting behavior 
o f the perturbed nuclei in the presence o f the magnetic field gives rise to a response that 
is interpretable as a spectrum and encodes physical, chemical, and structural 
information about a molecule. From a practical perspective useful NMR spectra of 
molecules in solution requires that the observed nuclei possess magnetic quantum 
number spin, I = 1/2, such as !H, 13C, and 15N. Arguably NMR spectroscopic analysis of 
these nuclei provides the only method that is able to provide detailed information at the 
atomic level on the three-dimensional structure o f biological macromolecules in 
solution.
One common goal in the use of NMR spectroscopy is to obtain high resolution three- 
dimensional structures o f proteins, similar to that which can be achieved by X-ray 
crystallography. Such applications of NMR are mainly limited to relatively small 
proteins, usually smaller than 25-30 kDa, though technical advances allow ever larger 
structures to be solved. In addition to structural information for folded proteins, NMR 
can also be usefully applied to obtain high resolution information on partially or wholly 
unstructured proteins, as well as to characterise the global and internal dynamic 
properties o f proteins and to monitor the interactions with other molecules.
2.11.1. ID NMR and the need for multidimensional NMR spectroscopy.
The one-dimensional spectrum of an organic molecule reports on the chemical 
nature o f the hydrogen atoms present and the resonance frequencies of the individual 
spectral features, routinely described as chemical shifts on a parts-per-million scale, are 
generally characteristic of the corresponding molecular fragment (e.g. aliphatic methyl 
group protons appear at ~ 1 ppm). In this context, the utility o f the chemical shift is 
demonstrated by the fact that chemists can often use the ID spectrum as 
confirmatory evidence o f the structure o f the target molecule. Complications arise in ID
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*H NMR spectra when there are more than a relatively small number o f protons present 
because o f chemical shift degeneracy (resonance overlap). In addition, the 
spectroscopist in general wishes to derive additional information about the structure of 
the target by revealing connections between resonances that will yield further evidence 
for the chemical and spatial relationships between the observed 'H atoms. The latter 
problem is clearly encountered in the application o f NMR to biological macromolecules 
where the constituent ‘units’ o f structure, e.g. amino acid residues and nucleotide bases, 
occur multiple times within the target molecule such that one is reliant on second order 
effects arising from macromolecular folding to provide some relief o f the resonance 
overlap. Whilst the differing local environments o f individual chemical groups in a 
protein give some dispersion to the NMR spectrum, deriving connectivity 
information between resonances requires extension o f the NMR methodology into the 
realm o f multiple dimensional NMR, including 2D, 3D and (sometimes) 4D 
spectroscopy. When nD NMR is combined with stable isotope labelling o f the ‘heavy’
13 15atoms o f the polypeptide chain with spin-1/2 nuclei ( C, N) then, in principle, the 
spectroscopist has the scope both to resolve all resonances and reveal inter-atomic 
connectivity information that permits the resonance assignment and the measurement o f 
both atom-by-atom structural and dynamic information. Over the past few decades the 
field o f multidimensional heteronuclear NMR spectroscopy has mushroomed into a 
highly diversified and broadly applicable set of methodologies, for which even a 
relatively short summary could fill many volumes. Because much o f what is practiced in 
the field has become essentially standard, what is described below represents a 
deliberately cursory description o f just a few relatively straightforward elements of 
techniques used during the execution o f the experimental work that is discussed in later 
sections o f this thesis.
2.11.2. Heteronuclear single quantum coherence (HSQC) spectroscopy.
In the most general modes of application multidimensional NMR spectroscopy relies 
upon extensions o f the ‘pulse-Fourier transform’ paradigm wherein a series o f RF 
pulses and delays (the ‘pulse sequence’) is designed to yield a time varying signal 
response (the ‘free induction decay’, FID) from the sample that is digitised and 
‘transformed’ in a computer into two or more frequency domains. Connectivities
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between resonances in the spectrum are encoded in the output spectrum as ‘cross peaks’ 
that have coordinates corresponding to the connected chemical shifts, and an intensity 
that reports upon the magnitude of the inter-nuclear coupling. A powerful physics 
enables the design o f pulse sequences that can provide different classes of connectivity 
information: these broadly fall into ‘through-space’ connections that rely upon inter- 
nuclear dipole-dipole couplings (e.g. the nuclear Overhauser effect), and ‘through-bond’ 
connections that rely upon scalar (or ‘J-‘, or spin-spin-) coupling networks that are 
mediated by electrons in covalent bonds.
The pulse sequence is designed so that systematically incremented delays between 
pulses provide for the time domain encoding o f the additional -  indirectly detected -  
frequency domains. Thus each pulse sequence is applied multiple times, with the series 
time data recorded directly for each instance o f the incremented time delay(s) stored 
separately in the computer. In general the output signal s(ti, t2 , t3 , etc.) is then Fourier 
transformed to yield the spectrum S(fi, f2 , f3 , etc.). Thus for a 3D NMR data set s(ti, t2 , 
t3) the directly recorded FID information (a signal vector in variable t3) is stored for 
each specific combination o f ti and t2 . In general the directly acquired dimension 
corresponds to a *H frequency and has relatively high digital resolution compared to the 
indirectly acquired dimensions.
By way o f an example o f the ‘through bond’ category o f NMR pulse sequences the 
following briefly describes the commonly used 2D heteronuclear single quantum 
coherence (HSQC) spectroscopy that connects a ]H atom to its directly bonded 
heteronucleus (in this description, the 15N atom of and N-H bond). In applications to 
proteins the 2D [15N, ^ j-H S Q C  pulse sequence provides for an information-rich 
‘fingerprint’ that correlates 15N and chemical shifts for the majority o f residues along 
the polypeptide chain, as well as a subset o f side chains.
As with many NMR pulse sequences designed to provide through-bond connectivity 
information the HSQC pulse sequence exploits the transfer o f so-called ‘transverse anti­
phase magnetisation’ between the J-coupled nuclei. Thus for two J-couple nuclei, it is 
possible -  with appropriate RF pulses -  to convert transverse magnetisation o f one 
nucleus that is antiphase with respect to the other into transverse magnetisation o f the 
second nucleus that is antiphase with respect to the first. In this way following Fourier 
transformation the two nuclei are seen to be coupled. In the HSQC pulse sequence a 
particular series o f pulses and delays known as INEPT (Insensitive Nuclei Enhanced by 
Polarization Transfer) is employed to transfer the superior polarisation of the *H atoms
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(with a ca. 10-fold higher magnetogyric ratio yH) to the attached 15N nuclei. Because 
phase cycling is used to suppress the intrinsic in-phase 15N magnetisation following the 
INEPT sequence element the 15N signal intensity is completely derived from the 
polarisation originating on the attached protons. A by-product o f the INEPT module is 
that it leads to transverse antiphase 15N magnetisation (arising out o f the !Jhn scalar 
coupling-dependent evolution).
Following the first INEPT element, the antiphase 15N magnetisation is allowed to 
evolve for a systematically incremented delay period o f duration ti, during which time 
the frequency o f the 15N magnetisation is effectively encoded. A second as-it-were 
‘reverse’ INEPT sequence element is then employed to convert the transverse antiphase 
15N magnetisation into in-phase !H magnetisation that is recorded in the acquired FID 
(i.e. the output signal, s(t2)). A 180° *H pulse centred in the ti delay and broadband 
decoupling o f the 15N nuclei during t2 is utilised to collapse the 15N and doublets 
respectively and thereby effect simplification and sensitivity enhancement o f the 
resultant 2D spectrum.
The forgoing describes only the most basic implementation o f the HSQC pulse 
sequence. In the applications of [^N^H]-correlated spectroscopy employed in this 
thesis, the applied pulse sequences included additional elements that provided for 
further sensitivity enhancements. Examples include the use o f shaped RF pulses and 
pulsed field gradients to achieve solvent suppression with minimal cross-saturation of 
the NH signals. These embellishments are well known in the field and a full description 
is beyond the scope o f this thesis (Kay et al, 1992 and Zhang et al, 1994).
It is important to bear in mind that the application of additional elements in the pulse 
sequence will impact the overall sensitivity. Thus, whenever transverse magnetisation is 
generated within a pulse sequence (as is in effect is always the case) this corresponds to 
the nuclei acquiring an excited state that, although really quite stable compared to other 
types o f spectroscopic excited states, begins to relax at a finite rate. It is important that, 
in order that NMR experiments are not compromised, that transverse magnetisation 
does not decay significantly on the timescale o f the optimal delay periods for INEPT 
transfers, themselves determined by the magnitude o f the relevant scalar coupling 
constant(s). In the case of the 15N-*H bond, the INEPT sequence employs two delay 
periods o f 1/(4* Vnh), where Vnh ~ 90 Hz, to facilitate magnetization transfer from ]H 
to 15N (and vice versa) corresponding to a total INEPT delay of 5.56 ms. For small 
proteins where 15N T2 values are greater than 100 ms the duration o f such INEPT
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transfer steps is not a limiting factor. However, for larger proteins the 15N 7? time is 
severely shortened and ultimately the applicability o f multi-pulse experiments is limited 
by the relevant transverse relaxation rate constants.
In principle, the HSQC spectrum has one peak for each !H bound to the relevant 
heteronuclei. Thus, in the [15N]-HSQC one cross peak is expected for each amino acid 
residue backbone amide group (except proline), along with some additional signals for 
certain N-containing side chains such as Trp (NeH), Arg (NeH, NnH2 ), and Asn, Gin 
(carboxy-NH2). The [15N]-HSQC spectrum is often referred to as the fingerprint o f a 
protein because each protein has a unique pattern o f signal positions. Analysis o f the 
[,5N]-HSQC spectrum allows researchers to evaluate whether the expected number of 
peaks is present and thus to identify possible problems due to multiple conformations, 
unanticipated degradation and sample heterogeneity.
By examining the overall pattern o f the chemical shift dispersion in a [15N]-HSQC 
spectrum it is possible to ascertain qualitatively the extent o f folding o f a protein. Thus 
disordered regions o f a polypeptide chain yield NH cross peaks in characteristic narrow 
ranges o f chemical shifts, and are often disproportionally intense with narrow line 
widths; the relatively distribution of dispersed and ‘random coil’ cross peaks allows an 
estimation o f the degree o f foldedness. Whatever the conformational status o f the target, 
where the [15N]-HSQC spectrum becomes extremely useful is as a convenient means to 
monitor the effects o f external perturbations to the protein, e.g. changes in the buffer or 
temperature conditions or the addition of potential binding partners. Because the 
chemical shifts o f both the NH group 15N and JH atoms is sensitive to the respective 
local chemical environments, changes to these parameters are interpreted to indicate that 
the NH is likely close to the site of interaction with the ligand, or point to a local change 
in the protein conformation in each o f these circumstances. NMR experiments where 
temperature is varied are especially useful when it comes to proteins exhibiting varying 
extents o f dynamic motion and is a useful method in probing the overall properties of a 
protein in solution. Performing NMR measurements at elevated temperatures carries the 
risk o f partial or global unfolding o f the protein which can be accompanied by non- 
reversible sample aggregation. On the other hand, a decrease in sample temperature can 
lead to slowing o f the both tumbling rate, and exchange processes. Nevertheless, so long 
as the temperature is maintained below the denaturation/aggregation threshold two 
major effects on the sample arise upon an increase in the temperature: (a) decreasing the 
rotational correlation time of the protein (faster tumbling) leading to favourable
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perturbations o f the global average Ti and T2 relaxation time constants; and (b) 
acceleration of dynamic exchange processes: a show exchange phenomenon may 
become intermediate exchange with concomitant line broadening/averaging, an 
intermediate exchange process a fast one with line narrowing. In general therefore for 
large molecules such as proteins, superior resolution of the spectrum should be obtained 
at the highest compatible temperature. However, use o f high temperatures risks the 
phenomenon known as ‘solvent exchangeable proton signal bleaching’, where the 
increased rate of exchange o f labile protons with the bulk solvent leads to selective 
signal losses related to the degree o f surface exposure.
The HSQC spectrum is often acquired with excellent sensitivity making it a relatively 
efficient means o f probing the status o f the protein under a variety o f conditions. 
Moreover, the scouting conditions with the HSQC pulse sequence allows one to assess 
the optimal conditions for the much more time- and sensitivity-demanding triple 
resonance NMR experiments that are required to obtain a full resonance assignment.
2.11.3. Triple resonance experiments using double 13C,15N-enriched proteins.
13 15Enriching a protein with C as well as N permits the recording o f NMR experiments 
that directly and often simultaneously correlate particular subsets o f atoms along the 
polypeptide chain. Usually the output o f these experiments separately encodes the 
chemical shifts o f the correlated !H, 13C and 15N nuclei in different dimensions. Many 
‘triple resonance’ NMR pulse sequences have been developed that correlate back-bone 
and side-chain !HN, 13C and 15N spins in three or four dimensions (Gronenbom and 
Clore, 1995 and Cavanagh, et al, 1995). The acquisition of such multi-dimensional data 
sets permits numerous inter-atomic through-bond and through-space interactions to be 
individually identified in a relatively efficient and unambiguous manner.
O f the great variety o f NMR pulse sequences that have been devised, the most popular 
can be thought o f as expanding the 2D [1H,15N]-HSQC spectrum into a third 13C 
dimension. These include the following: HNCO, HN(CA)CO, HNCA, HN(CO)CA, 
HN(CA)CB and CB(CACO)NH. The nomenclature o f these experiments highlights the 
nuclei involved in the magnetization transfer pathways (Figure 2.1); spins whose 
chemical shifts are not explicitly encoded are denoted by parentheses. For example in
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the HNCO experiment the spectrum contains a cross peak for each residue z at the 
chemical shift coordinates o f N(z'), HN(z') and C’(z'-l) -  in words, the [15N]-HSQC cross 
peak can be associated with the carbonyl carbon chemical shift o f the preceding residue. 
On the other hand, in the HN(CA)CO spectrum, for residue z cross peaks occur at both 
chemical shift coordinates representing (N(z'), HN(z'), C ’(z')}and {N(z), HN(z'), C ’(/-1)} 
(because the ^(N 'C a1) and ^ (N 'C a1’1) couplings have similar magnitudes). Similarly the 
HNCA experiment yields cross peaks at coordinates (N(z'), HN(z), Ca(z')}and (N(z'), 
HN(z'), Ca(z'-l)}, and the HN(CO)CA spectrum at (N(z), HN(z), Ca(z-l)}.
Combined analysis o f these four spectra should allow, in the absence o f significant 
chemical shift overlap, the connection of the majority o f back-bone resonances, limited 
only by the presence of Pro residues in the polypeptide sequence (Pro has no amide 
proton).
In identification o f stretches of connected spin systems obtained in this manner with the 
amino acid sequence o f the target protein is aided by the recording o f NMR spectra that 
connect side chain atoms with the Ca, HN, N and C’ resonances. The combination of 
experiments recorded using the HN(CA)CB and the HN(COCA)CB pulse sequences 
identifies the C|3 chemical shifts with each backbone amide group. Very often the 
pattern o f amino acid-characteristic Ca/C(3 chemical shifts pairings can be reliably 
linked with the amino acid sequence o f the target protein, allowing one to ‘anchor’ the 
sequential resonance assignments based on this set of triple resonance spectra.
As is illustrated in Figure 2.1 and summarized in Table 2.3, the magnetization transfers 
in these triple resonance NMR experiments are o f the ‘out-and-back’ type, both 
originating and being detected on the back-bone amide HN spin. Usually several o f these 
experiments are required to resolve chemical shift overlaps in the 13C dimension. This 
procedure is usually less ambiguous than the JH-NOESY-based sequential resonance 
assignment methods that were normally used prior to the advent of double [13C,15N]- 
isotope labelling, since it is based on unambiguous through-bond, as opposed to 
through-space, magnetisation transfers. In the NOESY-based methods additional cross 
peaks, corresponding to protons that are close in space but not belonging to the 
sequential residues will also appear, confusing the assignment process. When the 
backbone sequential assignment has been completed it is usually possible to assign the 
side chain 13C and *11 signals using, for example, the HCCH-TOCSY pulse sequence, 
which has the appearance of a 2D [’Hj-TOCSY experiment resolved in an additional 
13C dimension.
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Figure 2.1: Experimental strategy applied in the resonance assignments of back-bone *H, I5N, 
13Ca, 13CP and CO nuclei in a dipeptide fragment showing residues i and z-1. The magnetization 
transfer pathways for each of these experiments is shown with black arrows; A: HNCA, B: 
HN(CO)CA, C: HNCO, D: HN(CA)CB and E: HN(COCA)CB. Spins whose chemical shifts are 
not evolved are put in parentheses in the pulse sequence name. These experiments display the 
‘out-and-back’ description of magnetization originating and ending on the amide proton. Figure 
drawn using Adobe Photoshop CS2. - 70 -
Experiment name Correlation J coupling
HNCA ‘HN(i)-i:>N(i)-13Ca(i) lJNH, 'jlMCa
1HN(/)-15N(/)-13C a(/-l) !Jnh, “JnCci
HN(CO)CA lHN(0-l5N(z)-n C a(/-l) 1 JnH? J^nCO, *JcOCa
HNCO ‘h ^co-^ nco-^ c o o -I) 1 Jnh? *Jnco
HN(CA)CB ' h ^co-^ nco-^ cpco *JnH,  ^JnCci, * JcaCP
l
um
i
zin
i
ir*X 1 Jnh? 2JnCci? * JcaCP
HN(COCA)CB 1 H^CO- 1 ^ N(0-13C P(/-1) 'JNH, ^NCO, *JcOCa? ^CaCp
Key: A: ' j xy and 2Jxy refer to couplings between atoms (x, y) separated by one and two bonds, 
respectively.
Table 2.3: Spin correlation summary observed in 3D triple resonance experiments used for sequential 
assignment
The application o f double [13C,15N]-isotope labelling and triple resonance NMR 
methods to the sequential resonance assignment o f protein spectra has revolutionised 
the approach to NMR of the molecules, and expanded the scope to proteins significantly 
larger than could be reliably examined by !H NMR methods alone. However this 
approach is limited by the finite rates o f transverse relaxation o f 13C and 15N nuclei and 
the limits in resolution that these properties impose on multi-dimensional data. Thus, in 
general, full resonance assignments o f proteins with a molecular mass greater than 
about 30 kDa prove to be technically challenging (Venters et al, 1996).
It is now relatively common practice for NMR studies of globular proteins in excess of 
20 kDa to employ random fractional deuterium (2H) labelling. This has the advantage of 
reducing relaxation losses in triple resonance experiments. The following section will 
look at the common strategy applied in this project to achieve deuterium-substituted,
2 13 15and [ H, C, N]-labelled protein samples, and the distinct advantages these samples 
provide for multi-dimensional NMR spectra.
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2.11.4. HSQC -  the benefits of [2H]-labelling.
Traditionally, the application o f NMR spectroscopy has been limited to relatively small 
proteins or protein domains. As protein size increases, the sensitivity o f heteronuclear 
pulse sequences is hindered because of relaxation losses in the fixed delay periods. The 
progressive decrease in sensitivity with increase in protein size arises primarily from a
1 'y i
concomitant decrease in transverse C and Hn relaxation times associated with the
13longer rotational correlation time. The most significant contribution to C T2 relaxation 
is from the strong dipolar coupling to its directly attached proton(s) (Grzesiek et al, 
1993). In addition, dipolar coupling to surrounding aliphatic protons has been shown to 
contribute significantly (~40 %) to !HN T2 relaxation (Markus et al, 1994). To overcome 
the limitations imposed by these relaxation properties two separate but ultimately 
mutually beneficial approaches have been developed: a new class of NMR pulse 
sequence denoted ‘transverse relaxation-optimized spectroscopy’ (TROSY); and 
uniform randomised substitution of non-exchangeable protons with deuterons, or per- 
deuteration. The latter o f these two topics is discussed here.
Several strategies exist for the preparation of [2H]-enriched proteins which vary in the 
level and specificity o f substitution achieved (Sattler and Fesik, 1996 and Goto and 
Kay, 2000). With fractional deuterium labelling, the expression o f a recombinant 
protein is carried out in a medium containing D2O. During cell growth, the expression 
host incorporates deuterons from the medium into its amino acid reservoir and 
consequently into any translated protein products. The final level o f deuteron 
enrichment achieved in a protein varies from site to site. In most deuteration strategies, 
the protein is subsequently purified in F^O-based solvents, which promotes the 
protonation o f any exchangeable deuterated groups (e.g. hydroxyl, thiol, and back bone 
and side chain amide, guanidino and amine groups).
In general, relaxation in proteins is dominated by dipolar interactions with other 
protons (within ca. 5 A) and by interactions with directly bonded heteronuclei. A 
completely protonated Targe’ protein suffers from large line-widths o f the NMR signal 
and therefore low signal-to-noise as a result o f the highly efficient distribution of 
magnetization through the spin system o f dipolar coupled protons (known as ‘spin 
diffusion’). Another efficient means o f the dispersal o f magnetization arises through the 
dipolar interaction o f 13C and 15N with their directly bound proton spins, which
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constitutes the main source o f relaxation for C- and N-nuclei in isotope-labelled 
proteins (Cavanagh et al, 1996 and Sattler and Fesik, 1996).
Deuteration represents an attractive approach in dealing with both o f the problems of 
excessively rapid relaxation o f magnetization identified above. In respect to the rapid 
distribution o f magnetization exhibited by competing relaxation pathways in a network 
of dipolar coupled protons, decreasing the proton density by introducing deuterons at 
positions that modify the efficiency o f these relaxation pathways and thereby 
dramatically reduce the remaining !H line widths and improve the signal-to-noise ratio. 
Deuteration will also result in the reduction of dipolar interactions between 13C and ,5N 
with their directly bound proton spin which results in increased relaxation times leading 
to smaller line-widths and a higher signal-to-noise. These effects arise by virtue of the 
significantly smaller gyromagnetic ratio (y) o f the deuterium spin when compared to the 
!H spin, roughly a factor of 6.5-times lower than that o f *H (yo~ 1/6.5 yn), which results 
in relaxation rates that are scaled proportional to (yD/yH) 2 ~ 0.024. Therefore the dipolar 
contribution o f a deuteron to the line-width of a 13C spin attached to a molecule 
undergoing isotropic tumbling with a rotational correlation time o f 15 ns is ~1.5 Hz, 
compared with -2 0  Hz for the case of a 13C-!H pair (Yamazaki et al, 1994b).
The benefits to minimizing unwanted !H relaxation in protein NMR spectra are best 
realised for samples in which very high levels (> 80 %) o f substitution o f non­
exchangeable protons has been obtained -  so-called ‘perdeuteration’; even in this 
circumstance the dipolar interactions between the remaining NH, OH and SH protons 
provides for some degree o f ‘spin-diffusionaf broadening o f the proton signals. In 
respect o f the effects on 13C relaxation in triple resonance pulse sequences, commonly 
used methods that provide this overall level of proton-deuteron substitution typically 
yield > 95 % substitution at the Ca atom, because o f the metabolic pathways in E. coli, 
leading to very effective enhancements o f the signal-to-noise performance for these 
samples.
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Figure 2.2 provides a simplistic representation o f the very significant reduction in 
proton density for a normal (‘per-protonated’) protein that is theoretically achievable 
with 1 0 0  % perdeuteration at the non-exchangeable positions.
Non-deuterated
protein Perdeuterated protein:
All protons present back-bone NH (green) 
and side chain NH2 
(red) protons only.
Figure 2.2: Depiction of the reduction in proton density that is achieved upon perdeuteration of small 
protein. The fewer protons present in solution due to 2H-labelling results in 2D NMR spectral 
improvements that are not shown here.
The effects upon the !H line widths that result from perdeuteration of a protein are 
readily appreciated from a comparison of the [15N]-HSQC NMR spectra of a [15N]- 
labelled (protonated) protein and its perdeuterated equivalent. Figure 2.3 provides an 
example o f such as comparison, in this case for the ~28 kDa amino terminal domain of 
enzyme I from E. coli (Garrett et al, 1997). Perdeuteration clearly results in enhanced 
spectral resolution as a result o f the narrowing of the line widths.
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Figure 2.3: The difference in the 2D [15N]-HSQC spectra between a 1 mM, pH 7, 25 °C, at 600 MHz 15N- 
labelled (protonated) protein (A) and its perdeuterated equivalent (B) (Garrett et al, 1997). A significant 
improvement in spectral resolution of peaks and the corresponding reduction in cross peak overlap is seen 
as a result of [2H]-labelling.
The effect o f substitution o f Ca-bonded protons with deuterons on the performance of 
triple resonance NMR experiments is illustrated in Figure 2.4 which shows 2D 
projection o f 3D HNCA spectra recorded for [13C,15N]- and [2 H,13C,15N]-labelled 
samples of a phosphotyrosine-binding (PTB) domain (Sattler and Fesik, 1996). The 
dramatic improvement in achievable sensitivity and resolution is evident for the latter 
case.
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Figure 2.4: [HN,Ca]-spectra from 3D-HNCA experiments. The spectra were obtained from, A: uniformly 
[15N,13C]-labelled and B: 2H uniformly labelled 1 mM, pH 7, 25 °C, at 600 MHz of [15N,13C]-labelled 
PTB domain.
Experience shows that high level perdeuteration has a significant beneficial impact on 
the performance o f many heteronuclear NMR experiments that are used to obtain the 
back-bone resonance assignments of medium-sized proteins (e.g. Venters et al, 1996). 
These assignments have a wide utility in a variety o f contexts including chemical shift 
perturbation mapping (e.g. SAR-by-NMR), and the analysis o f polypeptide back-bone 
dynamics through the measurement o f 15N relaxation rates. However it is worth 
remembering that, by definition, the substitution of the majority o f non-labile protons 
with deuterons leads to difficulties in efforts to determine protein structure based upon 
the standard paradigm of collecting inter-proton NOE-based distance restraints. A 
number o f alternative strategies to circumvent this problem have been developed (e.g. 
partial molecular alignment and residual dipolar coupling measurements): these 
techniques are beyond the scope of the work described in this thesis and are not 
discussed further.
2.11.5. Transverse relaxation optimized spectroscopy (TROSY).
Whilst [2 H]-labelling has and continues to prove beneficial to the study o f small to 
medium-sized [13C,l5N]-enriched proteins, the application of traditional heteronuclear 
NMR spectroscopy is still ultimately constrained by the effective size o f the target 
molecule. In general the application of NMR to macromolecules is limited by the rates 
o f transverse relaxation that operate during the pulse sequences that are applied. Since 
the dominant factor that determines these rates is related to the overall tumbling 
(rotational correlation) time, it is generally the case that the sensitivity of NMR 
experiments becomes poorer as the hydrodynamic size o f the target increases, even with 
perdeuteration. Thus it remains the case that probing the 3D structure o f proteins larger 
than ca. 40 kDa by these methods is extremely challenging. However, recently the 
development o f new NMR methods that can be broadly collected under the heading 
transverse relaxation optimized spectroscopy (TROSY) have opened up the potential to 
obtain useful spectra for very much larger molecules (Pervushin et al, 1997). The 
principle that the TROSY methods exploit involves the interference effects o f cross­
correlation o f distinct relaxation pathways within J-coupled NMR multiplets, such that 
the different multiplet components exhibit differential transverse relaxation rates (Riek 
et al, 2000). For example for an N-H group, the interference between dipole-dipole 
coupling and chemical shift anisotropy (CSA) leads to one o f the (un-decoupled) 15N 
(and *H) doublet components having a narrower line, and the other a broader line. Thus 
for 1/4 o f the total signal contributing to a cross peak in an un-decoupled 2D HSQC 
spectrum, line broadening due to transverse relaxation is significantly reduced and a 
sharper, more intense signal results. Under conditions that optimise the interference 
effects (e.g. at the optimal magnetic field strength) pulse sequences that specifically 
select the slowly-relaxing multiplet component (e.g. TROSY-HSQC) can provide 
superior sensitivity and resolution than the more traditional (decoupled) HSQC 
spectrum, particularly for large molecules. TROSY performance is degraded when 
alternative [!H]-relaxation networks exist, so the full potential o f TROSY-based 
methods is only obtained when the protons are appropriately ‘diluted out’ to deal with 
*H-15N spin-pair relaxation with remote protons due to !H dipolar coupling. 
TROSY-based spectroscopy has provided for a plethora of applications to different 
types o f protein targets that perhaps would previously have been considered beyond the 
scope o f NMR otherwise have been refractory to NMR analysis. For example, the 3D
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solution structure of bacterial malate synthase G (82 kDa) was successfully solved 
(Tugarinov et al, 2005) as was the complete back-bone amino acid assignment of a 44 
kDa uniformly [15N, 13C]-labelled and fractionally (35 %) deuterated trimeric B. Subtilis 
chorismate mutase protein (Hu et al, 2003). The implementation o f the TROSY 
principle has been shown to increase the sensitivity o f key ]H, 13C, 15N triple resonance 
correlation experiments (Eletsky et al, 2001). Perhaps more impressively, TROSY 
NMR methods has aided in studies of proteins in complex with the 900 kDa chaperone 
GroES-GroEL (Fiaux et al, 2002). Much current interest in NMR methods development 
is centred upon extending the concepts underpinning TROSY to chemical moieties 
other than the back-bone amide NH group, such as 13CH3 in a 12C,2H background 
(Sprangers et al, 2007).
2.12. Discussion/Concluding remarks.
Multidimensional heteronuclear NMR spectroscopy is a powerful, rapidly developing 
field with an ever-expanding arsenal o f analytical tools applicable in protein science. 
This project will make use o f the practical aspects of protein based NMR spectroscopy, 
using optimized isotope protein labeling techniques, to gain an understanding, with the 
support o f other areas o f biochemical-based research, o f the physiochemical properties 
o f a variety o f protein targets involved in aspects o f bacterial persistence associated with 
Mycobacterium tuberculosis, as found in human and animal models.
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Chapter 3
Peroxiredoxins and the investigation into Mtb 
TPx
3.1. Chapter summary.
A member o f the peroxiredoxin protein family, Mtb thiol peroxidase (TPx) has 
recently been shown to catalyse the reduction of a range o f peroxide species in 
vitro. These include: hydrogen peroxide, phosphatidylcholin-A hydroperoxide (a 
lipid hydroperoxide), cumene hydroperoxide (a phenyl hydroperoxide), t-butyl 
hydroperoxide (an organic hydroperoxide) and peroxynitrite (Zang et al, 1992). 
The ability o f Mtb TPx to reduce these reactive oxygen species suggests that it 
may have a role in antioxidant defence in tuberculosis, similar to that o f alkyl 
hydroperoxide reductase (AhpC) which is also believed to protect against organic 
peroxides and peroxynitrites in Mtb (Chae et al, 1994 and Jaeger et al, 2004). 
Both wild-type Mtb TPx (TPxWt) and the Mtb TPx Cys60 —► Ser60 mutational 
variant (TPxC60S) exhibit quasi-identical homodimeric structures with an overall 
ellipsoidal shape. Although homodimeric in nature, Mtb TPxWt is functionally 
monomeric with two active reducing sites per dimeric unit. Mtb TPxWt is an 
atypical two-Cys peroxiredoxin with reactive cysteines Cys60 and Cys93 acting 
as the peroxidatic ( C p )  and resolving ( C r )  residues, respectively, within the active 
site. The crystal structures o f TPxWt and the TPxC60S mutant, solved by 
independent groups, and apparently mimicking the oxidised and reduced states 
respectively, suggest substantial local rearrangement o f secondary structure 
elements proximal to the active site, such as has been suggested previously for a 
homologous peroxiredoxin.
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3.2. Peroxiredoxins.
Organisms living under aerobic conditions have developed an array of 
antioxidative systems to protect cells from oxidative damage caused by reactive 
oxygen and reactive nitrogen species. An emerging family o f non-heme 
peroxidases, called peroxiredoxins, has been described in all kingdoms during the 
past few years (Chae et al, 1994 and Dietz et al, 2002). Anti-oxidant enzymes 
such as tryparedoxin peroxidase (TryP), alkyl hydroperoxide reductase (AhpC), 
and bacterioferritin-comigratory protein (BCP) belong to the peroxiredoxin 
protein family, which also includes thiol peroxidases (TPxs). AhpC has been 
shown to be pivotal for the survival o f many pathogens in the oxidative 
environment o f the host’s phagocytes (Storz et al, 1987). These ubiquitous 
proteins are able to reduce organic and inorganic hydroperoxides with electrons 
provided mainly by NADPH or NADH and different proteins such as thioredoxin 
(Trx), glutaredoxin (Grx), cyclophilin-A, and subunit-F o f alkyl hydroperoxide 
reductase, to produce either water (from H2O2) or corresponding alcohols (ROH) 
from ROOH species (Chae et al, 1994; Niimura et al, 1995; Lee et al, 2001 and 
Rouhier et al, 2002). In addition to protecting against reactive oxygen species, 
some peroxiredoxins can reduce and thereby detoxify reactive nitrogen (Bryk et 
al, 2000) and sulphur (Yim et al, 1994) species. Peroxiredoxins are also known to 
participate in signal transduction and cell proliferation (Wood et al, 2003a).
The defining characteristic o f peroxiredoxins (Prxs) is the presence o f conserved 
cysteine residues that are implicated in the catalytic cycle involved in reducing 
organic and inorganic hydroperoxides. As a family, these proteins are classified 
according to substrate specificity, structural features and oligomerisation state 
(Zang et al, 1992, Jaeger et al, 2004, Rho et al, 2006 and Trujillo et al, 2006). The 
peroxiredoxins were first classified into two sub-classes, the 1-Cys and the 2-Cys 
peroxiredoxins, according to the number o f absolutely conserved cysteine residues 
and dependent on whether they form, as part o f the reaction mechanism, 
intermolecular (Rhee et al, 2001) or intramolecular (Wood et al, 2003a) disulfide 
bridges, respectively. The 2-Cys peroxiredoxins were further sub-divided into 
typical and atypical 2-Cys peroxiredoxins. The basis o f the distinction between 1 - 
Cys, typical 2-Cys and atypical 2-Cys Prxs relates to the second step o f the
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peroxidase reaction mechanism - namely the resolution of the cysteine sulfenic 
acid intermediate (see below). The increasing number o f peroxiredoxins found in 
all organisms has prompted more complex categorisation schemes. Thus, in 
mammals the classification o f peroxiredoxins is sub-divided into six sub-groups (I 
to VI) on the basis of cellular localisation, protein size, and electron donor 
capability. Plant peroxiredoxins are classified into four subgroups (Dietz et al, 
2002) based upon function and location: 1-Cys, 2-Cys, type II peroxiredoxin and 
peroxiredoxin Q. Here the focus is on the bacterial 2-Cys Prx group.
The basic reaction mechanism for typical and atypical 2-Cys Prxs is illustrated 
schematically in Figure 3.1 In each case, the reaction is initiated by the 
nucleophilic attack o f one Cys side-chain thiol (the peroxidatic Cys, Cp) on the 
ROOH peroxide substrate leading to a cysteine sulfenic acid intermediate (Cp- 
SOH) and the corresponding alcohol product, ROH. The sulfenic acid is reduced 
by the action o f a second, resolving Cys ( C r )  thiol group leading to the generation 
o f a C p - S - S - C r  disulfide and loss of a water molecule. The reduced oxidized Prx 
is then recycled to the dithiol state by the action o f an upstream reductase (PrxR) 
-  usually a flavoprotein.
Typical 2-Cys Prxs are the largest class of Prxs and are identified by the 
conservation o f their two redox-active cysteines, Cp (generally near residue 50) 
and the C r  (near residue 170) (Hofmann et al, 2002). Typical 2-Cys Prxs are 
obligate homodimers containing two identical active sites (Wood et al, 2002). In 
the second step o f the peroxidase reaction (Figure 3.1 A), the intermediate 
peroxidatic cysteine sulfenic acid (Cp-SOH) from one subunit is attacked by the 
resolving cysteine ( C r - S H )  located in the C-terminal part o f the other subunit. 
This condensation reaction results in the formation o f a stable inter-subunit 
disulfide bond, which is then reduced by one o f several cell-specific disulfide 
oxidoreductases (e.g. thioredoxin, AhpF, tryparedoxin or AhpD) (Nogoceke et al, 
1997; Poole et al, 2000 and Wood et al, 2002), completing the catalytic cycle.
The second class o f Prxs are the atypical 2-Cys Prxs, which have the same basic 
mechanism as typical 2-Cys Prxs but are functionally monomeric (Declercq et al, 
2001). In these Prxs, both the C p  and the corresponding C r  residues are contained 
within the same polypeptide, with the condensation reaction resulting in the 
formation o f an intramolecular disulfide bond (Figure 3. IB).
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NADPH
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ROOH
PrxPrxR
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Figure 3.1: A: The typical 2-Cys Prx and B: atypical 2-Cys Prx mechanisms, with peroxidatic 
cysteines and resolving cysteines in the reduced (CpSH and CrSH, respectively), sulfenic-acid 
(CpSOH) or disulfide (CPS and CrS connected) state. In the case of typical 2-Cys Prxs, which are 
functionally dimeric, the peroxidatic cysteine (black CP) and resolving cysteine (pink CR) originate 
from different subunits and condense to form an inter-subunit disulfide bond (blue). Atypical 2- 
Cys Prxs are functionally monomeric. Reduction of typical and atypical 2-Cys Prxs usually 
involves a flavoprotein disulfide reductase, which is oxidized from a dithiol (PrxR-FAD-SH2) to a 
disulfide (PrxR-FAD-SS) state during Prx reduction.
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Although within typical and atypical 2-Cys Prxs the C r  residue is conserved, its 
position within the polypeptide chain is different. Atypical 2-Cys Prxs appear to 
couple to thioredoxin and thioredoxin reductase as upstream electron donors, in 
the recycling o f the intermolecular disulfide (Declercq et al, 2001).
3.3. Mycobacterium tuberculosis {Mtb) thiol peroxidase (TPx).
In the Mtb bacterial genome, several open reading frames have been identified 
encoding peroxiredoxins: two bacterioferritin-comigratory protein (BCP)-type 
peroxiredoxins [Rv 1608c (BCPB) and Rv2521 (BCP)], a 1-Cys peroxiredoxin 
[Rv2238c (AhpE)] and two 2-Cys peroxiredoxins [Rv2428 (AhpC) and Rvl932 
(TPx)]. The atypical 2-Cys peroxidase Mtb TPx was first described as culture 
filtrate protein 20 (CFP-20) in a search for vaccine candidates (Weldingh et al, 
1998). It was characterized as one of the antigens strongly recognized in Mtb 
infected animals and induces a strong proliferative response in both humans and 
mice (identified by increasing numbers of IFN-Y releasing T-cells, as part o f a 
delayed type hypersensitivity response). Proteomic studies o f Mtb have indicated 
that TPx is found in the cell wall as well as CFP fractions (Rosenkrands et al, 
2 0 0 0 a and 2 0 0 0 b).
Homologues o f Mtb TPx are distributed throughout most or all eubacterial 
species, both Gram-negative and Gram-positive, and are found in pathogenic 
strains such as Haemophilus influenzae, Streptococcus pneumoniae, and 
Helicobacter pylori (Wan et al, 1997). O f these, biochemical and genetic analyses 
have been limited primarily to E. coli TPx (E'cTPx) and I will discuss aspects of 
Mtb TPx structure and function largely with respect to the reported characteristics 
o f this protein. A degree o f functional equivalence between Mtb TPx and E’cTPx 
is illustrated by the increased susceptibility o f E. coli to oxidative stress when the 
TPx gene is deleted (Master et al, 2002).
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3.4. Antioxidant defences of Mtb.
The action o f the first-line tuberculostatic isoniazid (INH) depends upon the 
presence o f the Mtb heme-containing catalase peroxidase KatG. The constitutive 
function o f KatG is for the detoxification o f H2 O2 , and laboratory strains lacking 
KatG are avirulent. However, clinical isolates lacking the catalase are virulent and 
proved to be resistant to INH treatment. This is because KatG is evidently 
required to chemically activate INH (Zhang et al, 1992). Loss of catalase should 
in principle make the pathogenic bacteria more susceptible to the host’s oxidative 
immunological response, unless it is compensated for by other components o f the 
bacterial antioxidant defence in vivo. It has been suggested that there are two 
candidate peroxidases that participate in this defence. One of these peroxidases is 
the typical 2-Cys peroxiredoxin alkyl hydroperoxide reductase-C (AhpC) which is 
often found at elevated levels in catalase-deficient clinical isolates (Sherman et al, 
1996). The other peroxidase is TPx which belongs to the atypical 2-Cys 
peroxiredoxin class. Both TPx and AhpC exist as part of what could be termed as 
the ‘second line’ o f antioxidant defence for Mtb. TPx has recently been 
demonstrated as being the most efficient peroxidase o f the two peroxiredoxins in 
in vitro assays, as determined by rate constants for the reaction with 
hydroperoxides and peroxynitrite in vitro (Trujillo et al, 2006). Notably, the scope 
of TPx reducing ability includes a broad spectrum of hydroperoxides, including 
H2O2 , as well as being involved in oxidative and nitrosative stress defence in vitro 
(Jaeger et al, 2003). TPx is specifically regenerated, in its reduced state, by two of 
the mycobacterial thioredoxins, Mtb TrxB and Mtb TrxC. However, Mtb 
maintains NADPH-driven detoxification predominantly through the TrxC- 
mediated pathway (Zang et al, 1992, Jaeger et al, 2004, Rho et al, 2006 and 
Trujillo et al, 2006). It has been speculated that TPx also meets special 
antioxidant requirements in KatG+ strains by reducing hydroperoxides o f complex 
lipids and peroxynitrites. Thus, both TPx and AhpC appear to complement KatG 
catalase in antioxidant defence in Mtb. These characteristics have led to the 
speculation that TPx, alongside AhpC, could be considered as a potential drug 
target. The targeted inactivation o f AhpC and TPx could be especially relevant in 
cases o f antibiotic-resistant tuberculosis, where KatG' strains may increasingly
- 8 4 -
emerge thus making INH treatment ineffective (Sherman et al, 1996). The 
importance o f the apparently more efficient peroxidase, TPx, as a potential drug 
target is underscored by its low level of sequence similarity with mammalian 
PrxII, showing only 21 % identity, suggesting the potential for selective targeting 
o f the bacterial TPx.
3.5. The mechanism of peroxidase activity of atypical 2-Cys peroxidase from 
E. coli.
The Mtb TPx protein exhibits 52 % sequence identity with E. coli TPx (E'cTPx) 
(PDB code: 1QXH), as determined by both the 3D structure alignment tool known 
as DALI (Holm et al, 1995) and the ClustalW sequence alignment tool (Higgins et 
al, 1994) showing conserved catalytic regions to be present (Figure 3.2). The 
catalytic regions are represented by the peroxidatic cysteine residues: C60 (Mtb) 
and C61 (E. coli), and the resolving cysteine residues: C93 (Mtb) and C95 (E. 
coli).
To date, one o f the most documented and well understood peroxidase mechanisms 
is that o f the atypical 2-Cys EcTPx peroxidase. The following section will 
describe the peroxidatic mechanism of iicTPx and the resulting chemical changes 
occurring to the catalytic cysteines.
Baker and Poole (2003) studied the mechanism of action o f iscTPx by applying 
rapid reaction kinetic experiments, as a coupled NADPH-linked peroxidase assay, 
used to measure the steady-state turnover o f cyclic intermediates and products. 
Therefore examining the thiol group chemistry, and assessing the peroxide 
detoxifying properties o f wild-type £cTPx and four Cys —> Ser mutants (C61S, 
C82S, C95S, C82S/C95S).
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Figure 3.2: ClustalW sequence alignment of Mtb TPx with its closest structural homologue; EcTPx. Conserved catalytic cysteine residues; Cys60 {Mtb)/Cys61 (E. coli), 
Cys83 {Mtb)/Cys82 {E. coli), and Cys93 {Mtb)/Cys95 {E. coli) are shown coloured brown and boxed. Amino acid numbering is for Mtb TPx as used as the primary source 
alignment sequence. Highly hydrophobic residues are coloured green, weakly hydrophobic are light blue, polar residues are grey, positively charged residues are dark blue, 
negatively charged residues are red, and glycines are yellow. Displayed in Rich Text format using BioEdit v4.0.6 (Hall, 1997).
The proposed mechanism o f £cTPx reduction of alkyl peroxide (ROOH) to an 
alcohol (ROH) is shown in Figure 3.3. A series o f titration assays and tryptic 
peptide mapping techniques were executed using 5,5-dithiobis (2-nitrobenzoic 
acid) (DTNB) to show that the C61 (Cp) thiol group, which carries out a 
nucleophilic attack upon the -O-O- bond o f the alkyl hydroperoxide resulting in a 
C61 sulfenic acid, is then attacked by the C95 residue ( C r ) to form an 
intramolecular disulphide bond (see Figure 3.3 -  path B) (Baker and Poole, 2003). 
The activities of iscTPx Cys —* Ser mutants C61S and C95S were measured by 
stopped-flow spectrometry using H2O2 as the substrate. The C95S mutant was 
active although only at 20 % of the level o f wild-type EcTPx while the C61S 
£cTPx mutant was completely inactive. An equivalent reaction assay using C82S 
EcTPx revealed that the C82 residue had no overall influence on peroxidase 
activity when compared to wild-type £cTPx.
These results collectively identified C61 as the catalytic cysteine in iscTPx. C61 
(C p ) and C95 ( C r )  in EcTPx are essential for maximal catalytic activity but the 
third cysteine residue, C82, which is conserved in most atypical peroxiredoxins, is 
not essential (Cha et al, 1996 and Zhou et al, 1997).
In general, the regeneration o f the intermolecular disulfide bonded Prx to the 
dithiol peroxidase is carried out by one of either cell-specific oxidoreductase such 
as: AhpF, thioredoxin, and TryP. In E. coli, the £cTPx catalytic site is regenerated 
by the reduction o f the disulfide bond by thioredoxin-1 (Trxl), which in turn is 
reduced by thioredoxin reductase (TrxR), which uses NADPH as a substrate. An 
alternative pathway (Figure 3.3 -  path A) shows the conversion of Cp-SOH 
(cysteine sulfenic acid) to CP-SO2 H (cysteine sulfinic acid), which causes 
irreversible inactivation o f EcTPx in vitro. However, this pathway is believed not 
to occur in vivo, and instead is a result o f non-physiologically high levels of the 
substrate alkyl peroxide in the laboratory experiments.
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Figure 3.3: Proposed reaction scheme for reduction of alkyl peroxide by £cTPx (Baker and Poole, 
2003)
Recent identification o f a C60 residue oxidised to a sulfenic acid form in Mtb 
(Rho et al, 2006), comparable to the Cys61-SH —> Cys61-SOH transition 
identified for the C61 residue in EcTPx during its catalytic peroxidatic 
mechanism, was made using 7-chloro-4-nitrobenzo-2-oxa-l, 3-diazole (NBD- 
chloride) labelling. The sulfenic acid form of C60 was detected by observing 
changes to the visible absorbance properties of the respective adducts of Cys61- 
SH and Cys61-SOH upon reacting with the sulfhydryl-reactive reagent, NBD. The 
following section will therefore highlight the significance o f this Mtb TPx C60 
residue in providing detoxifying ability for Mtb TPx and describe the NADPH- 
linked peroxidase assay systems used to assess reactivity.
3.6. NADPH-linked peroxidase assay for Mtb.
Rho et al. and Trujillo et al. each established a coupled activity assay for Mtb TPx 
to assess TPxWt (Trujillo et al, 2006 and Rho et al, 2006) and the mutated variant 
TPxC60S (Rho et al, 2006). In the assay system, TPx is subjected to H2O2 as a 
substrate, in the presence o f an E. coli thioredoxin-thioredoxin reductase system 
which transfers electrons from NADPH to TPx. The assay is performed by 
monitoring the decrease in absorbance at 340 nm as NADPH becomes oxidised. 
As expected, o f the two Mtb TPx variants the only one which demonstrates
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NADPH oxidation is TPxWt; no activity was observed with the C60S mutant. An 
essentially identical result was obtained by Jaeger et al. where they combined a 
mycobacterial thioredoxin reductase and Mtb TrxC thioredoxin, with TPxWt in 
the presence o f H2O2 and observed the thioredoxin reductase-dependent oxidation 
o f NADPH (Jaeger et al, 2004). Mtb TPxWt also accepted Mtb TrxB, another 
mycobacterial thioredoxin as intermediate electron donor, although with lower 
reactivity when compared to TrxC. Oxidation of NADPH required all components 
of the thioredoxin-thioredoxin reductase system (thioredoxin reductase, 
thioredoxin and a peroxidase). This research group also examined the reaction rate 
differences that Mtb TPxWt and AhpC exhibit in this peroxidase assay (Jaeger et 
al, 2004). Their observations revealed that TPxWt exhibits an order of magnitude 
greater catalytic efficiency than Mtb AhpC. The TPx dependent reduction of 
peroxynitrite was also tested via stopped-flow analysis for wild-type Mtb TPxWt 
and two Cys —♦ Ser mutants, C80S and C93S. In the presence of TPxWt, 
peroxynitrite decayed rapidly, with a markedly increased reaction with the Mtb 
TPx mutant forms (Trujillo et al, 2006 and Jaeger et al, 2004). As cysteine 
residues are involved in the catalytic activity of peroxiredoxins, Rho et a l 
examined the effect o f sulfhydryl reactive reagents (NEM, IAA and NBD- 
chloride) on Mtb TPx and individual Cys —► Ser mutants in the presence of 
dithiothreitol (DTT). The results revealed that the TPxWt activity to be 
completely inhibited when in the presence o f H2O2 , in much the same way as that 
achieved with ifcTPx under the same conditions (Rho et al, 2006). The 
observation o f complete inhibition o f Mtb TPxWt peroxynitrite reduction using N- 
ethyl-maleimide (NEM), a known reagent in blocking peroxidatic Prx 
(Nogocheke et al, 1997), was also made by Jaeger et al, (2003). Both Rho et al. 
and Jaeger et al. showed that Mtb TPx mutants C60S, C93S were inactive and 
C80S (Rho et al, 2006) was found to be active along with the wild-type TPx 
(Jaeger et al, 2003). When C93 was replaced with a Ser residue through site- 
directed mutagenesis, a decrease in NADPH-linked peroxidase activity was 
measured using the stopped-flow technique, as observed by the decline in 
tryptophan fluorescence o f Mtb TRxB upon oxidation with TPxWt (Trujillo et al, 
2006). These results collectively highlight the importance of two specific cysteine 
residues, C60 and C93, in Mtb TPx peroxidatic activity, but more importantly 
indicate the catalytically essential C60 residue for optimal peroxide detoxification.
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The importance of the C60 residue to TPx activity was further tested by 
establishing its importance in protecting glutamine synthatase activity in the 
presence o f reactive oxygen species (Rho et al, 2006, and Jaeger et al, 2004) and 
in the protection o f supercoiled DNA from oxidative damage (Rho et al, 2006) 
using a thiol-dependent metal-catalysed oxidation (MCO) system (Kim et al, 
1985). In the glutamine synthase measurements, Mtb TPx exhibiting two Cys —* 
Ser point mutations at residues C80 and C93 was able to protect glutamine 
synthase from reactive oxygen species, whilst in the presence of DTT. 
Conversely, the C60S mutant was unable to protect glutamine synthase from the 
same reactive oxygen species, thereby indicating that C60 is the essential 
peroxidatic cysteine. For the supercoiled DNA protection assay the negative 
control in which the Mtb TPx was omitted from the reaction mixture resulted in 
nearly all the DNA being converted to a nicked form, whereas the positive control 
showed about 60 % protection from nicking in the reaction mixture. The mutant 
C60S failed to protect the supercoiled DNA from degradation. In contrast, the 
wild-type enzyme and variants C80S and C93S showed almost complete 
protection activity, indicating that C80 and C93 are not strongly involved in 
supercoiled DNA protection activity.
From the various activity measurements used to examine the peroxidase activity 
o f Mtb TPx, the results show that Cys60 is the peroxidatic cysteine and Cys93 is 
the resolving cysteine in Mtb TPx.
In summary, the similarities observed between iscTPx and Mtb TPx in the 
homologous cysteine positions at the C-terminal end (C95 in .EcTPx and C93 in 
Mtb TPx), the presence of a peroxidatic cysteine (Cp), the formation o f a disulfide 
bridge between Cp and the conserved cysteine within the same subunit and the 
replacement o f the distal cysteine (C95 or C93, respectively) by serine showing 
changes in activity (Rho et al, 2006 and Trujillo et al, 2006) reveals the cysteine 
conserved close to the N-terminal end at position 60 as the peroxidatic (Cp) 
cysteine in Mtb. The distal cysteine (C93) is suggested to be the functional 
equivalent o f the resolving cysteine C r  found in typical 2-Cys-Prxs (Choi et al, 
2003 and Baker and Poole, 2003), primarily due to its supportive role alongside 
the essential C60 residue in peroxidatic activity (Trujillo et al, 2006).
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The formation of an internal disulfide bridge between both the peroxidatic and 
resolving cysteine residues in Mtb TPx appears to be an essential and 
indispensable catalytic requirement in the peroxidase-thioredoxin-thioredoxin 
reductase catalytic system.
3.7. Peroxiredoxin structure.
Seventeen 3D x-ray crystal structures of peroxiredoxins originating from various 
organisms have been reported (see Table 3.1). Often in order to obtain tractable 
crystals mutation of the active site Cp residue has been required. To date, only the 
S. typhimurium AhpC and human peroxiredoxin-V have been crystallized in both 
reduced and oxidized forms. Most peroxiredoxins form dimers but some typical 
two-Cys peroxiredoxins also form decamers consisting o f a pentameric 
arrangement o f dimers.
-91 -
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Name: Species: X-ray
structure
resolution:
Oligomeric
state:
Redox
state:
Note (wild-type 
unless otherwise 
stated):
Reference: PDB
code:
Typical two-Cys Prxl Rat 2.6 A Dimeric Oxidised - Hirotsue/a/, 1999. 1QQ2
Prxs PrxII Human 1.7A Decameric Oxidised - Schroder et al, 2000. 1QMV
TRyP Crithidia fasciculate 3.2 A Decameric Reduced - Alphey et al, 2000. 1E2Y
AhpC Salmonella
typhimurium
2.5 A Decameric Reduced C46S mutation Wood et al, 2003b. 1N8J
AhpC Salmonella
typhimurium
2.5 A Decameric Oxidised Wood et al, 2002. 1KYG
AhpC Amphibacillus xylanus 2.9 A Decameric Oxidised - Kitano et al, 2005. 1WE0
Atypical two- PrxV Human 2.0 A Dimeric Oxidised - Evrard et al, 2004. 10C3
Cys Prxs PrxV Human 1.5 A Monomeric Oxidised - Declercq etal, 2001. 1HD2
£cTPx Escherichia coli 2.2 A Dimeric Oxidised - Choi et al, 2003. 1QXH
SpTPx Streptococcus
pneumoniae
2.3 A Dimeric Reduced Coordinates deposited/no publication. 1PSQ
HiTPx Haemophilus
influenzae
1.9A Dimeric Oxidised Coordinates deposited/no publication. 1Q98
TPx Mycobacterium
tuberculosis
1.75 A Dimeric Oxidised Rho et al, 2006. 1XVQ
TPxC60S Mycobacterium
tuberculosis
2.1 A Dimeric Reduced C60S mutation Stehr et al, 2006. 1Y25
One-Cys Prxs AhpE Mycobacterium 1.87 A Dimeric Oxidised - Li et al, 2005. 1XXU
-93 
-
tuberculosis
AhpE Mycobacterium
tuberculosis
1.9A Dimeric Reduced Li et al, 2005. 1XVW
PfAOP Plasmodium
falciparum
1.8A Dimeric Oxidised Sarma et al, 2005. 1XIY
PrxVI Human 2.0 A Dimeric Reduced C91S mutation Choi etal, 1998. 1PRX
AhpC Mycobacterium
tuberculosis
2.4 A Dodecameric Oxidised Guimaraes et al, 2005. 2BMX
Table 3.1: Structural survey of deposited 3D x-ray crystal structures of peroxiredoxins (Prxs).
3.8. The tertiary structure - the thioredoxin fold.
Although sequence identity is low (typically 20-30 %) among the peroxiredoxin 
family members, all these structures share a thioredoxin-like fold, as indicated by 
PFAM analysis (accession number: PF08534). The thioredoxin fold is fairly 
structurally conserved in nature (Creighton, 2000). It is a protein fold common to 
enzymes that catalyze disulfide bond formation and isomerization through a 
conserved Cys residue situated in an active site region. The fold is named for the 
canonical example thioredoxin and is found in both prokaryotic and eukaryotic 
proteins. The thioredoxin fold is composed of an alpha/beta configuration 
illustrated in Figure 3.4. The fold's spatial topology consists o f a four-stranded (3- 
sheet directly sandwiched between two a-helices, a l  and a3 (colored blue in 
Figure 3.4B) with an additional offset a-helix, a2, orientated towards the N- 
terminal end of the polypeptide (colored dark red in Figure 3.4B).
u 2
A B
Figure 3.4: The thioredoxin fold. A Human thioredoxin, reduced form, (PDB: 1TRX), 1.7 A 
resolution (Weischel et al, 1996). Figure obtained using PyMOL (DeLano, 2006). B A schematic 
diagram representing the thioredoxin fold comprising a 4p stranded sheet with 3a helices. The 
dark red a helix is one of three in the fold that does not sandwich the (3-strands, shown in blue.
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The thioredoxin structure shown in Figure 3.4 represents the ‘simplest’ example 
o f 3D structures in this class. Other examples from the family, such as the TPxs, 
have additional, often small secondary structure elements that elaborate the fold 
(Wood et al, 2003a).
A paper by Choi et al. describes a generalised scheme showing that 2-Cys Prxs 
can be classified into four molecular clades or branches (Choi et al, 2003). They 
begin their description by selecting three atypical 2-Cys Prxs, Mtb TPx, E. coli 
BCP and human Prx that differ from each other in the location of their resolving 
C r  residues and a typical 2-Cys Prx, represented by AhpC. Based on structural 
observations using the four 2-Cys Prxs, the research group identify four different 
locations o f the C r  residue relative to the location o f the conserved C p  residue 
(See Figure 3.5). The proposition is made that Prxs should uniquely belong to one 
o f the four classes based on the location o f the C r  residue and also upon the 
disulfide bridge formed within the polypeptide as intersubunit, L-intrasubunit, R- 
intrasubunit and intrachain bridges.
The schematic representation shown in Figure 3.5 identifies these four different 
locations and the representative classes to which they belong. The figure 
highlights the al-he lix  (C-atypical 2-Cys Prx, C stands for chain), the L (L- 
atypical 2-Cys Prx) and R (R-atypical 2-Cys Prx) chains flanking the a  1-helix, 
and the C-terminal chain that is situated opposite the Cp residue (typical 2-Cys 
Prx).
Considering the three-dimensional structures of Prxs, there cannot sensibly be any 
other distinct location for the C r  residue, and all 2-Cys Prxs should uniquely 
belong to one o f these four classes. Therefore, the set o f three atypical 2-Cys Prxs 
used to formulate this classification are designated as follows: TPx as the L- 
atypical type; PrxV as the R-atypical type; and 2-Cys BCP as the C-atypical type.
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C-atypical 
2-Cys Prx
L-atypical 
2-Cys Prx
R-atypical 
2-Cys Prx
typical 
2-Cys Prx
C-terminal
Figure 3.5. A schematic diagram showing that the 2-Cys Prxs can be classified into four molecular 
clades. Arrows indicate the directions of the disulfide formation. Shaded cylinders denote the a- 
helices and white cylinders denote the region that contains the C r  residue that undergoes a loop-to- 
helix or a helix-to-loop transition depending on redox states. L and R labels for the helices 
flanking the Cp-containing segment on a-helix a l .  These labels follow the scheme described by 
Choi et al, 2003. For Mtb TPx helix L corresponds to a4. Figure adapted from Choi et al, 2003.
- 9 6 -
3.9. Oxidised EcTPx structure and implications for local refolding as part of 
the reactive mechanism.
The structural comparison by Choi et al. led to the suggestion that the local 
conformation of the regions surrounding Prx Cp and C r  residues depends on the 
redox states o f these two cysteine residues (Wood et al, 2002, Wood et al, 2003a, 
Wood et al, 2003b, Declercq et al, 2001, Evrard et al, 2004 and Choi et al, 2003). 
Specifically they compared the structures o f oxidised iscTPx, reduced human 
PrxV, and S. typhimurium AhpC in two states -  the oxidised wild-type and Cp —* 
Ser mutant mimicking the reduced state. They observed that the polypeptide 
backbone at the Cp residue can be either part o f the a l  helix, or in a more coil-like 
conformation depending on the redox state. This variation is apparently coupled to 
local unfolding o f the structure at the position o f the C r  residue, in a manner that 
is dependent upon whether the protein is typical 2-Cys or L-, R-, or C-atypical 2- 
Cys (summarised schematically in Figure 3.5). The analysis suggested that in the 
situation relevant to Mtb TPx -  namely the case exemplified by EcTPx, an L-type 
atypical 2-Cys Prx -  the reaction of the enzyme with substrate leads to a Cp-S-S- 
C r  disulphide coupled to local restructuring o f the N-terminal end of the a l  (Cp) 
helix and the C-terminal end of a2 ( C r ) helix into non-helical conformations. This 
model has led to the reduced Prx state, with more extensive regular secondary 
structure, being referred to as ‘open’ whereas the oxidised state is ‘closed’.
3.10. The quaternary structure -  Mtb TPx dimer.
Two research groups have independently solved X-ray structures o f Mtb TPx 
(Rho et al, 2006 and Stehr et al, 2006) which form quasi-identical homodimers 
with an overall ellipsoidal shape o f similar dimensions. A structure o f wild-type 
Mtb TPx (TPxWt), from the Mtb Structure Genomics Consortium in Los Alamos, 
USA, resembles more the structures o f iscTPx and S. pneumoniae TPx (SpTPx) in 
their oxidised forms, with characteristics consistent with the presence o f a Cp-S-S- 
C r  disulphide bond, and thereby presumably mimics the closed, oxidised state of 
the enzyme. The Mtb TPxWt crystal structure resembles 2-fold related monomers, 
one molecule per asymmetric unit, whereas in all other Prx structures the dimer is
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in the asymmetric unit. An intriguing aspect o f this structure is that a major 
segment o f the polypeptide chain (residues 94-99) is not clearly represented in the 
electron density. In addition there is no interpretable electron density for the side 
chain o f the Cp residue Cys60 (see below). Polar/charged interactions at the dimer 
interface o f TPxWt involve residues in loop regions, as opposed to interacting p- 
strands from opposing interface monomers as is the case in typical two-Cys 
peroxiredoxins and one-Cys peroxiredoxins (Hirotsu et al, 1999 and Schroder et 
al, 2000).
The group o f Hecht and co-workers, together with our collaborators at the GBF 
Braunschweig laboratory, solved the structure o f the Cp —► Ser mutant of Mtb TPx 
(TPxC60S). The structure o f this variant differs from that of TPxWt in a manner 
broadly consistent with the local restructuring model of Choi et al. The TPxC60S 
structure has the extra regular secondary structure and C r  position that 
corresponds to an ‘open’ conformation, and thus probably mimics the reduced 
state o f the wild-type protein. The two molecules in the asymmetric unit of 
TPxC60S have nearly identical structures, with a back-bone atom root mean 
square deviation (R.M.S.D.) o f 0.3 A (Stehr et al, 2006).
3.11. Structural comparisons: Similarities and differences between Mtb 
TPxC60S and M tb TPxWt.
This section discusses the structural comparisons of the two Mtb TPx variants 
with each other, and with a selection o f PDB deposited 3D Prx structures.
At present there are two crystal forms o f Mtb TPx currently deposited in the PDB: 
a mutated variant o f Mtb TPx designated as Mtb TPxC60S (PDB code: 1Y25) and 
an oxidised wild-type form o f Mtb TPx (TPxWt) (PDB code: 1XVQ). Both 
structures exhibit an extended thioredoxin-like fold composed o f a central (3-sheet 
core (strands (33-(37) with flanking a-helices (al-a4), (3-strand segments ((31 and 
(32) and one a3io helix.
TPxWt and TPxC60S, although structurally thioredoxin-like, are somewhat 
different in the detailed secondary structure composition and organisation. The 
automatically generated (PDB SUM) secondary structure topology maps for
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TPxWt and TPxC60S are presented in Figure 3.6. The two structures have in 
common p i, P2, the 3io a-helix turn in a loop connecting p-strands p3, p4, p6 and 
p7 in the central p-sheet, and flanking helices al-a4 . Compared to TPxWt, 
TPxC60S has an extra p-strand (p5) in the central sheet. In addition, the length 
and residue boundaries of a l  and a2 helices are significantly different. In TPxWt, 
a l  starts at residue 61 and ends at residue 74, a total o f three residues longer than 
the equivalent a l  helix in TPxC60S. In helix a2, the reverse is true. In TPxC60S, 
a2 (starting at residue 85 and ending at residue 97) is longer by seven residues 
when compared to a2 in TPxWt (starting at residue 85 and ending at residue 90).
Figure 3.6: Secondary structure maps of A: oxidised TPxWt (PDB: 1Y25) and B: reduced 
TPxC60S (PDB: 1XVQ). P-strands are indicated as purple arrows and a-helices are represented as 
red cylinders. Figure adapted from PDB SUM.
The following schematic describes the structural relationship that TPxWt and 
TPxC60S have with each other and with their two closest homologues, ZscTPx and 
S/?TPx (Figure 3.7). The figure provides the best-fit superposition R.M.S.D. 
values, o f all back-bone atoms, for each pair o f structures.
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1.0 A0.9 A
Figure 3.7: A schematic diagram indicating the structural relationship, based upon 3D X-ray 
crystal structure comparisons, between TPxWt and TPxC60S and the two closest homologues, E. 
coli TPx (£cTPx) and S. pneumoniae TPx (SpTPx), as indicated by the double-headed arrows 
(heavy arrow: strong structural relationship, light arrow: weak structural relationship). The root 
mean square deviation (R.M.S.D.) is given for each 3D structure superposition.
Figure 3.8 shows the superposition of the TPxWt and TPxC60S structures which 
yields a back-bone atom R.M.S.D. of 1.4 A, obtained over 164 residues. Although 
the two 3D structures are clearly very similar at the global level, differences in the 
conformation of the N-terminal segment and the position of helix a4 are 
immediately apparent. Close inspection reveals additional differences in helix a2 
and neighbouring loop structures. The location of the Cp Cys60 residue in TPxWt 
and the equivalent Ser60 (mutated) residue in TPxC60S are found to differ 
substantially between the two structures. In TPxWt the Cys60 residue is part of 
the N-terminus o f helix a l ,  whereas in the TPxC60S mutant Ser60 is outside the 
helix a l ,  which starts at position 61, in a loop region.
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Figure 3.8: Superposition of reduced and oxidised Mtb TPx as represented by TPxC60S (blue) 
and Mtb TPxWt (green), respectively, with the positions of the CP (TPxWt) and Cp-equivalent 
(TPxC60S), including CR residues coloured magenta for TPxC60S and red for TPxWt. Figure 
obtained using PyMOL (DeLano, 2006)
With respect to the N-terminal region, the distal orientation of the N-terminal 
extremity found with TPxWt (compared to TPxC60S and other thiol peroxidases) 
is suggested by Rho et al. to be due to intermolecular interactions resulting from a 
different crystal packing arrangement (Rho et al, 2006). Indeed, TPxC60S adopts 
an N-terminal configuration consistent with other TPxs. In the TPxC60S crystal 
structure residues Ala2, Gln3 and Asn9 in one monomer make hydrogen bond 
contacts with Thr28, Thr30 and Seri 10 in the other monomer resulting in a 
compact N-terminus.
In respect o f the other differences between the two 3D structures, concerning 
helices a l  and a2, the variation occurs in a manner consistent with the Prx local 
restructuring model o f Choi et al. Examination of the position and orientation of 
helix a l  in the two structures reveals a tilt and shift in its position by 
approximately 4 A inducing a similar shift in helix a2 (Figure 3.8). Combined
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with the differences in helix length summarised in Figure 3.6 it can be seen that 
TPxWt and TPxC60S resemble the general model for L-atypical 2-Cys Prx 
polypeptides in the oxidised and reduced states, respectively, in agreement with 
the presumed presence (see below) o f a disulfide bond in the wild-type TPx 
enzyme and its absence in TPxC60S.
The two TPx crystal structures are shown as a separate best-fit superposition with 
the structure o f oxidised £cTPx (PDB code: 1QXH) in Figure 3.9A. The structure 
o f TPxC60S superimposes well on the structure o f oxidised £cTPx, with the 
exception o f the vicinities o f the Cp-equivalent and C r  residues. An R.M.S.D. of 
1.4 A is obtained for the superposition o f all back-bone atoms (Figure 3.9A). In 
general, the structures vary from each other in the orientation and length o f a- 
helices a l -a 4 ,  with milder positional variances in (3-strands (31 and p2. In 
comparison to the R.M.S.D. obtained for TPxC60S with £cTPx, the TPxWt 
structure superimposes on oxidised iscTPx with an R.M.S.D. of 0.9 A over the 
entire C“ back-bone (Figure 3.9A). This R.M.S.D. value is even better than the 
superposition o f TPxWt with TPxC60S (1.4 A). The lower R.M.S.D. value 
obtained for TPxWt with oxidised £cTPx, over that achieved by TPxC60S, is 
representative o f the oxidised state o f TPxWt in solution and is therefore 
consistent with the 2-Cys Prx model proposed by Choi et al.
When comparing the structures o f Mtb TPxC60S with a reduced form of S. 
pneumoniae TPx (SpTPx) (PDB code: 1PSQ), another close Prx family 
homologue, a back-bone R.M.S.D. o f 1.0 A for all the residues in the crystal 
structures is obtained. This fit includes the binding pocket in TPxC60S. The only 
regions o f the TPxC60S structure exhibiting any significant differences to the 
SpTPx structure are found in residues 12-23, which includes a loop region 
proximal to (3-strand (31, and residues 71-77 which includes a region of the 
polypeptide linking helix a l  to p-strand p4 (Figure 3.9B).
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EcTFx SpTPx
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Figure 3.9 A: 3D structural superposition of TPxWt (magenta background (BG)) and TPxC60S (blue BG) with £cTPx. B: 3D structural superposition of TPxWt (magenta background 
(BGV) and TPxC60S (blue BG) with SpTPx. The arrows indicate the ‘strength’ of structural similarity as indicated in Figure 3.7.
Structural superposition o f TPxWt with the reduced SpTPx (Figure 3.9B) yields a 
back-bone atom R.M.S.D. of 1.7 A. On examining the superposition, TPxWt 
exhibits a different positional conformation for the first six N-terminal residues 
when compared with the N-terminus o f SpTPx. In TPxWt, these six residues are 
located in a polypeptide loop region which is spatially isolated, distal to the rest of 
the molecule. In SpTPx, as in TPxC60S, a p-hairpin is present which is formed by 
two short [3-strands. The p-hairpin packs against the loop regions connecting a3 - 
p8 (a3-p6 in TPxWt) and p9-a4 (P7-a4 in TPxWt) thereby compacting the N- 
terminal end o f the polypeptide. Differences also occur in the positioning and 
length o f helices a l  and a2. In SpTPx, the N-terminal helix a l  and the extended 
a2 encompass the C p  (Cys58) and C r  (Cys92) cysteine residues. In TPxWt these 
residues are situated either on a loop region (Cys93) or close to a loop region 
(Cys60 found at the N-terminal end o f a l).
The lower R.M.S.D. value obtained for the global superposition o f TPxC60S with 
reduced S/?TPx, as opposed to the superposition of TPxWt with SpTPx, indicates 
that TPxC60S is apparently representative o f the reduced state o f TPxWt in 
solution. Together with the observation that the structure o f TPxWt is most 
similar to oxidised EcTPx at the global level, these structures fit well with the 2- 
Cys Prx structural remodelling scheme of Choi et al. (Figure 3.6).
3.12. TPxWt electron density discrepancies.
It is instructive to look in detail at the active sites of the TPxWt and TPxC60S 
structures. Curiously, in the TPxWt structure the Cp atom of Cys60 and the 
disulfide bridge sulfurs between Cys60 and Cys93 are missing from the electron 
density map, together with density for residues 94-99. To account for this, Stehr 
et al. made reference to the research carried out by Weik et al. When working on 
the crystal structure of acetylcholinesterase, this research group encountered a 
comparable absence from the electron density map o f an expected intermolecular 
disulfide bridge, together with a missing section o f polypeptide (Weik et al, 
2002). Weik et al. attributed the absence o f the disulfide bridge and corresponding 
residues to X-ray-induced formation o f disulfide radicals, a consequence o f the 
irradiation process used to generate the data for the crystal structure. The
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additional missing residues were presumed to exhibit weak electron densities due 
to radiation damage.
3.13. Active site structure.
In all Prx structures, the active site is located proximal to the dimer interface. In 
the TPxWt structure (Rho et al, 2006), the Cp and C r cysteines, as well as the 
conserved Thr57 and Argl30 residues, are located in a well-defined T-shaped 
cleft with surface dimensions 1 9 A x  1 7 A x 8 A  with a hole o f ~8 A in diameter 
on the right side o f the cleft (Figure 3.10).
When the TPxWt active site region is compared to the corresponding region in 
TPxC60S, there is a characteristic variation in the organisation o f the local 
secondary structural elements - as previously highlighted (see above). The Cp- 
equivalent Ser60 residue in TPxC60S is part o f the a l  helix, as opposed to being 
located on a loop region located to the N-terminal side o f a l  as in TPxWt (Figures 
3.10 and 3.11). The C r  residue in TPxWt is located on a loop region extending 
from the C-terminal end o f the a2 helix, while in TPxC60S the C r  residue is 
located on the a2 helix itself.
Figure 3.10: TPxWt active site comprised of 2 catalytic cysteines, CP and CR, and including 
Argl30 and Thr57, all shown coloured in magenta. Figure composed using PyMOL (DeLano, 
2006).
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Figure 3.11: TPxC60S active site comprised of the catalytic cysteine, Cys93 and Ser60, plus two 
Cp cleft residues A rgl30 and Thr57, all shown coloured in red. Figure composed using PyMOL 
(DeLano, 2006).
A total o f 19 out o f the 27 amino acid residues found on the surface o f the 
TPxC60S binding pocket cleft are conserved in £cTPx (the closest homologue), 
with 13 conserved in the S/?TPx enzyme. Two-thirds o f the residues that line the 
bottom o f the cleft are hydrophobic.
On the basis o f multiple Prx sequence alignments and early indications o f the 3D 
structure Hofmann et al. suggested that the Cp residue is ‘activated’ by the 
proximity o f a nearby positive charge o f a conserved basic residue and by 
hydrogen bonding with a conserved serine or threonine side-chain, which is 
presumed to promote the active site cysteine to form the thiolate that can readily 
attack the ROOH substrate (Hofmann et al, 2002). These three residues constitute 
what is colloquially known as the Prx catalytic triad. Figure 3.12 shows a 
schematic representation of the binding pocket regions o f the TPx structures from 
Mtb, E. coli and S. pneumoniae displayed as structural superpositions that indicate 
the inter-Ca between the Cp (or Cp-equivalent) and C r residues.
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In each case, the position o f the conserved active site Arg and Thr side chains is 
highlighted. In Mtb TPx the catalytic triad is constituted by Cys60 (Cp), Thr57 
(the conserved Thr) and Arg 130 (the conserved basic residue). Figures 3.12A 
shows the superposition o f the active site residues o f Mtb TPx (in the form of the 
C60S mutant) superposed on the equivalent residues o f the SpTY*x structure. The 
residues superpose almost exactly, suggesting that the interactions o f the Cp 
residue with the other two side chains o f the catalytic triad are maintained in the 
two structures. Notably the separation o f the Cp and C r  residues in these two 
structures is substantial (Ca-Ca 12.67 A in TPxC60S; Ca-Ca 13.07 A in SpTVx). 
These two structures appear to fit well with the proposal o f Choi et al. that the 
activation o f Cp involves the conserved Thr Oy positioning the Cp thiol proton for 
abstraction by a catalytic base (the origin o f which was not specified) while the 
conserved Arg residue might aid this process by stabilizing the effective negative 
charge on the Cp sulphur atom. Consequently, the pKa value o f the Cp residue is 
expected to be decreased and the nucleophilic attack on the hydroperoxide 
substrate to be facilitated (Choi et al, 2003). Interestingly the detail o f the H- 
bonding pattern o f the Ser60 residue in the TPxC60S mutant is not completely 
consistent with this model (Figure 3.13). Perhaps because o f the substitution at the 
Cp residue, or because o f the presence o f the acetate ion in the active site, the 
structure does not predict an H-bond interaction between the side chains of Thr57 
and Ser60, despite their evident proximity (2.89 A). Arguably the precise 
arrangement o f the side chains in this structure would be different in the reduced 
state o f  TPxWt.
Figure 3.12C shows the superposition o f the active site residues o f TPxWt and 
iscTPx, structures that are both presumed to contain a C p - C r  disulphide bond. 
Again the superposition o f these atoms appears to be very close. The presence of 
the disulphide bond is consistent with the relatively small C p - C r  residue 
separations (Ca-Ca 5.39 A in TPxWt; Ca-Ca 5.58 A in £cTPx) (Figure 3.12C).
However, when the TPxC60S binding pocket region is compared to that of 
oxidised TPxWt, the position o f the residues involved in the catalytic triad are 
substantially different (Figure 3.12B). The most notable difference is in the 
position o f the C p  and C r  residues. In TPxWt, the C p  and C r  residues are 
presumed (despite the absence of electron density for some atoms) to be bonded 
by the disulphide bridge linkage; while in TPxC60S the distance between the two
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residues is substantially greater (Ca-Ca 12.67 A). If the structures o f Mtb TPxWt 
and TPxC60S represent the conformations o f oxidised and reduced TPx pertinent 
to the reaction mechanism o f Figure 3.3, then it appears that the general features 
are conserved with TPxs from E. coli and S. pneumoniae. Moreover, the overall 
nature o f the structures combined with a detailed analysis o f the catalytic triad 
side chains appears to highlight that a significant remodelling o f the Prx structure 
is required to bring the C p  and C r  side chains together to form the oxidised 
disulphide bonded reaction intermediate from an initial state in which the side 
chains are much further apart.
C a-C a 13.07 . J 1
*
C a-C a 12.67
#■
A
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-C a 5.58
Figure 3.12: A stick-representation of the catalytic triad (CP, Arg and Thr), together with the CR 
residue, found in the binding pocket of most Prxs. A superposition of the catalytic triad of A: 
TPxC60S (magenta) and SjpTPx (cyan), B: TPxC60S (magenta) and TPxWt (green). Arrows and 
circles indicate the movement of the distal N-terminal end of each residue, from the reduced state 
position to the oxidised-equivalent state position. C: TPxWt (green) and EcTPx (orange). CP and 
CR residue distances (A) are shown as doted line in each figure-set.
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In the magnesium acetate buffer used to generate the TPxC60S crystal structure, 
free acetate ions were present in solution. In the resulting structure an acetate ion 
was observed to bind at a position identified as the ‘active site’ or binding pocket 
(Figure 3.13). This suggests a potential affinity o f TPx for acidic ligands, which is 
understood to be common among various types o f Prxs based upon the chemistry 
o f the residues commonly situated within the binding-pocket (Stehr et al, 2006). 
The crystallographers observed that the TPxC60S-bound acetate ion is apparently 
insufficient to trigger conversion o f TPxC60S to the open conformation of the 
oxidised state presumably because o f its small size and weak binding affinity 
(Stehr et al, 2006). As discussed above, the details o f the interaction o f the acetate 
group with the catalytic triad do not reveal the precise mechanism of activation of 
the Cys60 thiol grouping the wild-type protein. The precise arrangement of the 
triad may be altered in the presence of the native Cys60 thiol group (instead of the 
Ser60 substitution). Nevertheless, it is interesting to note that the presence of a 
ligand in the active site appears significant to promote a conformational change of 
Mtb TPxC60S towards one more closely resembling the open state. This leaves 
open the question o f how the protein’s C r  residue samples the reactivity of the C p  
residue; does this require a substrate-induced conformational change, or a sulfenic 
acid modulated allosteric transition, or any other mechanism? This matter is 
considered further in Chapter 4.
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Figure 3.13: A ball and stick representation of the TPxC60S binding pocket with associated 
acetate ion. Black dots are the carbon atoms, blue dots are nitrogen and red dots are oxygen. The 
letter (A) that accompanies each residue shown is in reference to all residues present in the same 
protomer.
3.14. Discussion.
Stehr et al. revealed that the acetate ion, found to bind to the TPxC60S binding- 
pocket, forms hydrogen bonds from a carboxylate oxygen atom to a number of 
closely orientated side chain residues that include Ser60, Thr57, and Arg 130 as 
well as the back-bone amide NH o f Ser60 (Stehr et al, 2006). They postulate that 
similar contacts may be possible for the typical Prx substrates, e.g. hydrogen 
peroxide, /-butyl hydroperoxide and cumene hydroperoxide (Jaeger et al, 2004 
and Stehr et al, 2006).
In the context o f the broad aims o f the work described in this thesis the 
availability o f  the crystal structures o f TPxWt and TPxC60S is extremely useful. 
The comparison o f the structures and their homologues clearly indicates that the 
L-atypical 2-Cys Prx reaction scheme o f Choi et al. should be relevant to the 
mechanism o f Mtb TPx. Thus one can anticipate that the structure around the 
active site is dependent upon the redox state o f the enzyme. For example in the
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‘open’ reduced state, which presumably is a representation o f the catalytically 
primed conformation, ready to bind substrate, the C p  and C r  residues are some 
distance (9.87 A), whereas in the ‘closed’ oxidised state, which must occur at 
some later stage in the reaction cycle (Figure 3.12C) the two are more tightly 
associated (4.61 A). In searching for potential ligands for Mtb TPx that might 
provide a framework for inhibitor discovery, it is necessary to confront (a) the fact 
that the Cp active site of many Prx proteins is highly conserved (e.g. by the 
catalytic triad o f Cys, Arg and Thr residues), potentially making the Mtb-specific 
activity hard to achieve, and (b) that the protein has an intrinsic potential for 
conformational reorganisation (evidenced by the structures described here) that 
may confuse design efforts.
Interestingly Stehr et al. discussed the fact that there is little evidence for dynamic 
properties o f Mtb TPx in the TPxC60S structure. Thus they found no pattern in 
the electron density, or in the X-ray temperature factors, that suggested the 
potential for dynamic behaviour in this region. They concluded that “the 
[structural changes] are either induced by ligand binding or oxidation of the 
peroxidatic cysteine. The acetate molecule ...is evidently not sufficient to trigger 
conversion to the open conformation o f the oxidized state” (Stehr et al, 2006). 
One can argue with the validity o f these comments, but it remains a fact that along 
the reaction coordinate the TPx protein appears to interconvert between 
substantially different sub-states, and by definition this can only be achieved by a 
dynamic process.
The NMR investigation o f Mtb TPx discussed in subsequent chapters was 
performed at the same time that the crystallographic results were emerging, and it 
is interesting to analyse these results, obtained in solution, in the context of the 
foregoing descriptions from X-ray diffraction.
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Chapter 4
TPxWt and TPxC60S -  Results: secondary 
structure determination and preliminary 
NMR spectroscopic data
4.1. Chapter summary.
E. coli strains transformed with plasmids for the expression o f Mtb TPxWt (wild- 
type) and a (Cys60 —► Ser60) mutant TPxC60S were obtained from the German 
Research Centre for Biotechnology (GBF) supplied on antibiotic-prepared LB 
agar plates. Following confirmation o f amino acid sequence by the amino acid 
sequencing company MWG-Biotech™, both TPx proteins were subsequently 
expressed in large quantities, and purified from the soluble fraction using the 
methods described in Sections 2 2 -2 3 .  Sufficient pure protein was obtained from 
3 L culture volumes to yield samples o f 2.0-4.5 mM concentration. The 
oligomerisation state and secondary structure content was assessed using 
analytical size exclusion chromatography (ASEC) and circular dichroism (CD) 
respectively. For NMR, the expression protocols for proteins was modified to
IS 9 13include uniform multi-isotope labelling to produce [ N, H, C]-enriched 
TPxC60S for triple resonance spectroscopic experiments. 80 % o f the resonances 
corresponding to the back-bone atoms o f TPxC60S were assigned. The 
corresponding “missing” cross peaks from the back-bone assignment process has 
been hypothesized as being due to dynamic motion between alternate states, 
resulting in chemical exchange between nuclei leading to line broadening. 
Potential scenarios to account for the pattern o f line broadening are discussed.
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4.2. TPxWt and TPxC60S -  expression and purification.
Studying proteins using NMR techniques typically requires proteins in multi­
milligram quantities at millimolar concentrations in aqueous buffers. In many 
cases, technical and/or economic limitations can become apparent in the 
production o f proteins.
In order to carry out a biologically relevant study o f both TPxWt and TPxC60S 
(the amino acid sequences o f each protein was confirmed through amino acid 
sequencing carried out by MWG-Biotech™) the buffer conditions must be kept as 
close to physiological pH (pH 7.4) and the salt concentration kept as in vivo, 
optimally below 200 mM for suitable NMR spectroscopic study. Before 
attempting a large scale preparation of either o f the TPx proteins, a small scale 
preparation was performed to assess the “foldedness” (stability and spectral 
characteristics (discussed in Section 4.5)) o f the TPx proteins in typical conditions 
commonly applied in protein NMR experiments. A I L  recombinant E. coli cell 
culture was grown for each protein independently (see Section 2.3). Following 
overnight induction using isopropyl (3-D-l-thiogalactopyranoside (IPTG), each 
culture was then assessed for protein expression levels in both the cell pellet and 
soluble fractions (as described in Section 2.2). Following rupture by French press, 
SDS-PAGE gels were run (as described in Section 2.2) revealing that each Mtb 
TPx clone did express substantial yields in the soluble fraction at the expected 
molecular weight (16.5 kDa). In fact, there was little evidence o f TPx in the 
insoluble fraction.
It was straightforward to demonstrate that the expressed TPx proteins could be 
isolated by immobilised metal ion affinity chromatography (IMAC) using Ni- 
NTA resin (see Section 2.3.3). The proteins were retained on the resin during 
buffer washes with low concentrations o f imidazole, and could be recovered in 
essentially pure form by elution with 150-300 mM imidazole.
To obtain sufficient material for biophysical investigations, I performed a larger 
scale preparation o f  each TPx protein: 3 L culture volume followed by cell 
rupture, and protein purification by Ni-NTA IMAC and preparative size exclusion 
chromatography (SEC) (see Sections 2.2-2.3).
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Figures 4.1 A and 4 .IB show the SDS-PAGE gels obtained after the Ni-NTA 
chromatography purification for both TPxWt and TPxC60S, respectively.
TPxW t TPxC60S
Key: Ex = Elution fraction, Mw = Molecular weight marker
Figure 4.1: A and B SDS-PAGE gels of [’H]-TPxWt and TPxC60S purified by Ni-NTA IMAC 
Lanes labelled E r Eio represent the fraction obtained with increasing imidazole concentration in 
the elution buffer: Ej (5 mM imidazole) -  E10 (500 mM imidazole). Red numbering indicates the 
Mw protein marker sizes for A and B gels, 1: 200 kDa, 2: 116.3 kDa, 3: 97.4 kDa, 4: 66.3 kDa, 5: 
55.4 kDa, 6: 36.5, 7: 31 kDa, 8: 21.5 kDa, 9: 14.4 kDa, 10: 6 kDa, 11: 3.5 kDa, and 12: 2.5 kDa.
Based solely on the qualitative interpretation of the SDS-PAGE protein gels 
produced, the Ni-NTA purification process reveals that both TPxWt and 
TPxC60S are obtained at high levels. As reducing state SDS-PAGE conditions 
were used, both proteins appear on the gel at the monomeric molecular weight 
(16.5 kDa). IMAC fractions ( E 3 - E 9 )  were then pooled and concentrated (as 
described in Section 2.2.) and the TPx proteins further purified by being passed 
down a Superdex-75 SEC column (as described in Section 2.3.4.). This step 
separates out any large aggregate impurities and additionally removes the bulk of 
the imidazole buffer from the IMAC step.
Figures 4.2A and 4.2B show the SEC chromatograms and corresponding protein 
gels obtained for the SEC of TPxWt and TPxC60S, respectively.
16.5
kDa
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TPxW t TPxC60S
V o lu m e  (m l)
Key: Ei (35 mL)— Ei3 (95 mL) = Fraction number, Mw = Molecular weight marker
Figure 4.2: A and B: SDS-PAGE of ['H]-TPxWt and TPxC60S purification by Superdex-75 SEC 
respectively. Each lane corresponds to an eluted fraction of 5 mL. Red numbering indicates the Mw protein 
marker sizes for A and B gels, 1: 200 kDa, 2: 116.3 kDa, 3: 97.4 kDa, 4: 66.3 kDa, 5: 55.4 kDa, 6: 36.5, 7: 
31 kDa, 8: 21.5 kDa, 9: 14.4 kDa, 10: 6 kDa, 11: 3.5 kDa, and 12: 2.5 kDa.
The results demonstrate that in each case the TPx protein is eluted as the dominant 
species with only relatively minor contamination by other (larger) proteins.
These additional species could either represent oxidised TPx oligomers (e.g. the 
band at ~33 kDa; Figure 4.2) or contaminant proteins that persist through the SEC 
process. Subsequent attempts to separate TPxWt and TPxC60S from the identified 
higher order oligomeric species using ion exchange chromatography (IEC) and 
varying salt concentrations (200-650 mM) proved unsuccessful (as described in 
Section 2.3.5).
The elution fractions corresponding to the protein peaks in both chromatograms 
(volume 50-80 ml; elution fractions E4 -E 11) were then pooled and subsequently 
concentrated to 1 mL volume. The final concentration, averaged over a number of
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subsequent similar preparations, ranged between 4-6  mM and 4.5-6.5 mM for 
TPxWt and TPxC60S respectively.
Both Mtb TPx proteins were then processed (as described in Section 2.2-2.3) in 
order to have the N-terminal amino acid sequence confirmed by a commercial 
sequencing service (MWG-Biotech™), prior to further experimental use. 
Successful sequencing data then allowed the continued use o f both proteins for 
further biochemical analysis.
4.3. Analytical SEC analysis of TPxWt and TPxC60S.
In an attempt to determine whether TPxWt and TPxC60S can exist as higher order 
oligomers like some other Prxs, PrxII (Human -  decameric), TRyP (Crithidia 
fasciculate -  decameric) and AhpC {Salmonella typhimurium, Amphibacillus 
xylanus -  decameric, Mycobacterium tuberculosis -  dodecameric) which exist as 
various state oligomeric redox-independent multimers (discussed in Section 3.7), 
analytical SEC (ASEC) was performed using each protein at progressively 
decreasing protein-concentrations, ranging from 6  mM to 1 mM (as described in 
Section 2.3.5.). Figures 4.3A and 4.3B display the ASEC data obtained for Mtb 
TPxWt and TPxC60S, respectively, using a Superdex-75 matrix and a buffer 
containing 1 mM DTT to maintain the reduced state.
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ASEC: TPxW t
6.0 mMA
3.0 mM
1.5 mM 
1.0 mM
ASEC: TPxC60S
B
6.0 mM
3.0 mM
1.5 mM 
1.0 mM
Figure 4.3: A and B Superdex-75 ASEC chromatograms of Mtb TPxWt and TPxC60S, 
respectively, at different protein concentrations. The asterisk in Figure A indicates a shoulder 
feature for the wild-type protein, attributed to a concentration dependent higher molecular weight 
species.
- 1 1 8 -
ASEC allows the assessment o f the hydrodynamic properties of the target protein 
by comparison o f the elution volumes with a range o f standards of known 
properties. To this end the Superdex-75 column was calibrated with four 
molecular weight standards (Figure 4.4A). The elution volumes of TPxWt and 
TPxC60S where then compared with the standards using the standard semi-log 
plot (Figure 4.4B).
ASEC chrom atogram  of protein s tandards for 
Superdex-75 calibration
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5.5 y = -0.2622x+ 8.1617 
R2 = 0.9957
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Figure 4.4: A: ASEC of protein standards obtained for the Superdex-75 column. B 
Semi-log calibration plot generated from the protein standards elution data in A, showing 
the experimental elution volumes of TPxWt (blue) and TPxC60S (red)
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The most dilute protein samples o f TPxWt and TPxC60S (1 mM) eluted with an 
apparent molecular weight o f 34.9 kDa and 34.7 kDa respectively. TPxWt has a 
predicted monomer molecular weight o f 16.9 kDa and therefore the ASEC result 
suggests that the protein is present in solution as a homo-dimer. The result is 
consistent with analytical ultracentrifugation studies of E. coli TPx (£cTPx) and 
S. pneumoniae TPx (S/?TPx), which have been shown to be non-covalent homo­
dimers in solution, regardless of oxidation state (as described in Section 3.10). 
The asymmetry o f the TPxWt chromatographic peak at higher concentrations is 
presumably a result o f higher order oligomerisation at higher concentrations 
(Figure 4.3A). The chromatogram shoulder (indicated by the asterisk in Figure 
4.3A) o f TPxWt at 6  mM elutes at approximately 12.15 mL corresponding to an 
apparent molecular weight of 70 kDa (anti-log104.85). This observation is perhaps 
representative o f a tetrameric (dimer of dimers) form o f TPxWt. TPxC60S 
appears to behave as a homodimer over the complete range o f concentrations 
tested, without evidence for higher order oligomerisation. Therefore, at a 
concentration o f ~ 1 mM in the presence of DTT, the reduced forms o f both Mtb 
TPxWt and TPxC60S behave as homodimers.
4.4. Secondary structure analysis of TPxWt and TPxC60S using circular 
dichroism (CD) spectroscopy.
The following is an examination into the secondary structure o f Mtb TPxWt and 
TPxC60S using CD spectroscopy (as described in Section 4.4.3). A brief 
description and the common applications o f CD spectroscopy are initially 
provided to highlight the usefulness o f this technique as a tool in structural 
analysis (sections 4.4.1-4.4.2).
4.4.1. Circular dichroism (CD) spectroscopy.
CD is a low resolution technique when compared to more complex methods of 
structural analysis o f proteins through NMR spectroscopy and X-ray 
crystallography.
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Circular dichroism (CD) spectroscopy measures differences (as a function of 
wavelength) in the absorption o f left-handed polarized light versus right-handed 
polarized light which arise due to structural asymmetry. CD data is often provided 
as the mean residue elipticity (MRE), in degrees cm 2 dmol’ 1 residue"1, for each 
amino acid residue measured and is calculated using the following equation:
CD signal
(lOx number o f  am m o  acids) x protein concentration (Molar) x  pa th -len g th  (cm)
Chiral or asymmetric molecules produce a CD spectrum because they absorb left 
and right handed polarized light to different extents and thus are considered to be 
‘optically active’. Biological macromolecules such as proteins and DNA are 
composed o f optically active elements and because they can adopt different types 
o f three-dimensional structures, each type o f molecule produces distinct CD 
spectrum (Whitmore, 2004 and Kalodimos, 2004).
4.4.2. Applications o f circular dichroism spectroscopy.
Despite its low resolution, CD spectroscopy is useful in a variety o f contexts 
including:
• Determining whether a protein is folded, and if  so characterizing its 
secondary structure content and thereby infer characteristics o f the overall 
tertiary structure, and the structural family to which it belongs.
• Comparing the structures o f a protein obtained from different sources (e.g. 
species or expression systems) or comparing structures for different 
mutants o f the same protein.
• Demonstrating comparability o f solution conformation after changes in 
manufacturing processes or formulation.
• Studying the conformational stability o f a protein under physical “stress” - 
thermal stability, pH stability, and stability to denaturants - or how this 
stability is altered by buffer composition or addition o f stabilizers and 
excipients.
• Determining whether protein-protein interactions alter the conformation of 
protein.
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For proteins, the secondary structure composition can be determined by CD 
spectroscopy in the "far-UV" spectral region (190-250 nm). At these wavelengths 
the chromophore is the peptide bond, and the signal observed is found to be 
dependent on the local structure of the polypeptide chain.
Alpha-helix, beta-sheet, and random coil structures each give rise to a 
characteristic shape and amplitude o f CD spectrum. This concept is illustrated by 
the graph in Figure 4.5, which shows spectra for identical peptides exhibiting 
different secondary structure conformations. Note: Delta 8  (y-axis below) is a 
simple conversion o f a proteins MRE data into a more manageable, clearly 
displayable form with the units (mdeg M 'c m 1).
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Figure 4.5: Characteristic far-UV CD signatures representing different secondary structures 
(adapted from Kalodimos, 2004)
The approximate fraction o f each secondary structure type that is present in any 
protein can thus be determined by analyzing its far-UV CD spectrum as a sum of 
fractional multiples o f such reference spectra for each structural type.
Like all spectroscopic techniques, the CD signal reflects an average o f the entire 
molecular population in the sample. Thus, while CD can determine that a protein 
contains about 50 % alpha-helix, it cannot determine which residues are 
specifically involved in the alpha-helical portion, or if the sample is in exchange 
between equimolar amounts o f helical and non-helical structures.
Far-UV CD spectral measurements require 20-200 pL o f solution and containing 
50 pg/mL to 1 mg/mL protein in a buffer which does not have a high absorbance 
in this region o f  the spectrum. High concentrations o f DTT (>2 mM), histidine, or 
imidazole, for example, cannot be used in the far-UV region.
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4.4.3. Circular dichroism spectroscopy of TPxWt and TPxC60S.
Figures 4.6A and 4.6B show the far-UV CD spectra obtained for TPxWt and 
TPxC60S respectively, using the method as described in Section 2.3.6.
TPxWt TPxC60S
260& .,*» 220210 230 250 260 200 220 230210 240 250
W avelength (nm) Wavelength (nm)
B
Figure 4.6: Circular dichroism spectroscopy spectra of both; A TPxWt (blue) and B TPxC60S 
(red)
The similarities between the two spectra are immediately clear. For both proteins 
the spectra are consistent with secondary structure characteristics common to 
proteins with mixed beta-sheet and alpha-helical content. This qualitative measure 
is based on the fact that both spectra fail to match exactly with either of the 
characteristic far-UV CD signatures illustrated in Figure 4.5. Both spectra have a 
minimum at -220 nm. For a completely alpha-helical content protein, two minima 
are common, 2 2 2  and 208 nm, while a protein composed entirely of anti-parallel 
(3-sheets has a single minimum at -217 nm. Both TPx proteins lack a minima at 
217 nm and as a result of lacking the complete alpha-helical minima complement 
it would be essentially reasonable to propose that both proteins are composed of 
an alpha-helical/beta-sheet mixture. The shifted minimum at -220 nm, as opposed 
to an expected alpha-helical minimum of 2 2 2  nm, may be accounted for by the 
intermediate spectral line-shape that would exist for such mixed alpha- 
helical/beta-sheet secondary structure content proteins. This result is consistent 
with the crystal structures that exist for both TPxWt (PDB code: 1XVQ) and 
TPxC60S (PDB code: 1Y25) and is typical of the thioredoxin-like fold that both 
proteins resemble (as detailed in Sections 3.8. and 3.11.).
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4.5. Heteronuclear NMR spectrosopy of TPxWt and TPxC60S.
Analysis by ID [!H]-NMR is often performed to assess whether a protein is 
folded, and is usually carried out on unlabelled protein samples prior to isotope 
labelling for more sophisticated 2D/3D NMR measurements.
The assessment o f a ID ['HJ-NMR spectrum is reliant upon specific spectral 
features and the experience o f the spectroscopist to recognise the extent of protein 
folding present. The regions o f a ID [’H]-NMR spectrum exhibiting spectral 
features typically attributed to that o f folded proteins is represented in the 
chemical shift ranges 9-11 ppm and <1.0 ppm, which correspond to the amide and 
methyl regions o f a sample protein respectively. For a disordered polypeptide 
chain, the chemical shifts o f the various protons resemble those o f the constituent 
amino acids, and therefore the spread (dispersion) o f the NMR signals is limited. 
Typically there would be no intensity up-field o f the methyl group signals o f Val, 
lie and Leu at 0.8 ppm, or downfield o f the back-bone amide NH groups at 8.3- 
8.7 ppm (excepting those few side chain signals that might appear in the region 
below -1 0  ppm, e.g. the Trp ring indole NH signal). In contrast, for an ordered 
folded polypeptide the chemical shift dispersion is typically substantially 
increased so that some aliphatic protons may appear at chemical shifts <0.8 ppm, 
and some amide NH groups appear in the region 8.6-10.5 ppm. The presence of 
signals in these regions o f the ID spectrum is usually taken as a good indication 
that the protein contains a folded component. The relative intensity o f the spectral 
envelope between ~0.8 ppm and the signals up-field o f 0.8 ppm (<0.8 ppm) is 
sometimes used to qualitatively assess the degree of folding (though there are 
risks to this approach). The unlabelled []H]-TPxWt and TPxC60S preparations 
were examined by ID  NMR which yielded spectra apparently consistent with a 
high degree o f folding (data not shown).
This result paved the way for the use o f isotope labelling o f the two proteins for 
detailed analysis.
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Figures 4.7A and 4.7B show the ID *H NMR spectra obtained for single isotope 
( i5N) labelled preparations o f both proteins. The spectra o f TPxWt and TPxC60S 
show both proteins to be folded, with the mutant exhibiting slightly sharper 
resolved spectral features compared to the wild-type protein. These spectral 
characteristics suggest that TPxWt and TPxC60S are globularly folded molecules. 
The fact that the resonances of the TPxWt spectrum appear slightly broader than 
those o f the mutant may be consistent with a higher order self association as 
witnessed in the corresponding SEC experiments (Section 4.3).
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Figure 4.7: A and B ID ‘H NMR spectra o f 15N-labelled TPxWt and TPxC60S, respectively. Red 
and blue boxes indicate the folded protein spectral features in the methyl and amide regions, 
respectively. Both A and B spectra obtained at 500 MHz, at 1 mM, pH 7.48 and 25 °C.
Subsequent 2D ['H , 15N]-HSQC spectra recorded (as described in Section 2.3.7.3) 
for 1 mM samples o f TPxWt and TPxC60S display highly dispersed and well- 
resolved cross peaks over the range o f chemical shifts typical for an ordered 
protein (Figures 4.8A and 4.8B, respectively). However, there are some 
significant differences between the two spectra. Thus, TPxC60S and TPxWt 
exhibit 149 and 130 cross peaks respectively. The cross peaks in the TPxC60S 
spectrum are better defined than those in the wild-type spectrum by virtue of 
exhibiting higher intensities and a more uniform appearance.
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Figure 4.8: A and B display the 2D [15N]-HSQC spectra of TPxWt and TPxC60S, respectively. A 
folded Arg side chain signals are highlighted in blue boxes. Both A and B spectra obtained at 500 
MHz, at 1 mM, pH 7.48 and 25 °C.
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Figure 4.9 shows a superposition o f [l5N]-HSQC spectra o f TPxWt and TPxC60S. 
Overall, the pattern o f chemical shifts are highly conserved suggesting that the 
two proteins have essentially identical structures. Small chemical shift differences 
are apparent for many cross peaks, but these are typically less than the width of a 
cross peak and probably represent very small adjustments o f the TPxC60S 
structure in response to the mutation. The broad cross peak line shapes observed 
in the TPxWt HSQC spectrum may be as a result o f a tendency to form higher 
order oligomeric forms, as identified in the ASEC experiment (Figure 4.3A). Even 
if only a small percentage o f TPxWt exists as the presumed tetramer, the 
exchange between this state and the majority homodimer could lead to substantial 
line broadening. Examples o f the cross peaks that are only identified in the 
spectrum o f the mutant are illustrated in Figure 4.9 (green boxes).
For these “extra” cross peaks it is presumed that the “missing” peaks in the 
TPxWt spectrum are absent due to line-broadening and not because o f a large 
chemical shift difference.
Q
10 9 8 7 6
'H  (ppm)
Figure 4.9: Superposition of [15N]-HSQC spectra obtained for TPxWt (red) and TPxC60S 
(black). Green boxes indicate the cross-peaks found in the mutant-type variant that are not 
found in the wild-type Mtb TPx variant Spectra obtained at 500 MHz, at 1 mM, pH 7.48 and 25
°C.
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4.5.1. Transverse relaxation optimised spectroscopy (TROSY) NMR using 
[*H, 15N]-labelled TPxWt.
In an attempt to increase the sensitivity o f the cross peaks obtained for TPxWt 
using []H, 15N]-HSQC NMR experimentation, transverse relaxation optimised 
spectroscopy (TROSY) NMR was implemented (as described in Section 2.3.7.5.).
4.5.2. Transverse relaxation optimised spectroscopy (TROSY) NMR.
15N transverse relaxation is predominantly caused by two mechanisms: dipole- 
dipole interaction and chemical shift anisotropy (as well as applied field in­
homogeneity). Dipole-dipole coupling causes a local magnetic field between 15N 
and nuclei; the rotation o f a protein molecule causes this field to fluctuate in 
relation to the large applied magnetic field. Chemical shift anisotropy refers to 
the directional local field exerted by surrounding nuclei; rotation o f a protein 
molecule relative to the applied magnetic field causes this local field to change in 
direction and magnitude. The “wobbling” o f these local magnetic fields leads to 
phase coherence loss and therefore transverse relaxation causes broader signals 
with a weaker signal/noise ratio (Levitt et al, 2001).
The TROSY principle makes use o f interference between dipole-dipole coupling 
and chemical shift anisotropy. HSQC experiments use decoupling to remove the 
splitting o f peaks from spin-coupled nuclei and therefore give a broadened 
average peak. TROSY allows selection o f the multiplet peak with the longest 
transverse relaxation time caused by interference between the two relaxation 
mechanisms and therefore gives rise to narrower line widths. The selection of 
multiplet peaks is made possible by the TROSY pulse sequence (Fernandez et al, 
2003). TROSY NMR is most useful in situations where the rotational correlation 
(tumbling) time is so long as to lead to significant line broadening. Experience 
shows that application o f the TROSY pulse sequence can be beneficial for 
globular proteins larger then -30  kDa (though the full benefits are only realised 
when the non-exchangeable C-H protons are replaced with deuterium atoms).
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Figure 4.10 shows the [!H, 15N]-TROSY spectrum obtained for TPxWt and a 
comparison with the HSQC spectrum of the same protein.
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Figure 4.10: A: [!H, l5N]-Transverse relaxation optimised spectroscopy (TROSY) NMR 
experiment of Mtb [l5N]-labelled TPxWt at 1 mM protein concentration, measured at 25°C and 
performed according to the experimental parameters described in Section 2.3.7.5 on the 600 MHz 
spectrometer. B: [’H, i5N]-HSQC spectrum of 1 mM [15N]-labelled TPxWt.
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Unfortunately, no new cross peaks were identified in the use o f TPxWt in the 
TROSY method spectrum, despite evident improvements in the lindwidths of 
individual cross peaks (compared to the [*H, 15N]-HSQC spectrum). This result 
perhaps indicates that the origin o f the cross peak intensity variation might be a 
reflection o f chemical exchange processes, which leads to differential line 
broadening. Such exchange may result from inter-conversion between alternate 
oligomerisation states.
From this evidence, it was concluded that continued NMR examination of the Mtb 
TPx protein would likely be more tractable with the mutant variant TPxC60S. To 
this end, and anticipating potential difficulties with the overall hydrodynamic 
behaviour o f the 33 kDa homodimer, a triple [2H, 13C, 15N]-labelled TPxC60S 
protein sample was then made, as described in Section 2.3.2.3.
The ID [lU] and 2D [lH, 15N]-HSQC spectra of [15N, 13C, 2H]-labelled TPxC60S 
are shown in Figures 4 .11A and 4.1 IB respectively. The ID spectrum of the 
perdeuterated sample (Figure 4.11 A) clearly indicates retention o f the globular 
fold (evidenced by the good dispersion o f the amide NH chemical shifts -6.0-10.5 
ppm) and also that the majority o f non-exchangeable C-H protons have been 
replaced by deuterons. Although not assessed quantitatively the overall 
appearance o f the spectrum suggests a level o f CH replacement greater than 85 %, 
as is typical for the labelling procedure that I have applied (i.e. protonated glucose 
carbon-13 source in 98 % D2 O).
The 2D [lH, 15N]-HSQC spectrum of [2H, 13C, 15N]-TPxC60S (Figure 4.1 IB) 
demonstrates essentially identical chemical shift dispersion to the corresponding 
spectrum of [15N]-TPxC60S, indicating retention o f the overall protein fold. As 
expected, the cross peaks o f  the perdeuterated protein appear narrower than the 
protonated sample. In addition, the spectra contain the same number o f signals 
(Figure 4.11C) thereby indicating that back exchange o f N-D groups to N-H 
groups is complete. This observation is important because artificially incomplete 
back exchange o f  the N-D groups would limit the completeness o f the subsequent 
analysis o f the spectrum.
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Figure 4.11: A: ID ['H] NMR spectrum of [2H, 13C, 15N]-TPxC60S and B: []H, ,5N]-HSQC 
spectrum of [:H, l3C, l>N]-TPxC60S. C: spectral superposition of ['H, 15N]-HSQC spectra of 
[2H, i3C, i5N]-TPxC60S with [15N]-TPxC60S, showing that both spectra match exactly in cross 
peak number. All spectra obtained at 500 MHz, at 1 mM, pH 7.48 and 25 °C.
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4.6. TPxC60S -  amino acid back-bone assignment.
The apparently superior properties of the preliminary NMR spectra of TPxC60S 
compared to TPxWt clearly indicated that it would be sensible to pursue further 
analysis o f the former rather than the latter. This decision would provide a greater 
chance o f completeness in the all-important resonance assignment process. 
Thereafter, given the high degree o f overlap in the spectra o f the wild-type and 
mutant proteins, the majority o f the assignments could be transferred with little 
ambiguity to the TPxWt spectrum.
To obtain the back-bone resonance assignments for TPxC60S, a [2H, 13C, l5N]- 
isotope labelled sample was prepared and a suite of essentially standard triple 
resonance 3D NMR experiments incorporating 2H-decoupling was performed. 
Full details o f the experimental parameters employed for each experiment are 
listed in Section 2.3.7.6, along with a brief description of the methodology 
employed in the analysis o f the recorded datasets (Section 2.10.3). Suffice to say 
here that the pulse sequences used are well-established and have been used 
multiple times in our laboratory. A full description o f the pulse sequence design 
and the particular choice o f the parameters employed for solvent suppression, 
shaped pulses and selective decoupling are outside o f the scope of this thesis.
With the assignment scheme that was employed for TPxC60S, it was anticipated 
that is should be feasible to obtain the ^ n, 15Nh, 13Ca, 13Cp, and 13CO chemical 
shifts for the vast majority o f amino acid residues. Because o f the [2H]-labelling, 
the 1Ha signal and the majority o f side chain 'H  signals were absent and these 
assignment were not pursued further.
It is typical to describe the outcome o f back-bone resonance assignment with 
reference to the ‘ro o f [15N, ^ j-H S Q C  or [15N, -TROSY spectrum. In the final 
analysis, for TPxC60S we detected 155 cross peaks in the [15N, 'HJ-TROSY 
spectrum o f which two were unambiguously assigned to arginine side chain Ne-H 
groups by the behaviour under different conditions o f ‘aliasing’. The construct of 
TPxC60S has 164 amino acid residues, with ten proline and no tryptophan 
residues. Because proline residues lack a back-bone H-N proton, they do not give 
rise to a cross peak in the [15N, !H] correlation spectrum, though one can hope to 
identify the Pro Ca and Cp shifts in the 3D HNCA and HN(CA)CB experiments
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through cross peaks that connect the N-H group o f the succeeding residue in the 
chain. Taking into account that the amino terminal a-N H 3+ group is invariably not 
detected in protein NMR spectra under physiological conditions, we would in 
principle ideally expect to observe 154 back-bone amide N-H cross peaks in the 
[15N, ^J-H S Q C  spectrum of TPxC60S.
Figures 4.12 and 4.13 show an example of the cross peak connectivities that could 
be unambiguously established using the commonly adopted ‘strip plot’ 
representation. Figure 4.12 shows the connections observed in the HNCA, 
HN(CO)CA, HN(CA)CB and HN(COCA)CB spectra for residues Thrl44- 
V all47. Figure 4.13 illustrates the corresponding connections that yield the CO 
shifts via the HN(CO)CA and HN(COCA)CB spectra.
The complete set o f connectivities that were obtained in the various triple 
resonance datasets are schematically illustrated in Figure 4.14A and 4.14B. Note 
that because o f redundancy the dipeptide assigned here to Val81-Ser82 could 
alternatively be attributed to Val63-Ser64.
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Figure 4.12: A: Four overlaid strip plots of the HNCA (red cross peaks), HN(CO)CA (red and green cross 
peaks), HN(CA)CB (orange cross peaks) and HN(COCA)CB (blue cross peaks) spectra showing examples of 
Ca,/-i —► Ca,/ and corresponding Cp,/.i —* Cp,/ correlations for residues T144-V147 of TPxC60S applied during 
the *Hn, 15N and l3C assignment process. The arrows indicate the consecutive sequence assignment of the Ca,M 
—*■ Ca,/ (black) and Cp,,.] —► Cp,/ (purple) nuclei for each respective strip plot. B: A 3D structural view of 
TPxC60S highlighting the assigned T144-V147 residues shown as ball-and-stick models with CPK colouring.
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Figure 4.13: Four overlaid strip plots o f the HN(CO)CA (pink) and HN(COCA)CB (pink 
and dark red) spectra showing examples of CO,m —► CO„• correlations for residues Thrl44- 
Vall47 of TPxC60S applied during the *Hn, 15N and 13C assignment process. The arrows 
indicate the consecutive sequence assignment of the CO,/.! —► CO„ (black) nuclei for each 
respective strip plot.
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A
Figure 14.4: A and B (page 89): Assignment graph -  a graphical representation of the assigned nuclei (NH, CO, Ca and Cp) obtained from TPxC60S using the triple 
resonance experiments performed as described in section 4.6. Colour coding: HNCA (red), HNCB (blue), HN(CO)CA (green), HNCO (brown) and HN(CA)CO (pink). 
The colours in the assignment graph indicate which spectrum was used to establish the assignment or connection. The other nuclei, below Cp, represent the carbon and 
nitrogen amino acid back-bone of individual residue nuclei that were not assigned using the resonance experiments previously mentioned. Note: the chemical shift 
values for residues 81-82 can be equally mapped to residues 64-65. Therefore the assignment presented here is based upon the author’s judgement.
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During the execution o f the TPxC60S assignment, a number of gaps in the cross 
peak connectivity were identified and in the end a total of 27 residues (not 
including proline residues) could not be associated with a specific cross peak 
assignment. Against that, 18 cross peaks in the [15N, !H]-HSQC spectrum, that 
appear to derive from backbone N-H groups, could not be attributed to a specific 
residue due to absent connectivities in the triple resonance spectra. Figure 4.15
2 15 13shows the [ H, N, C]-HSQC spectrum labelled according to the obtained cross 
peak assignments and the extent of the assignment is illustrated schematically in 
Figure 4.16. A full chemical shift list for the assigned resonances is given in 
Appendix A6. Figure 4.17 shows the [2H, 15N, 13C]-HSQC cross peaks that could 
not be explicitly assigned because o f an incomplete complement o f correlations in 
the HNCA and HNCACB spectra. A further 55 cross peaks were added to the 
HSQC spectrum that do not exhibit convincing correlations with any cross peaks 
found in the other 3D resonance spectra. These interesting cross peaks are 
provided because they exist above the background HSQC resonance noise and are 
features that may lack the necessary sensitivity to be fully correlated. Note, the 
sequence specific assignments o f the side chain NH2 groups were not pursued. 
The residues without back-bone N-H group assignments (hereafter described as 
‘missing’) are highlighted in Figure 4.16, and include residues 53-63, 66, 80-93 
and 105-111.
It is important to clarify here that ‘missing’ is used in the sense that the sequence 
specific assignment is not (yet) possible -  for 18 o f these residues the back-bone 
N-H groups must be represented by the unassigned HSQC cross peaks in Figure 
4.17. Table 4.1 documents the extent to which each of these 18 unassigned N-H 
signals could be correlated to other chemical shifts in each o f the triple resonance 
spectra. (Chemical shift coordinates for these connectivities are listed separately 
in Appendix A7.1.) It is noteworthy that in the majority o f cases these signals 
yielded a cross peak in the HNCO spectrum (as expected) and at least one cross 
peak in the HNCA spectrum (presumably corresponding to the intra-residue Ca).
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Figure 4.15: Assigned 2D l3C-decoupled ['H, l5N]-HSQC spectrum of 1 mM (pH 7.48) [2H, 13C, 15N]-labelled TPxC60S recorded on a 500 MHz Varian UNITYplus 
spectrometer at 298 K.
However in many instances correlations to a second C a chemical shift or any Cp  
shift were apparently absent. Database-derived predictions o f the amino acid type, 
based on the limited chemical shifts available, yield only low confidence results 
(Table 4.1). However even accounting for these visible yet unassigned cross peaks 
it is apparent then that the inventory o f backbone N-H signals is incomplete; 
apparently nine residues do not yield an identifiable HSQC cross peak. Taken 
together, it is the loss of connectivities for the visible spin systems o f Table 4.1 
coupled with the latter invisible spin systems that limits the extent o f the overall 
sequence specific assignment. In summary, the confirmed assignments constitute 
ca. 80 % o f the complete polypeptide chain.
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Figure 4.16: The amino acid sequence of TPxC60S showing assigned amino acid residues, 
prolines (bold), and unassigned amino acid residues (red) after triple resonance back-bone 
assignment as described in Sections 2.2.13.6 and 2.3.
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Figure 4.17: 2D n C-decoupled [ 'H, 15N]-HSQC spectrum of 1 mM (pH 7.48) [2H, l3C, 15N]-labelled TPxC60S recorded on a 500 MHz Varian UNITYplus spectrometer at 298 
K showing 18 cross peaks (denoted 1-18) that exhibit chemical shift correlations in two or more of the triple resonance experiments performed, but could not be assigned.
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2D NMR (*H, 15N) and Triple Resonance Experiments (*H, 13C)
(Spectral co-ordinates o f all nuclei presented in Appendix A7. Key: cross peaks represented as (Caj) = •  second co­
ordinate set (Co,,-/) = •
Spin System HSQC HNCA HN(CO)CA HNCB HN(CO)CB HNCO HN(CA)CO Predicted residue
1 • •  •  •  • • Met 9.4%
2 • •  •  • • Asp 15.7%
3 • •  • •  • Tyr 5.2%
4 • •  •  •  •  • • Leu 11.2%
5 • •  • • • • -  • •  • Glu 12.9%
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8
• •
9
10
•  •
11
12
13 •  •
•  • •  Glu 12.0%
•  - Ala 12.6%
•  - Ser 10.9%
•  •
•  •
Table 4.1: Spin systems identified from unassigned cross peaks found in the TPxC60S HSQC spectrum (Figure 4.17) and displayed to indicate the presence of 
Caj  (black) and Caj_i (purple) cross peaks as coloured dots for each respective 2D NMR and triple resonance experiment. The co-ordinates for all available 
cross peaks are provided in Appendix X.
4.7. Prediction of secondary structure elements from 13C chemical shift data.
The deviation o f chemical shift values from putative random coil values is often 
used in prediction and assessment of the secondary structural elements within the 
folded protein (Wishart and Sykes, 1994; Wishart and Bigam, 1995a and 1995b). 
Thus it has been shown that there is a statistical bias o f the ‘secondary’ shift of Ca 
and Cp resonances that correlates with the local secondary structure (Spera and 
Bax, 1991). In p-strands and extended structures the Ca nuclei experience an up- 
field chemical shift, whilst in a-helices they experience a down-field chemical 
shift. Conversely, the deviation o f Cp nuclei chemical shifts from random coil 
values displays the opposite correlation with local secondary structure.
It is o f interest to examine the predicted secondary structure composition of 
TPxC60S from the chemical shift assignments that have been obtained (displayed 
in Appendix A6). To do this it is useful to compute the quantity ACa - ACp, where 
ACa represents the difference between the observed chemical shift and the random 
coil value. The quantity ACa - ACp combines the influences o f the secondary 
structure on the chemical shifts and makes this a more sensitive predictor o f the 
secondary structure than either o f ACa and ACp alone. Typically one would plot 
the value o f (ACa - ACp) smoothed ((ACa -ACp)smoothed,z) over a window of i 
neighbouring residues, usually i = 3 (Salzmann et al, 2000):
(ACa -ACp)smoothed,/— (ACa,/+i + ACa,/ + ACa,/-i “ ACp /+i - ACp / -ACp /-i)/3
1 i  n
The forgoing holds for Ca and Cp shifts obtained from proteins that have not 
been subject to replacement o f non-exchangeable protons with deuterons. It is 
recognised that in the case o f a perdeuterated protein the 13C shifts obtained are 
systematically perturbed because o f substituent [ H]-isotope effects. Standard 
correction terms for the [ H]-isotope effects have been suggested and are listed in 
Table 4.2, and can be quiet large compared to the influence o f secondary structure
13 13of the C shift. Thus application o f these corrections to the observed C shifts is 
required prior to the computation o f ACa - ACp.
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Residue8 Cac o rrb Cpcorr
G -0.39 -
N, D, S, H, F, W, Y, C -0.55 -0.77
K ,R ,P -0.69 -1.11
Q, E, M -0.69 -0.97
A -0.68 -1.00
I -0.77 -1.28
L -0.62 -1.26
T -0.63 -0.81
V -0.84 -1.20
Table 4.2: Correction values in ppm applied to calculate for the 2H-isotope affect upon Ca and Cp 
chemical shift values for a random coil protein structure. aA one letter code is used to describe the 
residue in question. bCct/pCorr stands for the chemical shift correction value used to account for 
deuteration of random coil residue nuclei.
2
The [ H]-isotope corrected values of ACa - ACp have been obtained for the 
assigned TPxC60S residues and a plot o f (ACa -ACp)Smoothed,z is shown in Figure 
4.18C.
Salzmann et al. define the specific cut-off point for identifying secondary 
structure elements as being above and below a range o f +/-1.4 ppm (Salzmann et 
al, 2000). Therefore, when ACa - ACp > 1.49 ppm an a-helix is expected and when 
ACa - ACp < 1.49 the likelihood o f a (3-strand being present in the secondary 
structure is enhanced. The (3-strand content is identified as being negative in the 
correlated plot as a result o f highly localised hydrogen bonding.
Figure 4.18A shows the consensus secondary structure composition of TPxC60S 
as defined by the chemical shift data obtained from the triple resonance 
experiments. The comparison o f this (ACa -ACp)smoothed,z data to the same 
secondary structure composition and location obtained from the X-ray crystal 
structure o f TPxC60S (PDB: 1Y25) (Figure 4.18B) is well correlated.
In general the content and location o f a-helices in TPxC60S is well preserved, 
following the triple resonance experiments, but with some major a-helical content 
discrepancies proving vitally important in completing the back-bone assignment. 
The most obvious irregularity obtained is that o f a-helix a2 (containing the C93,
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residues 85-97), which is completely missing resonance data. Other a-helices have 
incomplete resonance assignments, such as a-helix a3 (residues 110-115), which 
is missing N-terminal residues 110-112 inclusive. The TPxC60S a-helix a l 
(residues 63-75) is also shorter, by six N-terminal residues, when compared to the 
X-ray crystal structure version (residues 57-75). To account for the complete a- 
helical complement of TPxC60S; a-helix a4 exhibits a complete resonance 
assignment (residues 155-164), correlating well with the X-ray crystal structure 
a4.
The P-strand content and location in the chemical shift data obtained for TPxC60S 
is very well correlated to the X-ray crystal structure, with all [3-strands present and 
situated in virtually identical locations baring small deviations. These minor shift 
deviations, together with the missing a-helical regions are presumably associated 
with the distinct absence o f resonance data, as shown by the bracketed regions in 
Figure 4.18A.
In summary, the quality o f the back-bone resonance assignment carried out using 
TPxC60S has been confirmed. This conclusion is based upon the comparative 
agreement reached between the predictions of the secondary structure elements,
13by the NMR C chemical shift analysis, with the secondary structure elements in 
the X-ray crystal structure o f TPxC60S. The deviations observed in some a- 
helical and [3-strand elements are presumed to be a consequence o f the three 
defined regions o f missing resonances and would be improved once the complete 
assignment is achieved.
As a comparative to the manual approach in obtaining a predicted structure of 
TPxC60S, the automated structural prediction program, designed by Berjanskii, 
Neal and Wishart, 2006, known as PREDITOR (PREDIction o f TORsion angles 
from chemical shift and homology) was used. PREDITOR is able to accurately 
predict a large number o f protein torsion angles (<P, \|/, co, %) using either ’H, 13C or 
15N chemical shift assignments or protein sequence (alone) as input. The data 
output obtained (not shown) using the TPxC60S chemical shift resonances from 
PREDITOR proved to be highly comparable, with all a-helical and [3-strand 
elements being comparable in both number and location.
- 148-
c  1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161
Residue Num ber
Figure 4.18: Prediction of secondary structure of TPxC60S from l3C chemical shift data. A: Consensus schematic representation of predicted TPxC60S a-helical (blue rectangle) and 13- 
strand (red block arrow) location using NMR-derived chemical shift data. Bracketed regions indicate sections of the amino acid sequence of TPxC60S that did not produce chemical shift 
values. B: Consensus schematic representation of TPxC60S (PDB: 1Y25) a-helical (green rectangle) and p-strand (violet block arrow) location obtained from X-ray crystallographic data. 
C: Predicted secondary structure histogram displaying chemical shift data as a function of residue number. The dashed line indicates the 1.4 ppm threshold value for the identification of 
secondary structure elements. Values higher or lower than 1.4 ppm or -1.4 ppm indicate the presence of a-helical or P-strand regions respectively.
By mapping the missing residues to the PDB deposited crystal structure o f 
TPxC60S (PDB: 1Y25) it can be seen that missing assignments cluster 
predominantly around the TPxC60S Cp-equivalent Ser60 residue on alpha helix 
a l  and Cys93 also on alpha helix a l  ( C r ) as well as the non-catalytically essential 
Cys80 on beta-strand (34 (Figure 4.19A) and on several loop regions. These 
secondary structure elements are closely associated with the dimer interface, as 
illustrated in Figure 4.19B.
93
C60S C80
A
Figure 4.19: A: TPxC60S dimer showing missing assignment back-bone residues (red) and the 3 
Mtb TPx cysteines (magenta). B: Magnification and surface interaction of the two TPxC60S 
monomers flanking the dimer interface.
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4.8. Discussion.
The comparison o f ASEC profiles and [15N, ^ j-H S Q C  NMR spectra of TPxWt 
and TPxC60S proteins suggest that whilst the latter behaves essentially as a 
mono-disperse homodimer, the former shows evidence o f the potential to form 
higher order oligomeric forms. Thus the wild-type protein yields an asymmetric, 
concentration dependent ASEC elution profile, whereas the mutant gives a 
symmetric elution peak at a volume consistent with a homodimer. In addition, 
TPxWt gives poorer quality NMR spectra (fewer cross peaks and more 
heterogeneous intensity distribution) when compared to the mutant, even at 1 mM 
concentration. Given these characteristics, we have focussed our chemical shift 
assignment efforts on the TPxC60S variant.
Application o f an essentially standard set o f triple resonance NMR experiments 
provided high quality datasets that allowed the sequence specific assignment of 
the majority o f N-H cross peaks. However incompleteness in both the total count 
o f HSQC/TROSY N-H correlations, and absences o f H-N-Ca and H-N-Cp 
correlations in the triple resonance data mean that 27 residues from a total of 165 
(~20 %) could not be assigned.
The “missing” cross peak resonances appear to be associated with the region of 
the homodimeric TPxC60S crystal structure that encompasses the active site and 
the inter-protomer contact surface (Figure 4.19).
Given that the N-H cross peak absences cannot be attributed to incomplete back- 
exchange o f N-D deuterons for protons (see above), explanation for the non- 
uniform completeness o f the inter-nuclear correlations in the triple resonance 
spectra must appeal to other factor(s). The intensity o f a given cross peak in these 
spectra is a complex function of the relaxation properties of the nuclei involved in 
the coherence transfer pathway, and ultimately upon the local dynamics of the 
polypeptide chain. Line broadening that could lead to loss o f intensity is 
commonly associated with exchange between two (or more) molecular substates 
on a timescale that is o f the order o f the difference between the relevant substate 
chemical shifts, and is usually on the micro- to milli-second timescale. Figure 
4.20 illustrates how this might arise from the classic case o f two-site exchange 
and the effect on the observe NMR resonances.
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Figure 4.20: An illustration of two species A and B and the corresponding resonance 
frequencies obtained during chemical exchange. In the absence of chemical exchange these 
species produce two resonance lines at the characteristic Lam or precession frequencies ooA 
and cdb. If the equilibrium concentrations of A and B are equal ATa_ b = ^b—a = K. Fast, 
intermediate and slow exchange between the two species is illustrated with lineshapes a, b 
and c respectively together with equations indicating the relationship between the chemical 
difference Aco and the exchange rate constant K.
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Thus the expectation is that for exchange between two environments on the 
intermediate timescale line broadening leads to potentially ‘vanishing’ peak 
intensities.
The non-uniform intensities o f TPxC60S cross-peaks therefore presumably reflect 
the differential effects of internal motions along the polypeptide chain on this 
intermediate timescale. In multidimensional spectra the broadening of a cross 
peak may result from one of more o f the correlated resonances, but unravelling 
the precise origin o f ‘absent’ NMR intensity is, perhaps by definition, intrinsically 
difficult.
The distribution o f the “missing” assignment residues in the crystal structure of 
TPxC60S points to the effects of these putative motions being clustered around 
the active site and inter-domain interface of the homodimer. One can speculate 
that the implied reorganisation of the structure may be related to exchange 
between substates that are either involved in the catalytic mechanism, remodelling 
o f the dimer interface, or both. It is intriguing to consider that the presumed 
mechanism o f Mtb TPx, based upon the known structures of oxidised and reduced 
homologues (see Section 3.11) directly predicts that the structure o f the protein 
must change significantly along the reaction coordinate. Thus it seems clear that 
in the reduced catalytically competent state, the Cp and C r residues are located at 
a distance from one another, but in the oxidized state the same two residues form 
an intra-monomer disulphide bond, having been brought into proximity by local 
helix-to-coil rearrangements. As Figure 4.21 suggests conversion between these 
open and closed states could either occur as a result o f an intrinsic property o f the 
isolated reduced polypeptide (i.e. in the absence o f a substrate); be induced upon 
formation o f the protein-peroxysubstrate complex that is formed at an early stage 
o f the reaction mechanism; or be induced by the formation o f the sulfenic acid 
intermediate following contact with the substrate.
Presumably resolution o f the sulfenic acid intermediate proceeds by nucleophilic 
attack of the C r  thiol upon the Cp S=0 group and by definition requires close 
approach o f the C r  and Cp residues.
The pattern o f the spectral characteristics encountered in the analysis o f the NMR 
spectrum o f TPxC60S implies a segmental dynamic profile, where one or more 
regions may well be undergoing conformational exchange leading to line 
broadening. Given that the line broadening effects appear to cluster around the
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active site and the interprotomer interface, it is tempting to speculate that the 
spectrum may reveal constitutive internal motion on the intermediate timescale 
that could be consistent with the scenario depicted in panel A of Figure 4.20. In 
particular since these motions are suggested to involve helix-to-coil transitions, 
and it is well established that 13Ca and 13Cp shifts are sensitive to the local 
secondary structure, it is not impossible that such changes would result in
• i o i o
selective broadening o f the Ca or Cp resonances and thereby lead to absences 
o f correlations in HNCA and HNCACB spectra, even when there is little evidence 
o f line broadening for the corresponding N-H moieties. Confirmation of this 
hypothesis would require more in-depth characterisation o f the relevant relaxation 
rate constants, which presently is beyond the scope o f this thesis.
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Figure 4.21: The mechanism of TPx proteins implies a conformation change that requires large changes in the distance between Cp and C r  side chains. Motion of both C r  and Cp 
residues accompanied by helix-to-coil back-bone conformational changes seems likely based upon the available crystal structures. Oxidized TPx, wherein the CP-CR distance is 
constrained by disulphide bond formation, occurs only after the formation of the sulfenic acid intermediate. The diagram illustrates three scenarios: A, motion of the CR and CP 
residues that allows close approach spontaneously in the absence of substrate; B, motion of CR and CP occurs only after nucleophilic attack of the CP thiol group on the substrate 
peroxide to form a covalent protein:substrate complex; and C, motion of CR and CP occurs only after decomposition of the protein:substrate complex to form the CP sulfenic acid 
intermediate. Squiggly lines, magenta and blue colours highlight states in which the protein internal motion allows close approach of CR and CP. The relative extent of predicted 
motion is suggested by the area of the colour. The double headed arrow emphasizes that this motion is to- and fro- (in exchange) between conformational substates. ‘B:’ indicates the 
base that putatively polarises the CP thiol group prior to attack upon the peroxy substrate ROOH.
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On the other hand, there are several reports o f enhanced transverse relaxation rates 
(line broadening) for resonances corresponding to interprotomer interfaces in 
oligomeric protein systems (Grassberger et al, 1992; van Amsterdam et al, 2001; 
Mohan et al, 2006; and Benison et al, 2006). Perhaps it is the case that such 
interfaces are in general more “conformationally plastic” than the core regions of 
the component globular protein domains, or the line broadening is a consequence 
of the exchange between oligomeric and dissociated monomer states (even if one 
of these states is only weakly populated). Since we did not observe any significant 
changes in the spectrum of TPxC60S with variation o f concentration we tend to 
discount the latter scenario, though the former rationalisation may hold true (in 
which case such interfacial plasticity may be correlated with the helix-to-coil 
transitions associated with the active site that has been described above). 
Unravelling the nature of the underlying states in a situation where NMR signals 
are broadened below the noise level is intrinsically difficult, especially when 
associated visible signals cannot be unambiguously assigned. However indirect 
evidence for the hypothesis that in Mtb TPx a substantial fraction o f the cross 
peaks are absent due to conformational exchange might be obtained if  one could 
“quench” the internal motion. Consideration of methods to demonstrate such 
quenching is the subject o f the following chapter.
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Chapter 5
Results: Unraveling the mystery of the 
missing TPxC60S HSQC backbone 
assignments and exploring the ligand binding 
capacity of Mtb TPx
5.1. Chapter summary.
In recording a series o f NMR spectra, for example in obtaining resonance 
assignments, it is imperative to maintain the sample conditions and other external 
parameters within very narrow ranges o f variation. This is because the spectral 
parameters (chemical shifts, resonance linewidths and peak intensities) can be 
very sensitive to such variation. On the other hand systematic variation of the 
sample conditions can be used to deliberately perturb the spectrum, thereby 
exploiting or exploring this dependence. For example one can straightforwardly 
monitor the dependence o f the protein tumbling time (hydrodynamic status), 
foldedness (local structural stability), and activity (ligand binding) using the 
NMR spectrum as a function o f the pH, protein concentration, experimental 
running temperature or sample buffer components.
Initially, the back-bone assignment process applied using TPxC60S yielded 
assignments for 128 amino acid backbone N-H groups (out o f a total of a 
potemtial 155 non-proline residues). However for 27 residues assignment proved 
impossible, in spite of the presence o f 18 cross peaks in the HSQC spectrum that
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could not be connected (Chapter 4). In an attempt to find these “missing” 
residues, a series o f experimental parameters was carefully varied, combined 
with monitoring o f the TPxC60S NMR spectrum in the hope of finding new or 
different features. The parameters varied include: sample pH, experimental 
running temperature and the application o f ligands implicated in interactions 
with Mtb TPx. TPxC60S was shown to be particularly pH sensitive, with the 
identification o f several ‘new’ cross peaks in the HSQC spectra exhibiting one or 
more correlations in the triple resonance experiments. However, with seven 
‘new’ cross peaks identified, none could be unambiguously linked to the 
currently unassigned sections of the TPxC60S back-bone. The temperature 
variations revealed Mtb TPx to be particularly thermally stable upto temperatures 
o f 95 °C but with little success in revealing ‘new’ cross peaks in the concurrent 
HSQC spectra taken. The use of ligands provided mixed results, with some 
having greater effects than others, with neither proving substantially bulky 
enough to ellicit quenching of the fluctuating altered conformation. TPxWt was 
also probed to determine the reason for the poor intensity and line-broadened 
cross peaks in the HSQC NMR spectra produced by examining the possibility of 
intra (intrinsic) or inter chain (external multimer) association by using excess 
DTT. The conclusion o f which describes TPxWt as being governed by 
mechanistically driven internal motion, closely modulated by residue Cys60.
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5.2. TPxC60S melting temperature (Tm) assessed using circular dichroism
(CD) spectroscopy.
As a prelude to NMR investigations o f the effect of temperature on the NMR 
spectrum of TPxC60S we set out to characterise the dependence of the overall 
folding status of TPxC60S upon the temperature using the convenient means of 
circular dichroism spectropolarimetry (CD). From the perspective o f the NMR 
experiment, which potentially risks relatively large amounts o f sample to 
irreversible unfolding and aggregation, it is useful to know the limiting 
temperature range within which the protein maintains its natively folded state.
The method applied during the CD data collection and subsequent processing is 
described in Section 2.3.6 and the results are shown in Figure 5.1. The CD data 
obtained reveals TPxC60S as being particularly thermo-stable, apparently still 
giving rise to a measurable elipticity in the range 205-240 nm at the highest 
temperature sampled, 95 °C (Figure 5.1 A). Upon reversing the temperature back 
down to 20 °C, TPxC60S apparently regains its original spectral form. The 
interchange o f conformations upon heating up to 95 °C and back down to 20 °C 
appears essentially completely reversible. In between these two temperatures the 
magnitude o f the CD spectrum clearly follows a classical sigmoidal trajectory 
characteristic of a cooperative two state transition with a mid-point melting 
temperature (Tm) around 63 +/- 1 °C (average o f fitted heating and cooling curve 
fits; Figure 5 .IB). Taken together the results are consistent with a conversion of 
natively folded TPxC60S to a higher energy, partially folded state, possibly a 
molten globule-like conformation.
The prediction from these measurements is that one can anticipate that the NMR 
spectrum o f TPxC60S should be dominated by the natively folded state at 
temperatures up to 55 °C where the fraction o f partially folded protein should be 
less than 5 %. Above this temperature there is a risk that the NMR spectrum will 
be complicated by the presence o f a substantial fraction o f the partially folded 
state.
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Figure 5.1: A: CD spectra of TPxC60S, before (red — 20°C) and after (blue -  95°C) temperature 
melt, with the corresponding data-plot fits for the heating and cooling down process. B: CD 
spectral overlay of TPxC60S spectra from A. The data-plot fit is the overlaid normalised data- 
plots from A, presented as the apparent fraction (Fapp) following the subtraction of the baseline.
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5.3. Experimental temperature variations using [2H, 1SN, 13C]-TPxC60S and
[2H, 1SN, 13C]-TPxWt.
5.3.1. Increasing the temperature of NMR experiments for [2H, 1SN, 13C]- 
TPxC60S and [2H, 1SN, 13C]-TPxWt.
It is well known that variation of the temperature can strongly influence the 
NMR spectrum o f a globular protein and is a useful variable parameter with 
which to probe the overall properties in solution. Fundamentally, increasing the 
sample temperature can have two major influences: (a) decreasing the rotational 
correlation time o f the protein (faster tumbling) leading to altered global average 
Ti and T2 relaxation time constants; and (b) acceleration of dynamic exchange 
processes: a show exchange phenomenon may become intermediate exchange 
with concomitant line broadening/averaging, an intermediate exchange process a 
fast one with line narrowing. Conversely a decrease in the sample temperature 
will lead to slowing o f the both tumbling rate, and exchange processes. 
Importantly, whilst faster tumbling can lead to improved line widths and peak 
intensities, this effect may be counteracted by bleaching o f solvent exchangeable 
proton signals due to averaging with the bulk solvent signal. Moreover if the 
temperature is raised too high then one risks partial or global unfolding o f the 
protein, possibility accompanied by non-reversible sample aggregation.
In the context o f the assignment issues for TPxC60S described in the previous 
chapter, it was felt instructive to explore the temperature dependence of the 
NMR spectrum. Because the wild-type Mtb TPx spectrum suggested a similar 
but more extensive variation in cross peak intensity, we also examined its 
spectrum under the same set o f conditions. Figure 5.2 shows a superposition of 
[2H, 15N, 13C]-TPxC60S (Figure 5.2A) and [2H, 15N, 13C]-TPxWt (Figure 5.2B) 
HSQC spectra, including the accompanying ID *H spectra, obtained over a series 
of increased temperatures. Close inspection o f these spectra reveal that for both 
o f Mtb TPx proteins there is no increase in cross peak numbers over those 
observed in the room temperature spectrum. At the final temperature point, 50 °C 
(blue spectra in Figures 5.2A and 5.2B), both the Mtb TPx protein spectra
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experienced losses in signal intensity and a disruption to the homogenous line 
shapes for the majority of cross peaks. For experiments performed at 50 °C and 
above the spectra contained increasing numbers o f signals with !H chemical 
shifts at 8.4 +/- 0.2 ppm, though this was clearly more evident for the mutant 
than the wild-type protein. We presume that these changes reflect partial 
unfolding or (more likely) degradation o f the sample: upon lowering the 
temperature again the spectra retained this features consistent with disordered 
peptides. At the highest temperature tested 58.8 °C the HSQC experiment 
indicated that both protein variants are undergoing rapid protein degradation, 
resulting in increasingly disrupted and un-interpretable spectra (data not shown).
Despite the apparent slow degradation o f a population of protein molecules in 
these samples, it is straightforward to inspect the more highly resolved regions of 
the spectra across the temperature range. Thus, for [2H, 15N, 13C]-TPxC60S there 
was no loss in the number o f resolved cross peaks present in the HSQC spectra at 
higher temperature. However for [2H, 15N, 13C]-TPxWt the number o f resolved 
cross peaks began to decrease as higher temperature spectra are obtained.
Taken together these data indicate that both proteins exhibit a degree of 
sensitivity to signal loss or degradation at higher temperatures, without any 
evidence o f spectral resolution o f ‘extra’ cross peaks that might derive from 
regions o f the protein suspected to display exchange-derived line broadening in 
the spectra recorded at 25 °C, either by selection o f a single conformer or by 
acceleration o f interconversion o f multiple conformers.
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Figure 5.2: HSQC and 
(red) and 50 °C (blue).
ID overlays of 1 mM, pH 7.48 (at 500 MHz); A: [2H, 15N, 13C]-TPxC60S and, B: [2H, l5N, l3C]-TPxWt HSQC spectra, at various temperatures; 25 °C (black), 35 °C
5.3.2. Decreasing the temperature of NMR experiments for [2H, 15N, 13C]-
TPxC60S and [2H, 15N, 13C]-TPxWt.
In NMR the effects of lowering the sample temperature o f a protein solution are 
the converse o f those described at the beginning o f the previous section. Whilst 
slowing o f the rotational tumbling is not expected to improve the quality of the 
NMR spectrum, because o f the overall shorter T2 values, the deceleration of the 
exchange o f N-H protons with the solvent and the potential to slow 
conformational exchange may lead to an increase in the number o f observable N- 
H cross peaks. We explored the effect of low temperature on the NMR spectrum 
of both Mtb TPx and TPxC60S in a possibly optimistic attempt to find signals 
that would permit a more complete back-bone resonance assignment.
Figures 5.3A and 5.3B display an overlay o f representative HSQC spectra o f [ H, 
15N, 13C]-TPxC60S HSQC and [15N]-TPxWt HSQC respectively, carried out at a 
series o f eleven decreasing temperatures. In each case the overall effect of 
lowering the temperature appears to be a loss o f signal intensity. This effect 
appears more dramatic for the wild type protein, but this would seem to be a 
reflection o f the overall broader characteristic of the peaks in this spectrum at 
ambient temperature, as is clear from the comparison o f the resolution o f the 
TPxWt and TPxC60S *H ID spectra included in Figure 5.3A and 5.3B. The 
overall dispersion o f the ID spectrum of each protein is retained throughout the 
series, indicating that loss o f signals in the 2D spectrum reflects a slowing of 
molecular tumbling only, rather than induction o f a ‘cold-denatured’ state.
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Figure 5.3: HSQC and ID overlays of 1 mM, pH 7.48 (at 500 MHz); A: [2H, 15N, uC]-TPxC60S and, B: [ l5N]-TPxWt HSQC spectra carried out at various temperatures; 25 °C (black), 
10 °C (blue) and 4 °C (red).
For the spectra recorded in Figure 5.3 the number o f transients recorded per ti 
increment was held constant, so the signal-to-noise ratio is normalised to the total 
recording time. In an attempt to improve the spectral quality o f the HSQC 
spectrum o f [2H, 15N, 13C]-TPxC60S at 10 °C (Figure 5.3A - blue spectrum) 
another HSQC experiment was run (as described in Section 2.3.7.3) under 
otherwise identical conditions but with an increase (2x) in the number of 
transients collected. In this manner it was possible to look for the presence of 
new weaker features in the spectrum at lower temperature. The resulting 
comparative spectral overlay o f [2H, 15N, 13C]-TPxC60S at 25 °C and 10 °C is 
seen in Figure 5.4. [2H, 15N, 13C]-TPxC60S at 10 °C exhibits a more homogenous 
cross peaks present, yet no ‘new’ peaks have appeared.
Importantly no ‘new’ cross peaks appeared in either o f  the Mtb TPx protein 
spectra at any low temperature, indicating that probably no signals are lost in the 
spectrum as a result o f cross-saturation o f fast-exchanging N-H protons with the 
bulk H2 O signal (the pulse sequences employed used flip-back pulses and 
WATERGATE-based detection pulse trains to minimize this risk in any case). In 
addition any conformational exchange process that is giving rise to selective line 
broadening (and incomplete resonance assignments) is apparently insensitive to 
the accessible temperature range.
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Figure 5.4: HSQC overlay o f 1 mM, pH 7.48, at 500 MHz of [2H, 15N, 13C]-TPxC60S HSQC 
spectra carried out at two different temperatures and data-point increments: 25 °C (black) -  64 
points and 10 °C (magenta) -  128 points.
5.4. ID [*H] and [2H, 15N, 13C]-labelled-HSQC: TPxC60S and TPxWt pH 
variations.
Another facile means to perturb the NMR spectrum o f a protein is via variation 
o f  the solution pH. In general, whilst the H* ion concentration is not expected to 
have an influence upon line broadening due to conformational exchange, it is 
well known to have a strong impact upon the rate o f exchange o f N-H, O-H and 
S-H protons (‘exchangeable’ protons) with the bulk solvent H 2 O. Thus when 
NM R experiments are recorded in a way that leads to saturation o f all or part o f 
the solvent resonance there is a risk that signals corresponding to these protons 
lose intensity or are saturated themselves (by a process termed cross-saturation), 
in a manner that depends quantitatively upon the pH. In general the lower the pH 
the slower the rate o f exchange o f protons with the bulk solvent and the lower the
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risk o f loss o f signal intensity due to cross-saturation. Thus it is often said that 
NMR of proteins is preferably performed at Tow’ pH (usually meaning below 
neutral pH). In fact, the risk o f cross-saturation can also be minimized to an 
extent by recording the NMR spectra in a manner that minimally excites the 
solvent H2O resonance, or at least attempts to restore the solvent magnetisation 
to the +Z axis as much as possible, e.g. through the combination o f non-selective 
hard RF pulses and solvent selective ‘flip-back’ pulses. In general the spectra 
reported in this thesis have been recorded with this last principle in mind. 
Nevertheless, in general it is worthwhile probing whether the spectrum changes 
as a function o f the pH.
Figure 5.5A shows an overlay of the HSQC spectra o f [2H, 15N, 13C]-TPxWt 
spectra conducted at two different pH conditions, pH 7.48 (black spectrum) and 
pH 6.0 (red spectrum). Figure 5.5B shows the corresponding ID spectra obtained 
prior to the HSQC experiments. Analysis o f the spectra, reveals that little change 
is observed. The protein clearly remains in solution and displays the same degree 
o f resonance dispersion indicating that the overall fold is maintained. Upon 
lowering the pH yet further, from pH 6.0 to pH 5.0, TPxWt precipitates into a 
stringy deposit that clings to the side of the NMR tube, without settling. The 
deposit was not fully re-solubilized upon raising the pH again to 7.5. Thus it 
appears that much below pH 6.0 TPxWt undergoes partial or complete 
irreversible denaturation. As a result o f this investigation -pH  6.0 is regarded as 
the pH minima recommended prior to irrevocable structural change occurring to 
[2H, 15N, 13C]-TPxWt. Importantly, no ‘new’ HSQC cross peaks are observed 
with a [2H, 15N, 13C]-TPxWt protein sample at pH 6.0; the only discernible 
changes were small shifts (less than, or of the order o f the resonance cross- 
section) in a few cross peak positions.
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Figure 5.5: Comparative overlays of 1 mM, 25 °C, at 500 MHz of [2H, l5N, 13C]-TPxWt HSQC (A) and ID (B) NMR spectra, respectively, carried out at 
two different pH values; pH 7.48 (black spectrum) and pH 6.0 (red spectrum).
[2H, 15N, 13C]-TPxC60S was similarly examined in pH variation experiments as 
those conducted with [2H, 15N, 13C]-TPxWt (Figure 5.6). The spectrum obtained 
at pH 6.0 differed more significantly from that recorded at pH 7.48 than in the 
case of the wild-type protein. Whether there were more cross peaks present at pH 
6.0 compared to pH 7.48 was difficult to determine unequivocally from simple 
inspection o f the superimposed HSQC spectra. As Figure 5.6A shows, the 
changes may reflect movement or disappearance and appearance o f several cross 
peaks in the region bounded by 5[15N] ~ 117-125 ppm; 5[*H] ~ 7.8-8.8 ppm. 
There was no indication o f protein precipitation at pH 6.0.
However, as soon as the pH was lowered to pH 5.0 the [2H, 15N, 13C]-TPxC60S 
protein precipitated in a similar manner exhibited by TPxWt, indicating again 
that operationally it was not possible to explore the effect o f pH on the spectrum 
much below pH 6.0.
It was decided to analyse the spectrum of [2H, 15N, 13C]-TPxC60S at pH 6.0 by 
recording a subset o f triple resonance experiments (as described in section 
2.3.7.6), thereby providing additional datasets to test the sequence-specific 
resonance assignments previously obtained, and probe for the presence o f ‘new’ 
cross peaks.
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Figure 5.6: Spectral overlays of 1 mM, 25 °C, at 500 MHz of [2H, 15N, nC]-TPxC60S HSQC (A) and ID (B) NMR spectra, respectively, carried out at two different pH values; pH 7.48 
(black) and pH 6.0 (red spectrum).
5.5. Amino acid back-bone assignment -  [2H, 15N, 13C]-TPxC60S at pH 6.0.
Using the experimental approach described in Section 2.3.7.6, the sequence 
specific assignment o f the spectrum of [2H, 15N, 13C]-TPxC60S at pH 6.0 was 
attempted and the results compared to those obtain at pH 7.48. All of the 
assignments obtained at the higher pH were recapitulated at pH 6.0 (Figure 5.7A) 
by observing cross peak migration across the pH titration range. The 18 cross 
peaks that were previously not assignable persisted in the lower pH condition, 
but despite some improvement in the complement o f scalar coupling correlations 
present in the [2H, 15N, 13C]-TPxC60S triple resonance data, it remained 
impossible to extend the assignment. These cross peaks are shown in Figure 
5.7A, highlighted in blue. Intriguingly an addition o f seven cross peaks appears 
exclusively at the lower pH spectrum when compared to the spectrum obtained at 
pH 7.48, as shown in Figure 5.7A and highlighted in red. Table 5.1 summarises 
the detectable correlations obtained for these seven residues. Unfortunately these 
‘new’ cross peaks could not be unambiguously connected to other cross peaks of 
the spectrum. However, fundamentally lowering the pH o f the [ H, N, C]- 
TPxC60S sample did not lead to the appearance o f the full complement of 
missing cross peaks. In spite o f these efforts there still remains five residues that 
still do not give rise to an observable cross peak in either pH spectrum and 
presumably these ‘absences’ contribute to the inability in connecting the seven 
unassigned cross peaks to other parts o f the pH 6.0 spectrum.
Peak Number Co-ordinates (ppm) HSQC 
15N/1H
Co-ordinates (ppm) Ca' - Ca"7
1 129.4/7.9 Ca': 57.0/7.9
2 132.0/8.0 Cot': 53.5/7.9
3 125.3/8.3 Ca': 52.0/8.3 Ca"7: 61.2/8.35
4 122.2/8.1 Ca': 62.2/8.1
5 121.2/8.4 Ca': 56.3/8.4 Ca"7: 62.8/8
6 120.6/8.2 Ca': 62.0/8.28 Ca"7: 62.8/8.28
7 118.2/8.4 Ca': 56.0/8.4
Table 5.1: HSQC coordinates for the seven cross peaks found using [2H, 15N, 13C]-TPxC60S at pH 
6 .0 .
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Figure 5.7 A: The assigned spectrum of 1 mM, 25 °C, at 500 MHz of [2H, 15N, l3C]-TPxC60S at pH 6.0. The red numbering denotes the ‘new’ cross-peaks observed and are directly 
related to Table 5.1. The blue numbering denotes the previous 18 unassigned cross peaks from the pH 7.48 spectrum. B: Superposition of TPxC60S spectra at differing pH conditions, 7.5 
(black), 6.5 (green) and 6.0 (red). Probable cross peaks sensitive to changes in pH are indicated.
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It is interesting to ponder the fact that the pH variation of the spectrum of ['H, 
15N, 13C]-TPxC60S give rise to some significant changes in N-H cross peak 
chemical shifts. Several cross peaks positions are perturbed by variation of the 
pH between 8.0 and 6.0, by a magnitude either greater then or of the order of the 
resonance line width. These cross peaks and the corresponding residues are 
highlighted in Figures 5.7A and 5.7B. The fact that a subset o f chemical shifts is 
sensitive to the pH suggests the potential for a local structural dependence on one 
or more protonation equilibria. Figure 5.8 shows that the pH sensitive residues 
cluster mostly on the ‘upper’ surface o f the crystal structure of TPxC60S, 
predominantly on or around alpha helices 1 and 2. That the shifts vary in the pH 
range 6.0-8.0 is predictive of an associated pKa in the range 5.5-8.5, and would 
most naturally be attributable to the titration o f a His residue side chain, or 
possibly the N-terminal amino group o f the polypeptide chain. In this instance 
the main globular part o f TPxC60S does not contain any His residues, and there 
is no evidence that the amino terminus makes any ordered contact with the rest of 
the protein chain. Alternative explanations for the origin o f a titratable group in 
this pH range include: a possible elevated Asp or Glu residue acidity constant 
arising from a close contact between two such acidic side chains; the result of 
transient interactions o f the appended His6-tag with a specific region of the 
protein surface; or titration o f an associated buffer ion that shows a charge/pH- 
dependent interaction with the protein surface. Examination o f the crystal 
structure o f TPxC60S predicts that the first scenario is unlikely, though further 
work to precisely probe the pKa values o f the Asp/Glu residues along the lines of 
that reported for another protein examined in the Driscoll laboratory (Chen et al, 
2000) would be required. The two ‘acidic dipeptides’ represented by Asp68- 
Glu69 and Glul 13-Asp 114 have side chains that are directed away from each 
other in the structure, apparently limiting the potential for specific H-bonded 
interaction that might be consistent with a strong perturbation o f the associated 
pKa values. On the other hand one might argue that the side chains of Glu98, 
Glu99, Asp68, Glu69 and G lu l57, appear to cluster together on the upper surface 
of the protein, and might give rise to an apparent elevated pKa through mutual 
electrostatic interactions.
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Figure 5.8: Crystal structure o f Mtb TPxC60S (PDB: 1Y25) indicating all the amino acid residues (red) perturbed upon a change of pH from 7.48-6.0. The residues coloured magenta 
indicate the C60S mutated residue and other constituents of the catalytic triad.
Resolution o f these ideas requires direct measurement of the microscopic pKa 
values for these residues that can be obtained by [13C]-based NMR 
measurements o f the type described by Chen et al. (Chen et al, 2000). Additional 
further work to resolve the potential for the other scenarios would also be 
required, including repeating the experiments for a His6-cleaved version of the 
protein, which would require a new DNA expression construct, and switching to 
a cationic buffer, e.g. Tris, or Bis-Tris.
5.6. Temperature and pH variation summary.
Circular dichroism of TPxC60S at room temperature yielded a spectrum 
consistent with a globular protein fold containing both alpha-helical and beta- 
sheet secondary structure. The analysis o f the CD spectropolarimetric data up to 
95 °C suggests that the natively folded TPxC60S converts to an alternative, 
presumably partially folded state that retains a CD signature consistent with the 
persistence of significant secondary structure. The data obtained suggest a 
cooperative two-state transition with a mid-point Tm around 63 +/- 1 °C. Perhaps 
surprisingly the protein does not appear by CD to be completely unfolded at the 
highest temperature tested. However this observation suggested that NMR 
measurements o f the protein would sensibly be limited to temperatures 
significantly lower than the mid-point o f this transition, so that the fraction of 
partially folded molecules would be kept to a minimum.
Variation of the temperature for NMR spectroscopic examination o f TPxC60S 
and TPxWt samples indicated that the native conformation was maintained at 
least up to 55 °C. At this and higher temperatures the effects o f partial unfolding 
was irreversible degradation became apparent. Unfortunately, from the 
perspective of attempting to uncover new signals for the completion of the NMR 
back-bone resonance assignment, no extra cross peaks were revealed by raising 
the temperature.
The inspection o f pH sensitivity o f both Mtb proteins revealed that the mutant 
variant had a more aggressive reaction to the low pH conditions applied. This 
was exhibited by observing characteristic HSQC-related shifts/perturbations for 
several cross peaks, together with the disappearance/appearance o f others. A
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subsequent recapitulation o f the TPxC60S triple resonance assignment obtained 
at pH 7.48 was reproduced at pH 6.0. By comparing TPxC60S spectra at the two 
different pH conditions, 32 cross peaks were identified as being especially 
sensitive to the low pH condition applied, including two that are as yet 
unassigned due to a variety o f cross peak “absences” in the related triple 
resonance experiments. Most intriguing o f all was the identification of a further 
seven cross peaks (seemingly exclusive to pH 6.0 TPxC60S spectra) exhibiting 
either complete or partial Ca i and T1 correlations in a partially-acidic 
environment. Although a significant observation, these seven “new” cross peaks 
could not be unambiguously connected to the currently unassigned sections of 
the TPxC60S sequence.
The next step is in the use o f ligands -  as a sequestering tool (if scenario three (as 
described in Section 4.8) is to be believed as the principal reason for internal 
dynamic motion), to further explore the dynamic fluctuations exhibited by 
TPxC60S and in so doing aid in completing the back-bone assignment. The 
following section will deal with the ligands used in this project to resolve the 
issue described above.
5.7. Ligand binding using TPxC60S and TPxWt -  prelude.
In the following sections, a series of experiments are described that attempt to 
probe the interaction o f Mtb TPx with chemical entities that are supposed or 
suspected to interact with the active site of the protein (as detailed in Section 
2.3.7.4). Specifically the interaction o f Mtb TPx is tested for magnesium acetate, 
an organic compound known as Diclofenac, and the thiol reactive compound 
DTDP is discussed. For the first two cases, crystallographic data suggest that the 
compound has the potential to interact directly with the protein active site. In the 
last case it was anticipated that DTDP might react with and ‘trap’ the side chain 
of the resolving cysteine Cys93, which might become exposed during the overall 
reaction mechanism o f the protein. In each case it was hoped that a productive 
interaction with the compound might perturb the presumed underlying dynamics 
that gives rise to substantial cross peak absences in the NMR spectrum.
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5.7.1 Magnesium acetate ligand binding.
The crystals o f TPxC60S reported by Stehr et al. were obtained using a buffer 
that had the following composition: 20 % PEG 8000, 100 mM sodium cacodylate 
pH 6.5 and 200 mM magnesium acetate. Electron density at the active site of the 
final model was interpreted as involving an acetate anion (Figure 5.9A) with H- 
bonds between the ligand carboxylate group and the side chains of C60S 
(including the back-bone nitrogen), Thr57, and Argl30 (Figure 5.9B). The ligand 
methyl group makes van der Waals contacts with hydrophobic residues Leu6, 
Arg7, Pro53, M etl24, and I le l50. The overall binding mode is similar to the 
interaction o f a benzoate ion with human peroxiredoxin 5 (Declerq et al, 2001).
The bulk o f the NMR data for TPxC60S described so far in this thesis have been 
obtained using a buffer with composition 50 mM NaH 2P0 4 , 100 mM NaCl, 1 
mM DTT and 0.1 mM EDTA. Whilst it is was not expected that introduction of 
acetate ions to the buffer would have a dramatic effect, nevertheless we formally 
titrated a sample o f TPxC60S with a solution of magnesium acetate up to a final 
acetate concentration o f 400 mM, with monitoring by ID ]H and 2D [^N^H]- 
HSQC spectroscopy (Figure 5.9C). As largely anticipated, changes to the 
spectrum in the presence o f  acetate where slight. However, a small number of 
assigned cross peaks, listed in Table 5.2, are perhaps perturbed in their chemical 
shift(s). Importantly in this regard the direction of the chemical shift changes for 
these signals (see Figure 5.10) is characteristically different from those obtained 
in the pH titration series described in Section 5.4, suggesting that the shift 
observed may well be due to specific interactions o f the protein with the acetate 
ions.
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Figure 8
corresponding boxes
Co-ordinates (ppm) 
HSQC ( V H )
Amino acid assignment
1 107.8/7.65 G94
108.2/7.61 G75
2 120.8/10.51 N155
3 120.2/7.74 R65
4 124.8/8.89 A104
Table 5.2: Chemical shifts co-ordinates and cross peak assignments relating to perturbed 
residues observed in Figure 5.1 OB, [2H, 15N, 13C]-TPxC60S in 200 mM magnesium acetate.
The corresponding residues cluster around the active site (Figure 5.1 IB) which 
might be consistent with binding o f the acetate ion in the active site, as in the 
crystal structure, with three o f the four alpha helices harbouring four o f the five 
perturbed residues: al:R 65, G75; a2:G94; and a4:N155. The remaining 
perturbed amino acid residue, A 104, is found on beta strand 05. O f course it is 
difficult to know whether phosphate ions in the ‘standard’ buffer used for the 
other NMR experiments also interact with the active site region. Importantly no 
‘new’ cross peaks have appeared in the HSQC spectrum as a result of the 
presence o f acetate ions. [Similarly, experiments in which TPxWt was titrated 
with magnesium acetate did not lead to any significant improvement in the 
spectrum (data not shown).] Thus any interaction o f the acetate ion with the 
protein is presumably rather weak, and the presence of acetate within the active 
site o f the TPxC60S crystal structure does not represent a highly stable 
interaction. As described by Stehr et al, (2006) acetate certainly does not appear 
to promote the formation o f conformations consistent with the formation of a C r- 
Cp disulphide bond, though perhaps this should not be expected in any event.
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C60S
Figure 5.9: A: The chemical structure of acetate anion (CH3COO) found in magnesium acetate, (drawn using BioRad’s KnowItAll™) using CPK colouring. B: Mtb TPxC60S 
active site; comprised of two catalytic cysteines, Cys60S and Cys93, plus the two important CP activating cleft residues; Argl30 and Thr57, all shown coloured in magenta. The 
acetate (ACT) molecule is as indicated by the coloured balls Picture drawn using PyMOL v0.99 (DeLano, 2006). [2H, 15N, 13C]-TPxC60S spectral overlays of; HSQC (C) and ID 
(D) NMR spectra, respectively, carried out at two different magnesium acetate concentrations; 0 mM magnesium acetate (black) and 200 mM magnesium acetate (red). Both C 
and D spectra obtained at 500 MHz, at 1 mM, pH 7.48 and 25 °C.
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Figure 5.10: A: [2H, 15N, 13C]-TPxC60S HSQC spectral overlays at two different magnesium acetate concentrations; 0 mM magnesium acetate (black) and 200 mM magnesium acetate 
(red). B: Close-up of perturbed residues from A, with movement indicated by boxed arrow. Spectra obtained at 500 MHz. at 1 mM. pH 7.48 and 25 °C.
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Figure 5.11: Perturbed residues mapped onto the TPxC60S crystal structure (PDB: 1Y25) shown in red and the catalytic, activating and mutated C60S amino acid residues shown in 
magenta. The binding site is circled.
5.7.2 Diclofenac sodium salt -  Compound-40.
Our collaborators (GBF Braunschweig) in the EU Framework Programme 7 
project that funded the work presented here, and that also determined the X-ray 
crystal structure of TPxC60S have also been engaged in a programme of ‘virtual 
screening’ for ligands that might potentially inhibit the activity o f Mtb TPx. 
Virtual screening refers to the computer-based paradigm o f identifying from an 
in silico library o f low molecular weight chemical compounds putative binding 
partners for a protein surface. Different incarnations o f virtual screening exist, 
varying in the way that the docking solutions are searched and in the manner that 
the hits are scored. A full description o f the virtual screening methods used by 
our collaborators is beyond the scope of this thesis. In summary however a 
ligand-protein docking program (Autodock3) combined with two compound 
diversity-sets that provide molecular spatial coordinates and atomic charges 
(NCI, -1990 compounds; ZINK, -49000 compounds) was used to ‘auto-dock’ 
flexible ligands to the crystal structure of TPxC60S. From a ZINK carboxylate 
subset, a molecule denoted as compound-40 (Figure 5.12A) emerged as a 
substance exhibiting a relatively high (i.e. strongly negative) docking energy and 
predicted binding to the TPxC60S active site (Figure 5.12B). Compound-40, 
identified by the full chemical name as 2-[(2,6-dichlorophenyl)- aminojbenzoic 
acid, is a known non-steroidal anti-inflammatory drug commonly used in the 
field of medical pharmacology, marketed under the trade name Diclofenac. 
Compared to many other potential hits in the virtual screen that yielded high 
docking energies, compound-40 was much readily available from commercial 
suppliers. Fifty auto-docking runs were carried out to assess the spatial 
compatibility o f compound-40, of which six runs were deemed energetically 
favourable (Figure 5.12C and 5.12D). As a result o f this promising theoretical 
binding potential for compound-40, co-crystallisation o f the compound with 
TPxC60S was then performed. This effort yielded a 2.4 A resolution model of 
the complex between TPxC60S and compound-40, electron density consistent 
with a molecule o f compound-40 occupying the active site (Figure 5.13A). The 
overall conformation o f the TPx protein is unchanged, with only a slight 
displacement o f the location o f the side chain o f Arg7 at the edge o f the binding
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pocket that makes room for the bulky dichlorophenyl ring. The compound-40 
carboxylate group makes H-bonds to the side chains o f Ser60 and Thr57 as for 
acetate in the previously reported structure (Figure 5.13B). [There is also 
evidence for a second molecule o f compound-40, sitting atop the first molecule 
in the active site (Figure 5.13B) which is in a more peripheral location with few 
contacts to the protein itself. This second molecule o f compound-40 makes a pi- 
stacking interaction with a symmetry-related neighbour in the lattice (not 
shown). ]
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Figure 5.12: A: The chemical structure of compound-40 (drawn using BioRad’s KnowItAll™) using CPK colouring. B: Theoretical TPxC60S ligand binding using the ZINK 
carboxylate compound group. Subset (1450 compounds) map, indicating compound-40 circled in red. C: TPxC60S structure indicating compound-40 as the high energy molecule at the 
active site, high energy compounds are shown in red, low energy compounds in blue. D: 6 out o f the 50 attempted of auto-docking conformations of compound-40 with TPxC60S.
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Figure 5.13: A: The binding of compound-40 with the active site o f TPxC60S using CPK colouring (drawn using PyMOL™). B: Crystal structure of TPxC60S indicating the 
association of two compound-40 molecules to the active site per monomeric unit. Colouring indicates the hydrophobic nature of the surrounding surface residues close to the active site 
of TPxC60S (blue > hydrophobic; red < hydrophobic). All hydrogen bond contacts are illustrated by dashed lines.
Given that the virtual screening and X-ray crystallography efforts had together 
provided some evidence for a productive interaction o f compound-40 with Mtb 
TPx, we investigated the impact of compound-40 on the nature of the NMR 
spectrum o f isotope-labelled TPxC60S. Thus, a series of NMR titration 
experiments was recorded, as described in Section 2.3.7.4, to probe the effect 
compound-40 had on the 2D [15N-1H]-HSQC spectrum. The results of the 
titration o f 1 mM [15N]-labelled TPxC60S with a concentrated stock solution of 
compound-40 up to a final concentration o f 50 mM are shown in Figure 5.14. 
(No further changes to the spectrum were detected at compound-40 concentration 
higher than 50 mM). The appearance o f the spectra indicate that TPxC60S 
retains its overall structure throughout the titration series, as the majority of cross 
peaks are completely unperturbed by the presence o f putative ligand (Figure 
5.14A). However a small subset of cross peaks show a small but definite 
chemical shift change that varies monotonically as more compound-40 ligand is 
added. The chemical shift changes are rather small, in all but one or two cases 
amounting to less then the apparent cross peak line width (Figure 5.14C). The 
identity o f each perturbed cross peak (where it is known) is listed in Table 5.3. 
Frustratingly, o f these effects, the two largest are ascribed to resolved back-bone 
amide cross peaks for which the assignments have thus far eluded identification 
(peaks 1 and 3 in Table 5.3). By elimination these peaks must derive from the set 
o f residues whose assignment has not been uncovered (Figures 4.16 and 4.17, 
Table 4.1).
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Figure 8 
corresponding 
cross peak 
numbering
Co-ordinates (ppm) 
HSQC (^N^H)
Amino acid 
assignment
Location on Mtb 
TPxC60S crystal 
structure
1 107.80ppm -  7.10ppm UNKNOWN N/A
2 105.59ppm -  8.82ppm Gly32 Loop connecting 
pi and p2
3 112.40ppm -  5.77ppm UNKNOWN N/A
4 116.14ppm -  7.00ppm Glul49 Loop connecting 
a4 and p7
5 116.35ppm -  7.63ppm Leu128 Loop connecting 
a l and p6
6 118.35ppm -  7.37ppm GInl52 Loop connecting 
a4 and p7
7 114.5lppm -  8.68ppm AsnlOO Loop -  connecting 
a2 and p5
8 122.07ppm -  7.77ppm Phe67 a l
9 124.35ppm -  7.39ppm Tyrl56 a4
10 128.13ppm -  8.3lppm V ail 47 Loop connecting 
a4 and p7
11 120.72ppm -  8.3lppm Ilel50 Loop connecting 
a4 and p7
12 122.05ppm -  8.33ppm Alal51 Loop connecting 
a4 and p7
13 122.1 lppm -  8.42ppm Glul53 Loop -  connecting 
a4 and p7
Table 5.3: The co-ordinates and amino acid assignments of the perturbed amino acid residues 
identified on addition of compound-40 to TPxC60S, as displayed in Figure 5.14A-C. More 
highly shifted cross peaks are highlighted in bold.
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Figure 5.14: A: Titration HSQC and B: ID NMR spectral overlay of TPxC60S with compound-40. Green boxes and green boxes with pale blue masking highlight cross peaks that are 
selectively perturbed in the presence of the ligand - blue spectrum = 0 mM, red spectrum = 30 mM, black spectrum 50 mM of compound-40. C: Green boxed sections only from Figure 
5.14A showing the chemical shift perturbation on increasing compound-40 addition (direction indicated by the arrows). All spectra obtained at 500 MHz, at 1 mM, pH 7.48 and 25 °C.
Whilst the data obtained are broadly consistent with an interaction between 
compound-40 and TPxC60S in solution, as in the crystal, the continued absence 
of a substantial fraction o f the cross peaks assignments intrinsically limits the 
ability to identify unequivocally the ligand binding site. When those assigned 
cross peaks which are perturbed, even though in a relatively minor way, by the 
presence o f compound-40 are mapped on the crystal structure of TPxC60S, one 
can argue that the majority cluster close to the active site (as shown in Figure 
5.15A-C). O f the group o f cross peaks that are perturbed, those that show the 
‘strongest’ (still weak) response correspond to residues Phe67, Leu 128, G lul49, 
lie 150, Alai 51, Gin 152, and two unassigned residues. The location of these 
residues on the 3D structure o f Mtb TPxC60S, particularly in the loop connecting 
a4 and p7 (residues 149-153), suggests that at least some o f these are close to the 
location of acetate binding in the structure, which is presumed to identify the 
putative active site adjacent to Cys60. It is possible therefore that compound-40 
does bind the active site in solution, similar to the observation in the crystal, but 
that the anticipated chemical shift perturbations are mostly masked by the over­
riding chemical exchange broadening, which is presumed to account for some of 
the ‘missing’ assignments for the polypeptide chain that surrounds the ligand- 
binding site on the ‘other’ side (see Figure 5.15A-C). The side chains o f Thr57, 
Val59, Ser60 and A rgl30 are those that directly interact with the acetate ligand 
in the Mtb TPxC60S crystal structure. O f these residues, only the N-H group of 
A rgl30 is unambiguously identifiable in the HSQC NMR spectrum, and this is 
unperturbed by the presence o f compound-40. It is formally possible that the 
unassigned peaks which are perturbed by the ligand include those from Thr57, 
Val59 or Ser60 but currently we are unable to unambiguously confirm and 
validate such assignments.
It should be noted however that, even if  these data do indicate that compound-40 
interacts with the active site (as anticipated from the crystal structure of the 
complex), then that interaction in solution is so weak as to have negligible impact 
upon the apparent underlying conformational exchange. In other words, a 
potential interpretation o f these data is that compound-40 does not lock the Mtb 
TPxC60S structure down into a single conformation that gives rise to a full 
complement o f cross peaks in the NMR spectrum.
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Figure 5.15: A - C: Crystal structure of Mtb TPxC60S (PDB: 1Y25) with compound-40, perturbed 
residues coloured red and catalytic residues coloured magenta. Missing residues, from back-bone 
assignment, are coloured yellow. Active binding site highlighted in semi-transparent circled region. B: 15° 
rotation of A. C: close-up of a single monomer of TPxC60S. Drawn using PyMOL™.
5.7.3. 4,4’-dithiodipyridine (DTDP).
Thiol chemistry is a rapidly expanding field in basic and applied bioscience 
(Packer, 1995 and Mrksich and Whitesides, 1996). The quantitative measurement 
of protein S-H groups is a task achieved using one o f several differing methods 
which include electrochemical (Nishiyama and Kuninori, 1992), fluorimeteric 
(Kirley, 1989), and spectropotometric assays (Reiner et al, 2002). O f the three 
different methods, the spectrophotometric assay system is both rapid and easy to 
implement at the expense o f a decrease in sensitivity. One o f the most widely 
used spectrophotometric methods in the quantification o f thiols is Ellman’s 
assay. As is shown in Figure 5.16A, the assay involves the reaction of a 
mercaptan thiol (R-SH) with Ellman’s reagent 5,5'-dithio-bis(2-nitrobenzoic 
acid) (DTNB). The reaction splits the symmetric DTNB into the mixed 
disulphide (R-S-TNB) releasing one equivalent o f free thionitrobenzoate anion 
(TNB ') for each S-H group. The reaction can be followed spectrophotmetrically 
by the monitoring o f the intense light absoption at 412 nm, which is pH 
independent at pH > 7.3, o f the thionitrobenzoate product. Both the educt 
(DTNB) and the mixed disulphide product (R-S-TNB) absorb poorly at this 
wavelength.
In a similar manner to the use o f Ellman’s reaction, 2,2'-dithiodipyridine (DTDP) 
(Figure 5.16B) can be used for the quantification o f thiol groups. DTDP has been 
used in characterisation o f enzymatically active cysteine residues (Brockehurst 
and Little, 1973), for measuring the ring-opening and closing rates o f thiosugars 
(Grimshaw et al, 1979), the quantification o f S-H groups in small molecules 
(Egwim and Gruber, 2001), and most recently in quantification o f cysteine in 
proteins (Riener et al, 2002). It is reported that DTDP has some advantages over 
Ellman’s reagent, for example, in being intrinsically more sensitive, though with 
the potential for higher background absorbance. DTDP is relatively small and it 
is also more hydrophobic and uncharged at -pH  7.0, consistent with a faster 
reaction with poorly accessible thiol groups in proteins.
We followed the reaction o f DTDP with TPxC60S by heteronuclear NMR, with 
aliquots o f the sample removed for spectrophotometric examination. As a control 
the reaction o f DTDP with bovine serum albumin (BSA) was concurrently
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monitored by the optical absorbance at 324 nm (Figure 5.17). The full 
methodological details of these experiments are described in Section 2.3.9. 
Increasing concentrations of DTDP were incubated with the protein substrate for 
50 minute periods during which the 324 nm absorbance reading was allowed to 
come to settle. Curiously the reaction o f DTDP with TPxC60S, monitored by 
absorbance as a function o f time (but including increasing DTDP loadings as 
indicated in Figure 5.17) follows a pseudo-sigmoidal pattern (Figure 5.18). With 
both BSA (Figure 5.17A) and TPxC60S (Figure 5.17B) prepared in the absence 
o f DTT the UV absorbance at 324 nm was found to increase in the presence of 
excess DTDP indicating that the thiol reactive agent is being consumed. In each 
case the total absorbance appears to approach a limiting value suggesting 
saturation o f the thiol binding sites. Quantitatively the data suggest that BSA 
contains < 1 mole o f reactive thiol groups per mole o f protein, similar to 
measurements for BSA reported in the literature (Riener et al, 2002). For 
TPxC60S the data suggest the presence of potentially two reactive thiol groups 
(Cys80 and Cys93) per mole o f protein homodimer, suggestive of the presence of 
a single reactive cysteine in each protomer. [An absorbance reading taken five 
days later indicated no further reactivity o f TPxC60S. The non-integral number 
of reactive thiol groups obtained presumably suggests some error in the 
estimation o f the protein concentration based upon the predicted extinction 
coefficient.]
Concurrent with the spectrophotometric analysis we followed the reaction of 
DTDP with TPxC60S by 2D [ ^ H J - H S Q C  NMR spectrum (Figure 5.18). A 
spectrum was recorded for each addition o f DTDP. Figure 19 displays a subset of 
the spectra recorded without addition o f DTDP, with DTDP concentrations of 1 
mM, 2.6 mM, and 4.6mM, and finally a spectrum recorded after prolonged 
exposure to excess DTDP.
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Figure 5.16: A: Reaction of a mercaptan with Ellman’s reagent, yielding a mixed disulfide and one equivalent of TNB2'. The molar absorptivities (e4i2) all refer to pH > 7.29. B: 
Two-step reaction of a mercaptan with DTDP, yielding one equivalent of 4-thiopyridone in each step. The molar absorptivities (e) all refer to X = 324 nm. Adapted from Reiner et 
al, 2002 and drawn using BioRad’s KnowItAll™.
Experiments: 1 2 3 4 5 6 7
Reagent (DTDP) 
concentration (pM):
200 400 1000 1600 2600 3600 4600
1.0
Absorbance at 324nm: 0.328 0.508 0.576 0.632 0.650 0.716 0.749
- 0 . 5  3
- 0.0
1.0
Reagent/ protein 
incubation time (min):
50 100 150 200 250 300 350
Free -SH  group 
reacting*:
0.172 0.284 0.322 0.353 0.363 0.375 0.392
- 0 . 5
Experiments: 8 9 10 11 12 13 14
Reagent (DTDP) 
concentration (pM):
200 400 1000 1600 2600 3600 4600
2.0
Absorbance at 324nm: 0.070 0.102 0.272 0.540 1.034 1.232 1.318
- 1.0
. 0.0
Reagent/ protein 
incubation time (min): 
Free -SH  group 
reacting*:
50 100 150 200 250 300 350
0.080 0.120 0.320 0.632 1.208 1.440 1.544
B
Figure 5.17: A: Measurement o f BSA sulfhydryls by the DTDP method results. B: Measurement of 
Mtb TPxC60S sulfhydryls by the DTDP method results. * denotes value obtained from the equation 
in Section 2.3.9.
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Figure 5.18: A: [I5N]-HSQC spectral overlay of 1 mM, 25 °C, at 500 MHz of TPxC60S; 0 mM DTDP 
(black spectrum), 1 mM DTDP (red spectrum), 2.6 mM DTDP (magenta spectrum), 4.6 mM DTDP 
(blue spectrum), 4.6mM DTDP after 5 days incubation (green spectrum). B: close-up views on 
perturbed amino acid residues from A. C: ID spectral overlay of the data presented in A.
Overall, the effect on the spectrum of DTDP is benign: the dispersion of the 'H 
spectrum is broadly maintained (Figure 5.18C) and the overall pattern of the 
cross peaks distribution in the HSQC is maintained. This indicates that the 
globular structure o f the protein persists in the presence o f the reactive DTDP 
molecule. Specifically, the majority o f  cross peaks are unperturbed throughout 
the experimental series (Figure 5.18A). On the other hand, a subset of cross 
peaks demonstrates specific chemical shift perturbations (Figure 5.18B). The 
nature o f these perturbations is characteristically different from those that are 
detected in titrations o f Mtb TPxC60S with compound-40 and magneisum acetate 
(four cross peak perturbations). Namely instead o f a dose-dependent change in 
the location o f  the cross peak centre (corresponding to chemical exchange which 
is fast on the NM R timescale), the perturbed cross peaks appear to ‘jum p’ from 
location in the spectrum to a new location. This behaviour is equated to ‘slow 
exchange’ on the chemical shift timescale and corresponds precisely to the 
expectation o f a system wherein the titrated ligand makes a covalent bond with 
the protein. Thus the two cross peak positions correspond to unreacted protein at 
low concentration o f DTDP/short incubation time, and the Cys-DTDP modified 
protein at high DTDP concentration/long incubation time, respectively.
In total 18 TPxC60S cross peaks were found to undergo DTDP-dependent slow 
exchange chemical shift perturbations. The magnitude o f the chemical shift 
changes is rather small, in the majority o f cases no more than the apparent 
linewidth o f the cross peak (Figure 5.18B). There was no specific pattern to the 
chemical shift changes in that either or both of the and 15N chemical shifts 
were observed to be changed in the DTDP-reacted state. Table 5.4 lists the 2D 
[^N^HJ-HSQC spectral coordinates, identities and location as found in the Mtb 
TPxC60S crystal structure, o f these pertubed amino acid residues. These 
perturbed residues are also highlighted in the individual panels in Figure 5.18B.
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Perturbed residue: 15N, !H chemical 
shift coordinates:
Location in Mtb 
TPxC60S crystal 
structure
T30 116/8.8 Loop connecting pi 
and P2
G31 115/9.0 Loop connecting pi 
and P2
G32 106/8.9 Loop connecting pi 
and p2
G35 107/8.3 P2
137 130/8.8 P2
L48 129/9.2 P3
L49 126/9.5 P3
A76 123/7.5 Loop connecting a l  
and P4
G94 107/8.3 a3
N100 114/8.7 Loop connecting a3 
and P6
V101 118/7.1 Loop connecting a3 
and p6
M102 124/9.0 Loop connecting a3 
and P6
1119 129/9.4 Loop connecting a3 
and p6
G126 108.5/8.7 Loop connecting a3 
and P6
1135 131.5/9.8 P6
V I47 128.5/8.2 Loop connecting a4 
and p7
N155 120.5/10.4 Loop connecting a4 
and p7
Y156 124/7.4 a4
Table 5.4: A list o f perturbed amino acid residues on incubation of DTDP with TPxC60S.
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The perturbed amino acid residues have been mapped onto the Mtb TPxC60S 
crystal structure (PDB: 1Y25), in order to observe their location relative to the 
potentially DTDP-reactive cysteine side chains in the protein (Figure 5.19). It is 
noteworthy that Cys80 is essentially completely buried in the core of the protein 
structure, which its side chains forming van der Waals contacts with the side 
chains o f Val78, Ser82, VallOl, and A la i04, based upon their proximities. A 
calculation with program NACCESS indicates that only 2 % of the side chain is 
exposed to a solvent probe with 1.4 A radius. On the other hand the side chain o f 
Cys93 is more exposed, ~18 % according to NACCESS, and could be envisaged 
to become more exposed to the protein surface with relatively minimal changes 
in a small number o f torsion angles.
All 18 cross peaks that are perturbed in the DTDP titration, correspond to 
residues that cluster predominantly in a region that could more sensibly be 
described as surrounding Cys93, rather than Cys80. As Table 5.4 describes 
several residues are found on alpha helices a2 and a4, with others located on 
beta-strands pl-p4 and p7. However, a significant proportion is located on 
various interconnecting loop regions. In both protomers, the majority o f  
perturbed residues cluster close to the dimer interface -  a region believed to 
encompass mobile secondary structural elements hindering the backbone 
resonance assignment o f particular sections of the TPxC60S amino acid 
sequence.
The results o f the DTDP titration are as follows. Clearly the slow exchange 
characteristic o f the spectral perturbations is consistent with a covalent 
modification o f the protein attributable to reaction of DTDP with an exposed 
thiol group. Given the apparent stoichiometry of the reaction which suggests that 
not more than 1 Cys residue per TPxC60S protomer reacts with DTDP, and the 
pattern o f residues in the structure o f the protein that are sensitive to the chemical 
modification, it is presumed that DTDP reacts with the more exposed Cys93 side 
chain. It seems extremely unlikely that Cys80 could react with DTDP with global 
remodelling o f the protein structure -  a circumstance that is inconsistent with the 
rather limited chemical shift effects in the titration. Interestingly since from the 
NMR perspective the reaction appears to go essentially to completion, i.e. that
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the cross peaks corresponding to the un-reacted protein diminish to vanishing 
intensity by the end of the experiment, it appears that the Cys93 residues in each 
half o f the TPxC60S homodimer are equally reactive. Notably there is no 
evidence in the spectra for a Cys93-SH/Cys93-SS-TP heterodimer, an 
asymmetric species that might give rise to an increase in the numbers o f NMR 
cross peaks due to symmetry breaking. Assuming that this species does not 
represent the end point of the reaction, the fact that we do not detect this species 
at intermediate points in the titration indicates that the chemical shift effects of 
the DTDP-modification are ‘local’ to the site of reaction. That is, any structural 
perturbation that accompanies the modification o f the Cys93 residue is not 
transmitted across the dimer interface (a conclusion which again would be 
consistent with the relatively small magnitude of the DTDP-induced chemical 
shift changes).
Yet again this experiment demonstrates that it is possible to perturb the spectrum 
o f TPxC60S, albeit in a relatively minor way, without inducing the appearance of 
‘new’ cross peaks. Thus even the covalent attachment of a chemical moiety to 
the side chain o f Cys93 appears insufficient to quench the intermediate timescale 
polypeptide dynamics that has been invoked in this thesis to account for the 
‘missing’ cross peaks.
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Figure 5.19: A: TPxC60S crystal structure (PDB: 1Y25) exhibiting perturbed residues on addition of DTDP. B: Monomer 1 and C: Monomer 2: perturbed residues situated close to dimer 
interface. Both monomers show perturbed residues to cluster (heavy outline) close to the recognised TPxC60S binding pocket (dashed outline).
5.8. Ligand binding summary.
The analysis o f the NMR spectrum of TPxC60S throughout the course of this 
work has been impacted by the inability to complete the back-bone resonance 
assignment, in large part due to the apparent absence of 30 N-H cross peaks, and 
leaving 18 observable cross peaks unidentified (see Chapter 4). The underlying 
assumption that has pervaded our approach to this aspect is that the cross peak 
absences are the result o f dynamical exchange broadening, presumed to arise 
from interconversion between multiple conformational sub-states on the 
intermediate timescale. As discussed already, it is attractive to imagine that the 
conformational exchange is related, or directly attributable to the observed 
differences between the structures of oxidized and reduced L-atypical 2-Cys 
peroxiredoxins (see Chapter 3): perhaps even the TPxC60S protein is constantly 
sampling the conformational trajectory between these two structures, which is 
predicted to include local folding/unfolding o f the ends of the a l and a4 helices 
and permitting the close approach of the side chains o f residues 60 
(corresponding to the peroxidatic cysteine, Cp) and 93 (the resolving cysteine, 
C r ).
We sought to explore the potential to ‘freeze out’ the putative motion, to 
‘improve’ the NM R spectrum through the administration o f ligands that might 
interact with the active site residues. The hope was that perhaps the binding of 
the ligand would either inhibit or slow down the rate of conformational 
exchange, thereby either trapping the structure in one conformation, or limiting 
the line broadening effects o f the exchange respectively.
Specifically we tested the effect on the TPxC60S spectrum of acetate ions (found 
to occupy the active site in the original TPxC60S crystal structure); compound- 
40 (a known low molecular weight pharmaceutical substance identified as a 
potential active site ligand by computational screening and subsequently co­
crystallised with the protein); and DTDP (a material that is reactive with cysteine 
side chains would be predicted to add a bulky chemical moiety to the thio-S atom 
o f Cys93). In each case, effects on the TPxC60S NMR spectrum were 
observable: for acetate and compound-40 a small number of cross peaks 
migrated a little with a fast exchange characteristic; for DTDP a subset o f cross
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peaks underwent a step-wise (as if  ‘slow exchange’) shift consistent with a 
covalent modification. Importantly however in each case the chemical shift 
perturbations were few in number and small in magnitude, often no more than 
the width o f the cross peak, and unfortunately no ‘extra’ cross peaks were ever 
detected. The conclusion is that the NMR data suggest that whilst each ligand 
may well interact with the active site as expected, in no instance is that 
interaction so strong as to influence the proposed conformational exchange so as 
to permit the completion of the back-bone resonance assignment. Table 5.5 
summarizes the results obtained from the three compounds used during these 
experiments.
Compound used Protein used: The number of Any new cross peaks
in ligand cross peak in the resulting HSQC
binding: perturbations: spectra:
Magnesium TPxC60S 4 NO
acetate TPxWt 0 NO
Compound-40 TPxC60S 13 NO
DTDP TPxC60S 18 NO
Table 5.5: Summary of the ligand binding experiments conducted during the course of this 
project using the two different Mtb TPx variants.
5.9. Oxidised vs. reduced TPxWt and the significance of the Cys60-Cys93 
disulfide bond.
As has been shown elsewhere in this thesis (Chapter 4), the NMR spectra 
obtained for the wild-type Mtb TPx, whilst resembling the spectra for the C60S 
mutant, are always o f a poorer quality. For example, whilst the chemical shift 
dispersion o f the ]H ID spectra o f both TPxWt and TPxC60S forms are typical 
o f folded globular proteins, the 2D [^N^Hj-HSQC spectrum of the wild-type 
contains many fewer cross peaks than for the mutant. (Importantly the subset of 
peaks that are visible for TPxWt has a similar distribution o f chemical shifts to 
the peaks also detected in the mutant, again indicating an overall similar globular
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fold.) We have been intrigued in how the simple substitution of a single sulphur 
atom in the thiol group o f Cys60 by an oxygen atom in each protomer chain 
could have such a dramatic influence on the overall quality of the NMR 
spectrum. We thought it important to check whether the chemical reactivity 
represented by the Cys60 side chain (which is after all the peroxidatic active site 
group), where it could potentially covalently bond with other parts of the same or 
other protein chains, was responsible for the overall appearance o f the spectrum. 
To this end we recorded NMR spectra of Mtb TPxWt in various relatively 
elevated concentrations o f DTT.
Figure 5.20 shows a series o f ID !H and 2D [15N,1H]-HSQC spectra of isotope- 
labelled wild-type TPx recorded with DTT concentrations up to 10 mM. Whilst 
there were hints from the ID spectra that the line width o f the resonances was 
slightly improved in the presence of excess DTT there is relatively little 
difference between the corresponding 2D spectra. This result suggests that in 
each case the protein maintains a consistent oligomeric state and that it remains 
essentially completely reduced. There is a consistent difference in the ‘quality’ of 
these NMR spectra compared to that of the TPxC60S mutant (Figure 5.20C), 
particularly in terms o f the visible cross peak count.
5.10. Oxidised vs. reduced TPxWt: summary.
Clearly the spectrum o f the wild type protein is impacted by line broadening 
effects that are more extensive even than those that appear to operate in the 
spectrum o f the C60S mutant. Formally it is possible that the extra broadening 
could result from higher order self-association o f the protein (e.g. by the transient 
formation o f dimers o f homodimers) leading to an overall increase in the average 
rotational correlation time. NMR spectra recorded at 0.5 and 1.0 mM protein 
concentration are essentially the same (data not shown), and this observation and 
the non-uniform nature o f the comparative peak intensities between the wild-type 
and C60S TPx spectra argue against this interpretation. Rather we suspect that 
the additional line broadening observed for the wild-type protein may reflect 
enhanced amplitude o f exchange broadening associated with the putative 
conformational exchange that has been described above for the mutant protein.
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Consistent with this interpretation we note that there is no cross peak in the 
spectrum o f the wild-type that does not occur in that of the mutant. Most likely 
there is a common mechanistic origin for the line-broadening in each case, with 
the rate or amplitude o f the putative internal motion modulated by the chemistry 
of the side chain o f residue 60. In this respect it is intriguing to speculate that the 
rate determining step o f the mechanism o f exchange depends upon the relative 
strength o f the non-bonded (perhaps H-bonding) contacts for the Cys60 thiol -  
SH and Ser60 hydroxyl -O H  moieties respectively.
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Figure 5.20: A: HSQC spectral overlay of TPxWt at various DTT concentrations: 1 mM (red), 4 mM (magenta) and 10 mM (black). B: Two isolated spectral HSQC overlays of TPxWt at 
two different DTT concentration extremes: 1 mM (red) and 10 mM (black). C: Two HSQC spectral overlays. One of TPxWt at 10 mM DTT (black) and the other of TPxC60S at 1 mM 
DTT (red). D: ID spectral overlay of TPxWt at differing DTT concentrations, as seen in A, and TPxC60S at 1 mM DTT (black spectrum -  top). All spectra obtained at 500 MHz, at 1 
mM, pH 7.48 and 25 °C.
5.11. Discussion:
This chapter has described efforts to use physical (temperature) and chemical (pH and 
ligand titration) approaches to perturb the NMR spectrum of Mtb TPx to reveal 
‘missing’ cross peaks that otherwise have limited the ability to more completely 
assign the cross peaks and thereby provide a fuller description of the protein in 
solution. The putative intrinsic conformational exchange, based upon the evidence of 
homologous crystal structures of oxidised and reduced Mtb TPx orthologues, 
developed as a concept to rationalise the NMR data in Chapters 3 and 4 is apparently 
not impacted sufficiently by our physical and chemical perturbations to achieve the 
stated goal. As is often the case for conformational exchange on the intermediate 
timescale in the NMR spectra o f proteins, the line broadening has proved difficult 
(impossible thus far) to circumvent with the frustrating aspect that the broadening of 
the line widths leads to a loss o f information, just when one needs more in order to 
better understand the underlying process(es).
The following chapter discusses the possibility of isolating an Mtb TPxC60S 
monomer by mutating amino acid residues contributing to the stabilizing interactions 
within the Mtb TPx homodimer. This would prove particularly significant in light of 
the fact that many o f the missing residue assignments are located within, or close to, 
the interprotomer interface. As it is suspected that conformational exchange is at the 
root o f the difficulty experienced in completing the back-bone resonance assignments 
for TPx, the mutation(s) o f interfacial residues may help yield better NMR spectra 
consistent with that o f a monomer. This may ultimately help in fully assigning the 
Mtb TPxC60S back-bone.
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Chapter 6
Project summary, conclusions and discussions
The general approach to the rationalisation of the appearance o f the NMR spectrum of 
Mtb TPx in this thesis has been slanted towards an expectation that the protein is 
undergoing conformational exchange that is related in some respect to the observed 
differences in the X-ray structures of oxidised and reduced Mtb TPx and species 
homologues. Because o f the exchange broadening, which leads to a loss of 
information because o f diminished, often vanishing, cross peak intensity we are 
intrinsically inhibited from using the NMR spectrum to unravel the nature of the 
exchanging conformations in solution. There is another aspect to this scenario that has 
so far not been exposed in this description. Namely, it is formally possible that 
conformational exchange that is proposed may also involve reorganisation o f the 
inter-protomer interface o f the Mtb TPx homodimer. Whilst no such rearrangement of 
the interface is suggested by the available crystal structures, it remains possible that 
the interface in solution is conformationally ‘plastic’. Examination of the crystal 
structure o f Mtb TPx indicates that the buried surface area in the homodimer contact 
is ca. 725 A2 per protomer. Whilst not a particularly small contact surface area, it is 
not incomparable with instances where NMR data have implied or confirmed that a 
dimer in a crystal is able to disassociate in solution, albeit to a greater or lesser extent 
(Jones and Thornton, 1996 and Plevin et al, 2007).
In this context it is interesting to recount the recent example, from work in the same 
laboratory, where the bacterial enzyme Dimethylarginine dimethylaminohydrolase 
(DDAH), a homodimer o f  two 29 kDa promoters, was studied by both X-ray 
crystallography and NMR. The contact surface buried in the interface in this instance 
was ca. 860 A2 per protomer, and the protein behaved essentially as a dimer in 
solution at concentrations used for NMR experiments. When resonance assignment of
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the [15N, 13C, 2H]-labelled DDAH was attempted, several cross peaks could not be 
assigned or were not detected. Again it was suspected that conformational exchange 
was at the root o f  this difficulty, though in this instance it was much more the case 
that reorganisation o f the protomer-protomer interface, rather than any more gross 
reorganisation o f the protein structure, is the mechanism by which the selective 
exchange broadening arises. (This conclusion was drawn in part because of the five- 
bladed p/a-propeller nature o f the DDAH fold -  it seems rather unlikely that this 
structure can locally unravel without global effects on the NMR spectrum -  plus there 
was no crystallographic data to support the invocation o f a locally reorganised 
polypeptide topology). On the basis o f a per-residue analysis o f the inter-protomer 
contact surface, mutations o f interfacial residues were introduced into the DDAH 
protein and these variants were screened by analytical size exclusion chromatography 
and sedimentation equilibrium analytical ultracentrifugation to assess the 
hydrodynamic status. Ultimately a double mutant DDAH was derived that behaves 
exclusively as a monomer, and retains a level o f biological activity equivalent to the 
wild-type. The double mutant DDAH yielded essentially ideal NMR spectra, 
consistent with a monomeric species. Full resonance assignments were obtained in a 
straightforward manner for this form o f the protein. Comparison o f these results with 
the spectrum o f the wild-type homodimer indicated that the ‘missing’ cross peaks in 
the latter case derived from residues either at or close to the interprotomer interface in 
the crystal structure, lending support to the proposition that the exchange broadening 
could arise from local reorganisation o f that interface in solution.
Given this example, which in many respects mirrors concepts that have arisen in the 
examination o f the Mtb TPx protein, it is instructive to consider whether a similar 
analysis o f the homodimer interface observed in the crystal might provide a basis for 
decoupling the exchange broadening effects that could arise from the proposed local 
reorganisation o f the a l  and a 2  helices (including the Cp and C r active site residues) 
and any conformational plasticity o f the homodimer interface.
Thus, the sites that constitute the interaction surface between the Mtb TPx homodimer 
protomers in the homodimer crystal contact surface were assessed in a residue-by- 
residue fashion using NACCESS, a program used to calculate the solvent accessible 
surface area (SASA) o f a molecule from a PDB (Protein Data Bank) format file. To
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identify the residues involved that contribute stabilizing interactions in the Mtb TPx 
homodimer, we examined the predicted changes in side chain SASA for each residue i 
(ASASAi) upon self-association o f two monomers into the symmetric homodimer. By 
this assessment, a total of 19 residues - spanning a total area of ca. 725 A2 per 
protomer -  exhibit a fractional change in side chain SASA (i.e. fSASAi > 0), as shown 
in Figure 6.1B. The value o f fSASAi is calculated according the formula below:
/SASA, =
s a s a ^ ' - s a s a , ^
SASA, dimer
For a residue whose side chain is entirely enclosed in the interface fSASAj —► 1; for a 
residue entirely outside the contact surface fSASAi —► 0. The residues exhibiting the 
highest fSASAi (> 0.8) are shown in red in Figure 6 .IB and include: Ser54 and Asp56 
(both located on the loop region between (33—>al); Asp84 and Leu85 (both located on 
the loop region between p4—hx2); Pro86, Phe87 and Ala87 (all three located on a2); 
and Leu 127 (located on loop region linking (36—hx3). Additional residues that show a 
smaller value o f  fSASAi are indicated by the graded colour scheme in Figure 6 .IB. 
Judged simply on the number o f residues implicated by this calculation, only ~10 % 
of the residues in the protein contribute to dimer formation to any degree and the rest 
o f the surface appears white in the diagram.
O f the side-chain exposed residues located at the interacting surface, a sub-total of 
nine residues display a significant absolute change in SASA (i.e. ASASAi > 25 A2) 
accounting for 509 A2 of the interacting side chain regions per protomer 
(corresponding to 81 %), as shown in Figure 6.1C. O f these residues, two (Leu85 and 
Phe87) are exhibit the dominant contribution to the total side chain A SASA for the 
homodimer interface. Examination o f the crystal structure o f Mtb TPx indicates that 
the opposing Leu85 residues form a pair-wise symmetric hydrophobic side chain-side 
chain contact, buttressed on each side (as it were in cis) by the side chains o f Phe87. 
Each Phe87 phenyl ring makes a hydrophobic interaction, in trans, with the methyl 
group o f Thr57 o f  the opposite protomer.
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Figure 6.1: Analysis o f solvent-accessible surface area (ASA) for TPxC60S. A: Cartoon representation of Mtb TPxC60S protomer indicating the location of the two alpha-helices 
responsible for the catalytic triad involving the C60S mutation. Also indicated is residue L85, the primary residue involved in the homodimer interaction; the binding face is to the 
front. B and C. Molecular surface representation of a TPxC60S protomer in the same orientation as A, coloured according to (B) fractional change in ASA per residue, fASA,, and 
(C) absolute change in ASA per residue, A ASA/, in units of A2, upon formation of the homodimer. For a residue that is enclosed entirely in the interface fASA/, —» 1; for a residue 
entirely outside the contact zone fASA/, —» 0. All images were created using PyMOL.
Additional significant contributors to the interaction surface for Mtb TPx, assessed by 
the criteria fSASAi > 0.5 and ASASA, > 50 A2 include Leul27, Asp84, Asp56, and 
Argl08. It is interesting to consider whether these residues are conserved in 
homologous proteins. A BLAST search with the amino acid sequence o f Mtb TPx 
returns a large number o f close homologues (CLUSTALW alignment in Figure 6.2). 
The alignment shows that in general the chemical characteristics o f these positions is 
strongly conserved suggesting that perhaps all o f these proteins exist in a 
homodimeric (or higher order) oligomerisation state. In fact in the top 100 BLAST 
hits residues at positions corresponding to positions 85 and 87 are absolutely 
conserved. Mindful however that these BLAST hits are dominated by TPx 
orthologues, and that TPx shares an overall structural architecture with a great many 
other peroxiredoxins and proteins in the thioredoxin-fold super-family -  at least some 
of which are monomeric in solution -  we sought to test whether these positions were 
maintained as hydrophobic residues in the wider class o f structurally related proteins. 
Thus we performed a DALI search o f the Protein Data Bank using the coordinates of 
an isolated Mtb TPx protomer. DALI is a programme that systematically compares a 
single protein coordinate set with the rest of the PDB to find examples o f closely 
related structures, even in the absence o f extensive sequence homology. In the DALI 
output the similarity between the query structure and any ‘hit’ is characterised by a 
‘Z-score’, where Z > 2.0 implies a significant structural homology. For Mtb TPx 
DALI returned 150 coordinate sets with a Z-score greater then 2.0, o f which we 
concentrated on the subset o f 27 PDB entries with Z > 5.0, corresponding to sequence 
identities with Mtb TPx in the range 10-45 % and back-bone RMSD of the order of 
1.5-3.8 A. O f these proteins, ten are reported or predicted to be monomeric in 
solution. The amino acid sequences and the secondary structure content o f these ten 
proteins are depicted in Figure 6.3. Interestingly when we analyse the sequences of 
these proteins at the positions corresponding to the homodimer interface o f Mtb TPx, 
the chemical characteristics are strongly divergent (Figure 6.4). Thus for the position 
corresponding to Mtb TPx Leu85, these monomeric homologues can present the more 
polar Asp, Gin or Lys side chains. Likewise for the position corresponding to Mtb 
TPx Phe87 the homologues sometimes present Lys, Glu, or Gly. Whilst the absence 
o f an absolutely conserved secondary structure in this region (Figure 6.3) makes it a 
potentially optimistically naive concept, it seems that a potential route to obtain a 
monomeric variant o f Mtb TPx would be to mutate either one or both o f Leu85 or
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Phe87 into alternative residue types, with the specific side chain substituents selected 
from amongst these examples. At the time o f writing attempts at this objective are 
underway by others in the laboratory.
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: K83, D84, L85, P86, F87, A88 JI_________________
G126, L127Mtb TPxC60S
P123. M124.A125
"a»m? OklHt t
Figure 6.2: A ClustalW alignment of the top 100 sequence-related homologues for Mtb TPx 
(top o f the list). By definition, blue segments indicate identical residues and green segments 
indicate similar residues. The amino acid residues identified as responsible for homodimer 
stability of Mtb TPx, in particular residues Lue85 and Phe87 (additionally highlighted in 
yellow), are shown above the alignment. All 18 residues are coloured blue and 
representative o f high conservation across the alignment. Species and protein identifiers are 
listed on the far left o f the alignment.
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Figure 6.3: Structural alignments o f Mtb TPxC60S (top of each alignment) with the top ten based Z- 
scored (numbers shown to the left) monomer PDB structures (PDB identifier and RMSD shown to left) 
as obtained from the Dali structural comparison server. The structural alignment highlights the a-helical 
(orange)/p-strand (purple) content o f the aligned structures as compared to the secondary structure 
composition o f Mtb TPxC60S (shown at the top o f the alignment).
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Figure 6.4: Structural alignments of Mtb TPxC60S (top of each alignment) with the top ten based Z- 
scored (numbers shown to the left) monomer PDB structures (PDB identifier and RMSD shown to left) 
as obtained from the Dali structural comparison server. The structural alignment is as shown in Figure 
6.3 but with the residues exhibiting the greatest extent o f ASASA,- colour coded as shown in Figure 
6.1C.
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Chapter 7
Bacterial sigma factors and Mtb sigma factor
J (sigJ)
7.1. C hapter sum m ary.
A sigma factor (a factor) is a prokaryotic transcription initiation factor that must 
be part o f RNA polymerase for specific binding to promoter sites on DNA. At 
present, two large protein families exist into which sigma factors are classified; 
the a 70 and the a 54 families. Several phylogenetic groups are sub-categorized 
from within the ct70 family, o f which there are currently 5 groups, with 
diversification based upon, but not always, the correlation of functional 
characteristics.
Sigma factors have four main regions that are generally conserved; o u -a i . 2 , 
<7 2 1 - ^ 2 .4 , G3 .0-C 3.2 and 0 4 .0- 0 4 . i- Regions; 0 2 .1- 0 2 .4  and 0 4  0- 0 4 .1  are recognized as 
being able to bind to the -10 and -35 DNA promoter elements, respectively, prior 
to transcript synthesis.
In Mtb there are at least 13 different sigma factors, of which sigJ (Rv3328c) 
exhibited increased levels o f mRNA synthesis in late stationary-phase cultures. 
SigJ proved to be strongly up-regulated and its importance deduced to be 
significant in helping Mtb to survive prolonged stationary phase, to withstand 
stress conditions and to tolerate antibiotics. This reasoning is the driving force by 
which sigJ was singled out for experimental analysis.
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7.2. Introduction — SigJ.
Coates and Hu, (2001b), investigated the transcription of 82 genes from Mtb in 
the hope o f  identifying those genes involved in maintaining viability of 100-day 
stationary phase bacteria and persistent bacteria, both before and after antibiotic 
treatment using rifampicin. Rifampicin is used together with other antibiotics in 
treating M tb  infected individuals (Department o f Health Services -  Australia, 
2002).
Coates and Hu, (2001b), showed using in vitro and in vivo studies that persistent 
bacilli which are tolerant to antibiotics are also transcriptionally active. 
Rifampicin treatment selectively isolated those bacteria still persisting post­
antibiotic/antimicrobial treatment as high doses o f rifampicin kills actively 
replicating bacteria.
Using a mini-DNA array they selected those genes recognised as being up- 
regulated or highly expressed in adaptation to stationary phase in other bacteria. 
Up-regulation o f  genes suggests an important role in stationary-phase survival in 
Mtb.
The mRNA levels from three target areas were monitored: exponential-phase 
cultures (4 days), late stationary-phase dormant cultures (100 days) and in 
persisters (the 100-day culture, after rifampicin treatment). The data collected 
showed that 12 % o f the genes investigated exhibited an increase in transcription 
level (as opposed to the mRNA levels monitored during exponential growth) in 
the late stationary-phase cultures (100 days), 44 % o f the genes investigated 
showed no change in transcription level, while another 44 % exhibited a two- or 
more fold decrease in mRNA level.
In the cultures treated with rifampicin, no up-regulation was observed. From the 
82 genes monitored, 67 genes remained unchanged in mRNA levels monitored 
while 10 genes were down-regulated.
O f those genes whose mRNA levels increased in the late stationary-phase 
cultures, sigJ (Rv3328c), with a 17-fold increase, was found to have the highest 
change in mRNA level o f all the genes monitored suggesting it may have a 
significant role in the non-replicating form o f Mtb.
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The results reveal that sigJ together with sigl, both being strongly up-regulated 
(two-fold mRNA level increase during stationary phase growth for sigl), may 
serve as important alternative sigma factors which control the expression of 
stationary phase-associated genes which help Mtb to survive prolonged 
stationary phase, to withstand stress conditions and to tolerate antibiotics.
7.3. Bacterial sigma factors and transcription. 
7.3.1. Overview.
In bacteria, specific transcriptional initiation by RNA polymerase (RNAP) 
requires a single polypeptide (sigma (a) factor), which binds to core RNAP to 
form the active holoenzyme (Darst et al, 1996) and is directly involved in 
promoter recognition, DNA melting and promoter escape and clearance 
(Borukhov et al, 2002). The following sections examine sigma factor reliance for 
RNAP for transcription initiation in bacteria and the various clades into which 
sigma factors are classified depending upon their discriminate properties.
7.3.2. Bacterial RNA polymerase.
The DNA-dependent RNAP is the principal enzyme o f the transcription process 
and is a final target in many regulatory pathways that control gene expression in 
all living organisms (Borukhov et al, 2002).
RNAP is a complex multisubunit enzyme that contains a dissociable sigma 
subunit responsible for promoter recognition. In bacteria, RNAP is responsible 
for the synthesis o f all the different types o f RNA in the cell such as messenger 
RNA, ribosomal RNA and transfer RNA. Typically, the vast majority of 
transcription in rapidly growing bacteria requires a single, primary a  factor 
subunit similar to a 70 o f Escherichia coli. Control o f genes transcribed by this 
dominant RNA polymerase often rests with DNA-binding repressor and activator 
proteins. In other cases, however, transcription is regulated by a o factor
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switching mechanism in which the primary a  subunit is replaced by an 
alternative a  factor with distinct promoter selectivity. Alternative (encompassing 
the classified ct factor grouping; Group 3 and 4) a  factors function in place o f the 
primary a  factor by binding to core RNA polymerase to allow promoter 
recognition. In general, alternative a  factors control specialised regulons which 
are active during growth transitions, in stationary phase, in response to stress 
conditions and during morphological differentiation (Helmann, 2002).
The bacterial RNAP exists in two forms: the core enzyme or the holoenzyme. 
The core enzyme has a relative molecular mass o f approximately 400 kDa and 
consists o f four subunits (Figure 7.1).
RNAP is conserved in all living organisms. Thus, bacterial RNAP, archaeal 
RNAP, and eukaryotic RNAP I, RNAP II, and RNAP III, are members of a 
conserved protein family, termed the ‘multisubunit RNAP family’. Members of 
this protein family contain a conserved subunit o f -160  kDa (P in bacterial 
RNAP; A in archaeal RNAP; RPA1, RPB1, and RPC1 in eukaryotic RNAP I, II, 
and III), a conserved subunit o f -150 kDa (p in bacterial RNAP; B in archaeal 
RNAP; RPA2, RPB2 and RPC2 in eukaryotic RNAP I, II, and III), a conserved 
subunit o f -35  kDa (a1 in bacterial RNAP; D in archaeal RNAP; RPC5 in 
eukaryotic RNAP I and RNAP III; RPB3 in eukaryotic RNAP II), a conserved 
subunit o f -1 0  -  35 kDa (a 11 in bacterial RNAP; L in archaeal RNAP; RPC9 in 
eukaryotic RNAP I and RNAP III; RPB11 in eukaryotic RNAP II), and a 
conserved subunit o f  —6 kDa (oo in bacterial RNAP; K in archaeal RNAP; RPB6 
in eukaryotic RNAP I, II, and III). Bacterial RNAP contains only these 
conserved subunits. Archaeal and eukaryotic RNAP contain these conserved 
subunits as well as additional subunits (Ebright, 2000).
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• p -  Subunit which includes the RNA polymerase 
catalytic site.
• P' -  Subunit, includes DNA binding site.
• a 1 and a 11 -  Two sequence identical subunits both 
possessing a C-terminal (aCTD ) and N-terminal 
(aNTD) domains. Both domains are involved as 
scaffolding units that interacts with other proteins 
that regulate transcription.
• to -  Role not well characterized.
aCTD
aNTD
DNA coding strand
Figure 7.1: Diagrammatic representation of the RNAP five subunit assembly, with annotation.
7.3.3. Bacterial transcription.
The transcription cycle in bacterial cells can be divided into three main stages: 
initiation, elongation and termination. Although it is catalytically active, the core 
enzyme is incapable o f initiating transcription efficiently and with specificity. 
For this, it must bind an initiation factor, a, to form a holoenzyme that can 
recognize specific DNA sequences (promoters) (Gross et al, 1992). A promoter 
sequence is located upstream from the start site o f transcription and contains the 
consensus sequence to which the polymerase binds. During initiation, the 
holoenzyme specifically binds to two conserved hexamers in the promoter at 
nucleotide (nt) positions -35 and -10 relative to the transcription start site (+1), 
to form a closed promoter complex (Borukhov et al, 2002). E. coli promoters 
include the so-called TATA box (-10 bp -  rich in adenine and thymine base 
pairs) and the -35 region (-35 bp upstream) from start site. The holoenzyme 
specifically recognizes these promoter regions (Cummings and Klug, 1994; 
Bishai and Manabe, 2000 and Borukhov et al, 2002). The holoenzyme unwinds 
the double stranded DNA around the -10 region (between nt -12 and +2), 
resulting in the open promoter complex and initiates transcription in the presence 
o f nucleotide triphosphates substrates. Incoming ribonucleotide triphosphates 
(RTPs) form the correct hydrogen bonds to the template. New phosphodiester 
bonds are formed at the RNAP catalytic centre with the concurrent release of 
pyrophosphate (PPi) which is thermodynamically assisted by PPi hydrolysis. 
After the synthesis o f RNA approximately 9-12 nt long, 8nt or 9nt are base- 
paired with the DNA template strand (DNA-RNA hybrid), the transcription 
complex passes from the initiation to elongation stage (von Hippel, 1998). This 
transition is characterized by the escape o f RNAP from the promoter, the 
dissociation o f a  from the core, and the formation o f a highly processive ternary 
elongation complex (Borukhov et al, 2002). This process produces mRNA that 
is then incorporated into the process o f translation -  the biological 
polymerization o f amino acids into polypeptide chains. From the transcriptional 
process, mRNA associates with a ribosome, which consists of two subunits (one
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large and one smaller -  based upon their sedimentation behaviour in sucrose 
gradients) and several rRNA components.
Specialized, alternative a  factors direct transcription o f specific regulons 
during unusual physiological or developmental conditions such as heat shock 
or the presence o f extracellular stresses (Darst et al, 1996).
The core RNAPs from bacterial and eukaryotic cells, which are catalytically 
active in RNA chain elongation, are homologous in structure and function 
(Aheam et al, 1987), showing that the structural and functional nature of core 
RNAPs is ubiquitous.
Bacterial a  factors are an essential component o f prokaryotic RNA 
polymerase and determine promoter selectivity. The substitution o f one o 
factor for another can redirect some or all o f the RNAP in a cell to activate 
the transcription o f genes that would otherwise be silent.
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7.4. The sigma-70 (cr70) family — Introduction.
Bacterial a  factors belong to two large protein families, both apparently 
unrelated; the a 7 0  and the a 54 families (Helmann, 1994 and 2002). Within the a 70 
family, there are several phylogenetic groups that often, but not always, correlate 
with function (Table 7.1). Thereby showing the variable structural nature relative 
to functional characteristics found in this family.
Group 1 or primary sigma factors have a highly conserved sequence identity 
through a variety o f diverse organisms. The regions within a sigma sequence 
involved in promoter recognition are especially highly conserved. This is not 
surprising, as all known sigma factors appear to recognize closely related 
promoter sequences. There are three amino acid sequence segments that show 
almost complete conservation among primary sigma factors. They include two 
segments that overlap promoter recognition regions (RpoD box) that include the 
-10 DNA binding element, a conserved 20-mer that overlaps the -35 recognition 
region and a third conserved region that comprises a 14-mer just downstream of 
the RpoD box. These conserved sequences can be used to discriminate Group 1 
from Group 3 and 4 sigma factors.
Group 2 sigma factors are regarded as non-essential for exponential cell growth. 
However, the Group 2 sigma factors are highly similar to the primary sigma 
factors in their DNA-binding regions, suggesting that the two groups of sigma 
factors may recognize similar promoter regions.
Group 3 sigma factors, o f which Group 4 can be regarded as a subfamily, exhibit 
poor sequence identity to the sigma factors o f Group 1. Group 3/4 sigma factors 
fall into functional subgroups that include members from diverse organisms. The 
members o f a subgroup are highly similar in sequence identity to one another, 
regardless o f the source organism from which they originate. This suggests that 
Group 3/4 sigma factors that regulate similar activities have common functional 
constraints.
Group 5 sigma factors are a fairly new addition to the sigma factor classification 
system and include functional characteristic found exclusively in this group. 
Group 5 sigma factors are integral to bacterial resistance against elevated toxic 
conditions by stimulating appropriate bacterial gene expression.
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707.5. The ct protein family -  structure and homology.
The family o f related a 70  proteins share four regions of amino acid sequence 
homology designated o i—0 4 , which are further divided into several sub-regions 
(Figure 7.2). The regions <34  2 , 0 2 .3 - 0 2 . 4  were shown to recognize the -35, -10 and 
the colloquially known ‘extended -10’ (approximately nucleotide residues -17 to 
-13) elements o f a DNA promoter region, respectively (Bame et al, 1997 and 
Fenton et al, 2000). However, interactions between residues in region 3.0 and the 
upstream ‘extended -10’ m otif substitute for region 4 interactions with the -35 
element. Research by Campbell et al, (2002) showed that a crystallized 0 2 - 3  
fragment is sufficient for transcription from an extended -10 promoter. In 
addition, regions 0 2 .3 - 0 2 . 4  are known to interact specifically with the - 1 0  region 
of the non-template strand in the open promoter complex (Marr and Roberts, 
1997 and Borukhov et al, 2002).
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Group Description
1 Responsible for regulating most transcription in rapidly growing bacterial cells. DNA promoter sequence elements -35 and -10 are recognized by Group 1 
sigma factors when in complex with core RNAP. Contain four characteristic conserved regions: O] to o4.
2 Nonessential paralogues to the Group 1 sigma factors. One of the differences between Group 1 and Group 2 sigma factors is the differing selectivity for 
promoters lacking a consensus -35 element or having a cytosine adjacent to the upstream thymidine of the -10 DNA element. Contain all 4 of the conserved 
sequence regions found in Group 1.
3 Also known as ‘alternative sigma factors’. Under conditions of either stress or developmental processes the number of RNAPs associated with Group 3 
sigma factors increases in relation to Group 1 sigma factors.
Such RNAP-Group 3 sigma factor complexes function as global regulators allowing the coordinate activation of numerous unlinked operons. Region Oi and 
(often) region a 3 are absent.
4 Also known as the extracytoplasmic function (ECF) subfamily but also an extended classification encompassing the ‘alternative sigma factors’ from Group 
3. In many cases the ECF sigma factor is cotranscribed with a regulatory transmembrane anti-sigma factor. ECFs often control functions associated with 
some aspect of the cell surface or transport and generally involve cell envelope functions that include secretion and extracytoplasmic stress.
5 Also known as the TxeR subfamily. Sigma factors in this group have been identified as being positive regulators of toxin and bacteriocin gene expression.
Table 7.1: Five groups by which sigma factors are classified depending upon functional characteristics, as reviewed by Helmann 2002.
°1.1 °2 °3
Figure 7.2: Diagrammatic representation o f the a 7 0  family o f sigma factors (Dove et al, 2003). 
Darst et al, (1996) solved the crystal structure o f  0 2  (as well as deducing the
• • 70domain organization o f  E. coli a  ), which is the most highly conserved region in
70the a  family. a 2 , a 39 kDa domain was implicated in core RNAP binding
70recognition with a  and binding o f  the -1 0  promoter element on the non­
template DNA strand. Region <52 was also implicated in promoter melting and in 
the separation process o f  the RNAP complex from DNA at the end o f  the 
transcriptional process.
Region 3 is divided into two sub-regions that essentially extend from the end of 
region 2.4 to the beginning o f  region 4. The more conserved region 3.1 bears a 
weak resemblance to the helix-tum -helix (HtH) DNA binding motif, while 
conserved am ino acid positions in region 3.2 are largely acidic. However, region 
3.2 has been implicated in core-RNAP binding (Lonetto et al, 1992).
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7.6. Sigma factor and sigma factor region - structural survey.
Several papers to date exist where crystallographic methods have been used to 
elucidate the structures from one or more o f the four regions and numerous sub- 
regions, from the a 7 0  family o f sigma factors. 2 papers currently depict 3 of the 4 
connected regions from three different, unrelated species (Table 7.2). The crystal 
structure o f region cti i has not yet been determined.
Region 1.1 is believed to lack a stable structure (Sorenson et al, 2004) as a result 
o f being rapidly and completely degraded during limited proteolysis (Campbell 
et al, 2002). Region 1.1 is also a self-inhibitory domain, which is known to mask 
the DNA-binding regions o f a  before it binds to the core RNAP (Dombroski et 
al, 1993). Its precise role in transcription is not understood.
From the survey conducted the structure o f an intact a  factor containing 0 2 , 0 3  
and 0 4  has not been determined without either, core RNAP included, DNA or 
anti-a factors used as co-crystallizing binding partners, or isolating individual 
domains using limited proteolysis. So the disposition o f the domains in a free o 
factor form remains elusive and thus the structural basis for auto-regulation 
remains unknown.
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o factor region(s)
Details: PDB ID 
Number
Reference
02.1 -  02.4
04.1 ~  04.2
2.00A resolution crystal structure of E. coli a  factor, (A, in complex with the N-terminal domain of its anti- o  factor, 
RseA. Complex size: ~30kDa.
10R7 Campbell et 
al, 2003.
02.1 ”  02.4 2.40A resolution crystal structure of N-terminal (obtained from limited proteolysis) o R factor from S. coelicolor, c ^ ,  
in complex with its anti- a  factor, RsrA. Complex size: ~22kDa. o R involved in thiol-disulphide redox homeostasis.
1H3L Burton et al, 
2 0 0 2 .
01.2“  03.0 2.50A -  3.0oA resolution crystal structure of 3 individual domains, obtained using limited proteolysis, from aA (a7 0 0 1 .2- 0 3 . f  1KU2 Campbell et
04.1 “  04.2 homolog) factor from T. aquaticus. One crystal structure complex of a 4 plus DNA. 
Molecular weights of the 2 domains modeled:
1. a 2 o (includes <Ji 2) -  o 2 4: ~22 kDa 2. 0 4 1 - a 4 2: ~6 kDa
0 4 1 -  0 4 .2 ' 1KU3 
0 4 1 - 0 4 2 /DNA: 
1KU7
al, 2 0 0 2 .
01.2 ~  02.4 
03.0“  03.2 
04.1 ~  04.2
2.60A resolution crystal structure of T. thermophilus 0  factor, c /0, in complex with RNAP core. Complex size: 
~420kDa.
1IW7 Borukhov et 
al, 2 0 0 2 .
02.1 ~  02.4 2.60A resolution crystal structure of E. coli 0  factor, containing region 2  (obtained from limited proteolysis), 
including part of region 1.2. Complex size: ~39kDa.
1SIG Malhotra et 
al, 1996.
02.1 — 02.4 
03.0— 03.2
04.1 — 04.2
3.25A and 2.30A resolution crystal structure of A. aeolicus 0  factor, c2!* in complex with its anti- a  factor, FlgM. 
Complex size: ~38kDa.
1RP3 Sorenson et 
al, 2004.
04.1 — 04.2 2.30A resolution crystal structure of: A,cl (bacterial activator from bacteriophage which binds to specific DNA 
sequences, operators, just upstream of the promoter -35 element)/o4  ( 0  factor from T. aquaticus) /DNA. Complex 
size: ~18kDa.
1RIO Jain et al, 
2004.
Table 7.2: Structural survey for all available a  factors currently deposited in the PDB database.
707.7. The a  protein model.
Borukhov et al, (2002) demonstrated a model, from crystallographic data, for the
70 •a  family o f proteins that consists entirely o f a-helices, connected by either 
turns or loops. This model can be divided into four structural domains 
(equivalent to the four a  regions); N-terminal domain 1 (ND1), N-terminal 
domain 2 (ND2), ‘linker’ domain (LD) and C-terminal domain (CD) (see Figure 
7.3A).
ND1 domain consists o f  eight a-helices (a74-254) comprising four helix turn— 
helix (HtH) motifs; HtHl (a75-121), HtH2 (a94-147), HtH3 (al23-147) and 
HtH4 ( a l 52-203). This domain encompasses sequence region G1.2 up to the N- 
terminal half o f region <32 4 , including the non-conserved segment between 
regions <3i and <3 2 - ND1 has a U-shaped structure and is connected to the ND2 
domain (o260-312) by a short linker loop (o253-260), which lies at the C- 
terminus o f region 0 2 .4 .
ND2 domain, corresponding to regions 0 3 .0 , <*31 and <73 2 , consists o f three a- 
helices that fold into an a-helical bundle. The C-terminal helix o f the ND1 
domain and the N-terminal helix o f the ND2 domain (o234-281) form a V- 
shaped structure near the opening o f the upstream DNA-binding channel. The 
inner surface o f the V is lined by the residues from the C- and N-terminal a- 
helices o f domains ND1 and ND2, respectively. These a-helices correspond to 
regions <1 2 .3—0 2 . 4  which are known to be involved in the specific binding of a  to 
the -10 and extended -10 elements o f the promoter (Figure 7.3B).
The 30 residue LD domain (o313-339; region <7 3 2 ) intervenes between the 
globular N- and C-terminal portions o f o, and has mostly an extended, unfolded 
conformation. Roughly at its midpoint, the LD domain forms a hairpin loop 
(a318-329) that protrudes into the active site cleft, between the ‘rudder’ loop 
(p’584-601) and the ‘lid’ loop (p 526-538) o f the RNAP, which are believed to 
interact directly with nucleic acids. The rest of the LD domain is stretched along 
the RNA exit channel o f the RNAP holoenzyme complex towards the <7 factor 
CD domain (04.1 and < 34  2 ) .
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Figure 7.3: A: A schematic representation of the homologous regions typical of a 10 family proteins (adapted from Borukhov et al, 
coli a  factor, a 2 (PDB: 1SIG) and o 4 (PDB: 2H27) color coded as shown in A (drawn using PyMOL version 0.98).
2002 and Dove et al, 2003). B: Crystal structure of E.
The CD domain (o340-423), which includes conserved regions 0 4 .1  and 0 4 .2 , 
contains four a-helices (Figure 7.3B), which are arranged as a pair o f HtH motifs 
(HtH5, o341-376 and HtH6, o387-418). The conserved a  region 4 was shown to 
recognize the -35 promoter element specifically. The CD domain is located on
70the surface o f  a  in the vicinity o f the opening o f the RNA-exit channel. This 
site is about 57 A from the N-terminal half o f the protein, containing regions
<32.3-<*2.5-
Darst et al, (1996) also found that the helix upon which region 0 2 .1  can be found, 
containing residues; Leu-384, Ile-388, Phe-401, Leu-402 and Ile-405, might be 
important for core-RNAP binding. Adjacent to this feature is a cluster of 
conserved, hydrophobic residues that form a solvent-exposed hydrophobic patch 
that is suggestive o f a protein-binding surface and may also be involved in 
sigma-core RNAP binding. The significance o f region 0 2  and relatively recently 
also 0 4 , as promoter-binding determinants for RNAP was demonstrated by 
Borukhov et al, (2002). The research summarized that among the four structural 
domains within a 70, ND1 (0 2 ) makes the most extensive contacts with the core 
RNAP along with region 0 4 . Region <74 was found to be a second binding 
determinant, o f a less extensive tight-binding nature, to the RNAP surface than 
Therefore the two regions, <72 and <74 are important in the binding o f a sigma 
factor to its cognate core-RNAP surface.
A sequence analysis adapted from Campbell et al, (2002) (Figure 7.4) shows an
7 0aligned series o f 53 Group 1 sigma factors (a  ) from various bacterial species. 
What can be deduced from this alignment is the extensively ubiquitous nature of 
sigma factor regions; 0 2 .1- 0 3 .0  and <7 4 .1- 0 4 . 2  as opposed to the comparatively less 
ubiquitous presence o f sigma factor regions; 0 1 . 2  and 0 3 .o-<*3 .2  (Figure 7.4, color 
coded boxed areas).
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<*1.2 <*2.1 <*2.2 <*2.3 <*2.4 <*3.0 <*3.1 <*3.2 <*4.1
Figure 7.4: Shown is a sequence alignment within conserved regions 1.2—4.2 of 53 primary or group 1 sigma factors (Lonetto et al., 1992; Gruber and Bryant, 1997). The sequences are 
presented in one-letter amino acid code and are identified by the species in the rightmost column. Numbers at the beginning of each line indicate amino acid positions relative to the start 
of each mature protein sequence. Amino acid identity in >50 % of the sequences is indicated by a black background, amino acid similarity by a blue background. Groups of residues 
considered similar are: ST, RK, DE, NQ, FYW, and ILVM. Gaps are indicated by dashes. Helices are indicated above the sequences as rectangles, loops as a solid line. The histogram at 
the top represents the level o f sequence identity at each position. Sequence identity of 100 % is represented by a tall red bar, less than 20 % is represented by a small blue bar, and 
intermediate levels are represented by orange, light green, and light blue bars. As adapted from Campbell et al, 2002 using BioEdit™.
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7.8. DNA binding domains in sigma factors: 0 2  and 0 4 .
The promoter-binding determinants o f o factors, 0 2  (-10 hexamer element) and 0 4  
(-35 hexamer element) are solvent exposed and spaced according to their cognate 
DNA elements (Figure 5). The 0 3  and 0 4  domains are separated by 45 A in the 
holoenzyme. This distance is spanned by an extended 33-residue linker, 
comprising primarily a  region 3.2 (the 0 3 2  loop), which loops into the RNAP 
active-site channel and then winds its way out through the RNA exit channel 
(Murakami and Darst, 2003).
Figure 7.5: Crystal structure o f Thermus aquaticus RNA polymerase/DNA complex at 6.5 A 
resolution (1L9Z). The interaction of sigma factor regions; a 2  and a4, with their cognate DNA 
elements is shown (boxed). All component RNAP holoenzyme subunits are as indicated and 
color coded. The rest o f  the sigma factor adjoined to a2 and a4 is colored orange.
-35 element
Extended -10 
element
-10 element
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Binding to core-RNAP induces large relative movements of the o domains 
(Callaci et al, 1999), converting a  into an active conformation in which the DNA 
binding determinants in 0 2  and 0 4  are exposed and appropriately spaced to 
recognize the -10 and -35 elements, respectively, as seen in Figure 7.5 
(Murakami and Darst, 2003). The holoenzyme form o f RNAP forms 
transcription-competent open complexes on double-stranded DNA at promoters, 
suggesting that a  factors are involved in DNA melting at the -10 consensus 
element perhaps by sequence-specific binding to one o f the DNA strands 
(Helmann and Chamberlin, 1988 and Juang and Helmann, 1994).
The residues implicated in -10 recognition and melting all face into a cleft-like 
feature. However, potentially occupying this cleft is a highly acidic stretch of 
residues from 188-209 (numbering based on E. coli a 70). In this stretch of 22 
residues, 18 are negatively charged. Most o f this acidic loop (192-209) is 
disordered. The presence o f this highly acidic loop within or near the apparent 
DNA-binding cleft might sterically inhibit DNA interaction and would also repel 
the negatively charged DNA electrostatically. This would help explain why a 70 
and also 0 2  do not interact with DNA in the absence of core-RNAP, consistent
70with studies implicating regions o f o N-terminal o f region 2 in inhibiting DNA 
interactions (Dombroski et al, 1993). Since many sigma factors lack the acidic 
loop, it cannot be the only mechanism by which specific interactions o f sigma 
factors with promoter DNA are inhibited in the absence o f core-RNAP, also
7 0consistent with the studies o f Dombroski et al, (1993). Since the a  core-RNAP 
complex binds specifically to a single-stranded DNA oligo with the non-template 
- 1 0  consensus sequence, a mechanism involving substantial conformational 
changes a  and/or neutralization o f the acidic loop upon core-RNAP binding must 
exist for the auto-inhibition o f DNA binding from the acidic loop to be 
overcome.
7.9. Anti-sigma factors.
Anti-sigma factors modulate the expression of numerous regulons controlled by 
alternative sigma factors. Anti-sigma factors are themselves regulated by either; 
secretion from the cell (e.g. FlgM export through the hook-basal body),
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sequestration by an anti-anti-sigma (e.g. phosphorylation regulated partner- 
switching modules), or interaction with extracytoplasmic proteins or small 
molecule effectors (e.g. transmembrane regulators o f extracytoplasmic function 
sigma factors) (Helmann, 1999 and Campbell et al, 2002). Anti-sigma factors 
have often been used as co-crystallizing binding partners (Table 7.2) for sigma 
factors and their subsequent structural elucidation.
7.10. Sigma factors in Mtb.
In Mtb there are at least 13 different sigma factors (Cole et al, 1998) and the role 
o f most o f them in dormancy is unknown (Hu and Coates, 1999). The abundance 
o f different sigma factors at various stages of Mtb growth and replication is 
influenced by many factors, such as stationary phase and various stress related 
conditions. The complete genome sequence of Mtb reveals two sigma 70 
homologues, sigA and sigB, and a subfamily of the sigma 70 class, called the 
extracytoplasmic function (ECF) family which contains 11 alternative sigma 
factors (sigC, sigD, sigE, sigF, sigG, sigH, sigL, sigJ, sigK, sigL and sigM) with 
very little known concerning their physiological functions (Coates and Hu, 
2 0 0 1 a).
7.11. Bioinformatic analysis of sigJ.
PFAM; a database which is essentially a large collection o f multiple sequence 
alignments based on hidden Markov models covering many protein domains and 
families, identifies with confidence the presence of 0 2  within sigJ (Figure 7.6A - 
shown in bold) and a probable 0 4  region, both located at amino acid residues 5 - 
70 and 110-160 respectively. The same result was obtained when the NCBI 
conserved domain search program was used to determine the presence o f any 
domains within sigJ that correlated with the NCBI protein database (Figure 
7.6B).
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The PFAM and NCBI-CD analysis correlates with the a 70 alignment analysis 
carried out by Borukhov et al, (2002) in showing that sigJ contains a <32 region at 
the N-terminus, which was found to be conserved amongst other sigma factors 
from different bacterial species within the same alignment data. Conversely the 
Q4 region is not present at the extreme C-terminus, as is common with other 
bacterial a 70 proteins, but is rather comparable to sigG and sigl in that 0 4  is 
‘supposedly’, through low amino acid similarity/identity correlation, found to be 
close to <3 2 , i.e. near the N-terminus. An independent alignment using sigJ was 
performed; utilizing the NCBI-BLAST program (Altschul, et al, 1997) to align 
the sigJ amino acid sequence against the entire NCBI protein database (Figure 
7.7). What is observed is a highly conserved sequence identity comparison 
between the sigJ amino acid sequence and other ECF group sigma factors with 
other a 70  proteins, from a variety o f bacterial sources, exhibiting either complete 
sequence or 0 2  and/or <34 region sequence correlations. When the search is refined 
by creating a sequence alignment o f the sigJ amino acid sequence against the 
contents o f the protein database (PDB), the result is an alignment o f poorly 
correlated protein sequences. This indicates that sigJ bears little structural 
resemblance, based upon poor E’-threshold values which are a statistical measure 
o f the number o f expected matches in a random database. The lower the £-value, 
the more likely the match is to be significant, ^-values between 0 . 1  and 1 0  are 
generally dubious, and over 10 are unlikely to have biological significance. The 
initial NCBI-BLAST provides evidence to support the unique C-terminal 
characteristic o f sigJ and the apparent common region found at the extreme N- 
terminus by producing an alignment for 19 proteins o f £ -values between 0.21 
and 9.00.
The differences in the location o f the <34  region found in sigJ, relative to the 
majority o f other sigma factors, shows the nature of a C-terminus to be relatively 
unique in structure and by inference possibly in function as well.
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Figure 7.6: A: PFAM analyses for the Mtb sigma factors {sigJ highlighted in bold). B: NCBI conserved domain search analysis of sigJ revealing the presence of sigma factor regions; o 2 
and <x«.
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Figure 7.7: BLAST Link (BLink) to Protein Alignments and Structures. Pre-computed sequence 
alignments, generated from routine all-against-all BLAST comparisons performed at NCBI. 160 proteins 
aligned against the sigJ sequence (top) are displayed with the ubiquitous N-terminus identity found 
across the alignment highlighted (boxed).
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Theoretical secondary structure prediction program, JPred, showed sigJ to be 
composed o f  11 a-helices and 5 (3-sheets with prediction confidence being low 
within amino acid residues 200-310 (Figure 7.8). Other such theoretical structure 
prediction program s such as PsiPred and Jnet produced similar results.
MEVSEFEALRQHLMSVAYRLTGTVADAEDIVQEAWLRWDSPDTVIADPRAWLTTWSRLGLDKLRSAA
- - HHHHHHHHHHHHHHHHHH------ HHHHHHHHHHHHHH------- HHHHHHHHHHHHHHHHHHHHH
HRRETYTGTWLPEPWTGLDATDPLAAWAAEDARFAAMWLERLRPDQRVAFVLHDGFAVPFAEVAE
HH-------------------------HHHHHHHHHHHHHHHHHHH---HHHHHHHHHHHH---- HHHHHH
VLGT S EAAARQLAS RARKAVT AQ PAL IS GD PD PAHNE WGRLMAAMAAGDLDT W S  LLH PD VT FTGDS
HH HHHHHHHHHHHHHHHHH---------- HHHHHHHHHHHHHHH HHHHHHHH---
NGKAPTAVRAVRGSDKVVRFILGLVQRYGPGLFGANQLALVNGELGAYTAGLPGVDGYRAMAPRITAI
-------------- HHHHHHHHHHHHH--------      EEEI-.
TVRDGKVCALWDIANPDKFTGSPLKERRAQPTGRGRHHRN 
EE EEEEEEE HHHH---------------------
H = ALPHA HELIX 
= BETA SHEET
Figure 7.8: Theoretical secondary structure predication of sigJ using the program JPred.
CPHmodels version: 2.0 Server is a structural modelling server which utilises a 
computer program (XM3) to extract 3D models based on fold 
recognition/hom ology modelling, in which a large sequence database o f  proteins 
with known structure (PDB-BLAST) is iteratively searched to construct a 
sequence profile o f  suitable templates. The server can be accessed via this web 
address: http://www.cbs.dtu.dk/services/CPFImodels/. A sequence-based
alignment is then produced based upon the query sequence applied, using a score 
reliant on profile-profile comparisons. This produces more accurate alignments 
than m ethods based on sequence-profile or sequence-sequence alignment. The 
alignment score is modified so as to ensure unreliable parts o f the alignment is 
discarded. By adding the amino acid sequence o f  sigJ to this modelling server, a 
predictably low threshold scoring alignment is produced. However, by removing 
poorly correlated sections o f  the initial query sequence, 20 % identity to PDB 
deposited proteins is achieved with amino acid residues 10-158, from the full 
initial 312 am ino acid sigJ sequence.
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PDB entry: 10R 7  chain: A. Score: 54. E: 2e-07 
PDB entry: 10R 7 chain: B. Score: 45. E: le-04 
PDB entry: 2H27 chain: A. Score: 37. E: 0.018 
PDB entry: 2H27 chain: D. Score: 37. E: 0.020 
PDB entry: 1H3L chain: A. Score: 37. E: 0.027 
PDB entry: 1H3L chain: B. Score: 36. E: 0.033
Figure 7.9: A: The six best aligned PDB entries to the sigJ sequence query using the CPHmodels version: 2.0 Server. All entries are below the 0.05 E-threshold, making them biologically 
significant. Entry 10R7 is used as the template around which residues; 10 -  158 of the amino acid sequence of sigJ is modelled around. B: The sigJ theoretical model has DNA binding 
regions o 2 and a 4  highlighted and annotated.
The model created, composed entirely o f 8  a-helices and connective loops, 
identifies DNA binding regions, 0 2  and 0 4  (Figure 1.9A) as a homologous 
structural m otif with 6  PDB entries scoring better than the non-significant 
threshold o f 0.05 (Figure 7.9B). The PDB entry achieving the best score, 10R7, 
is then used as a template around which residues 10-158 o f the sigJ sequence 
align around. By examining the predicted theoretical model of sigJ, the DNA 
binding regions, 0 2  and 0 4 , are found at amino acid residues 10-70 (3 a-helices), 
and 100-158 (4 a-helices), respectively. This correlates extremely well to the 
previous identification o f the <72 and 0 4  DNA binding domains located at amino 
acid residues 5-70 and 110-160 respectively. When the theoretical sigJ model is 
compared to the secondary structure content o f the E. coli PDB deposited DNA 
binding domains, <72 and 0 4 , the a-helical composition is very similar. The crystal 
structure o f E. coli a  factor, 0 2  (PDB: 1SIG) and 0 4  (PDB: 2H27) both have 4 a- 
helices each.
7.12. Discussion and concluding remarks.
Many o f the experimental observations made into sigJ so far suggest a uniquely 
structured monomeric sigma factor (Coates and Hu, 2001b). Bioinformatic 
evidence and the in vitro and in vivo studies carried out by Coates and Hu, 
(2001b) suggest the existence o f a 0 2  and probable <74 region, indicating that sigJ
70deserves to belong as an alternative sigma factor group within the ECF a  
subfamily. The significance o f sigJ for Mtb survival during a prolonged 
stationary phase is to allow the bacilli to withstand stress conditions and to 
tolerate antibiotics by virtue o f increased mRNA levels during stationary phase 
growth, as well as by being strongly up-regulated. This suggests that sigJ is 
important in controlling the expression o f stationary phase-associated genes.
SigJ could invariably be an important drug target for future development and 
therefore merits an effort into its structural determination. As a result, a process 
towards structural determination will evolve during the various analytical 
procedures applied to sigJ described in the following chapter.
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Chapter 8
Results: Mtb sigma factor J (sigJ)
8.1. C hap ter sum m ary .
PolyHis-tagged Mtb sigJ protein was expressed according to the protocol 
suggested by collaborators. The protein was purified both from inclusion bodies 
and solubilised/refolded or directly from the lysed cell supernatant. Together 
with NMR spectroscopy, analytical size exclusion chromatography (SEC), 
freeze/thaw studies and circular dichroism (CD), the biochemical characteristics 
o f sigJ were investigated. The characteristics o f sigJ purified from inclusion 
bodies differed significantly from those o f sigJ expressed in the cytoplasm. 
Whilst the ID  NM R spectrum suggested the presence o f globular protein 
features, the 2D ^H ^N J-H SQ C  NMR measurements obtained o f sigJ yielded 
predominately disordered spectra with inhomogeneous cross peak line shapes 
due to extensive line broadening. Attempts to resolve the poor spectral features 
identified observed in HSQC spectra o f sigJ included the use of limited 
proteolysis to isolate globularly folded domains, known as the 0 2  and 0 4  ( - 1 0  and 
-35 nucleotides upstream o f the start site) DNA binding elements. The 
investigation diversified into using electrophoretic mobility shift assays (EMSA) 
to examine the putative DNA-binding nature o f sigJ, the results o f which suggest
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that the future application o f an appropriate DNA ligand might potentiate further 
examination by 2D heteronuclear NMR spectroscopy by quenching dynamic 
structure fluctuations that presently complicate the spectrum.
8.2. SigJ -  purification and expression.
Studying proteins using NMR techniques typically requires multi-milligram 
quantities in aqueous buffers at millimolar concentrations. In many cases, 
technical and/or economic limitations can become apparent in the production of 
proteins and polypeptides to achieve such quantities. In order to carry out a 
biologically relevant study o f sigJ the buffer conditions must be kept as close to 
physiological pH (pH 7.4) and salt concentration as possible, optimally below 
200 mM for NM R spectroscopic study.
Initially sigJ was expressed and purified from the soluble fraction o f the cell 
lysate using a 1 L scale cell culture as described in Chapter 2.3.2. Suitably 
consistent, high concentrations (-0.5-0.6 mM) o f soluble expressed sigJ were 
obtained, at a relatively pure level -  with few contaminants and at the predicted 
monomeric molecular weight, i.e. 34 kDa. An immediate scale up o f the initial 1 
L preparation to a 3 L preparation was then carried out as described in Section
2.3.2. Figure 8.1 A shows the protein gel obtained after Ni-NTA chromatography 
purification (the process o f which is described in Section 2.3.3.) for sigJ. The 
corresponding fractions containing sigJ (Figure 8.1 A, blue box) were then 
concentrated (as described in Section 2.2.) and passed through a Superdex-75
SEC column (as described in Section 2.3.4.). The fractions corresponding to the
1 2peak in the chromatogram (Figures 7.1 B and B -  red boxes) were then pooled 
and subsequently concentrated. The final sigJ concentration, displayed as an 
average range for a number o f identical 3 L scale sigJ preparations made during 
the course o f this project, ranged between 1.2-1.4 mM.
The subsequent concentrated sigJ sample was then processed (as described in 
Section 2.3.1-2.3.1.4), in order to have the N-terminal amino acid sequence 
confirmed by a commercial sequencing service (MWG™). The successful amino 
acid sequencing data then allowed the continued use o f natively folded sigJ for 
structural probing using NMR spectroscopy.
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Initially our collaborators claimed that higher protein yields of sigJ could be 
obtained from the insoluble fraction following cell lysis, as opposed to the 
protein obtained in the soluble part o f the lysate. To test this, sigJ was also 
purified from inclusion bodies and refolded as detailed in Section 2.10. Yields of 
purified sigJ comparable to those obtained from the purification of the natively 
folded (‘soluble’) sigJ were obtained.
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A: Key: Ex = Elution fraction, Mw = Molecular weight marker.
B2: Key: A! (20 m L )- A n  (60 mL)/Bi (65 mL) -  B4  (80 mL) = Elution’s and 
total collected volumes, Mw = Molecular weight marker.
Red numbering indicates the Mw protein marker sizes for A and B gels, 1: 
200 kDa, 2: 116.3 kDa, 3: 97.4 kDa, 4: 66.3 kDa, 5: 55.4 kDa, 6 : 36.5, 7: 31 
kDa, 8 : 21.5 kDa, 9: 14.4 kDa, 10: 6  kDa, 11: 3.5 kDa, and 12: 2.5 kDa.
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Figure 8.1: A: NI-NTA protein gels of natively folded sigJ, showing protein in the soluble fraction across a range of wash steps of increasing imidazole concentration; Ei (5 mM 
imidazole) -  E 10 (500 mM imidazole). Boxed in blue; fractions concentrated. B 1 and B2: SEC Superdex-75 chromatogram and SEC fractional analysis by SDS-PAGE of natively 
folded sigJ, respectively, showing quantities o f monomeric protein (B2 red box) at the correct molecular range, that was then concentrated.
8.3. Freeze/thaw and analytical size exclusion chromatography (ASEC) tests.
A freeze/thaw experiment was carried out to determine suitable storage 
conditions and to examine the stability o f sigJ to large changes in temperature. 
The temperatures used varied from -80°C to room temperature (~27°C) and in the 
presence o f varying amounts o f glycerol (used as a suppressor o f water crystal 
formation) (Figure 8.2A). All tests were carried out over a 48 hour period as 
described in Section 2.9. As shown in Figure 8.2B, sigJ exhibits no signs of 
protein degradation or precipitation under any o f the conditions examined.
Analytical size exclusion chromatography (ASEC) was performed using sigJ as 
described in Section 2.3.5 to probe the hydrodynamic characteristics and to test 
for the presence o f oligomers. The superdex-75 column used was calibrated as 
described in Section 4.3. ASEC of purified sigJ samples indicates a 
concentration-independent elution time, consistent with a mono-disperse 
molecular species (Figure 8.2B). Compared to protein standards the elution time 
predicts an apparent molecular weight o f 45 kDa for sigJ refolded from inclusion 
bodies (Figure 8.2C), which is larger than the apparent mass o f 34 kDa obtained 
with the natively folded form. The molecular weight o f sigJ is predicted from the 
amino acid sequence is -33  kDa.
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Analytical size exclusion chrom atography of 
soluble and refolded sigJ.
1 2 3 4 M
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(refolded sigJ) 
1:2 dilution 
(refolded sigJ) 
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Figure 8.2: A: Freeze/thaw test upon sigJ under various temperature and glycerol conditions: Lane 1: 10% (v/v) glycerol, Lane 2: 20% (v/v) glycerol, Lane 3: No glycerol. Lane 4: no freeze 
thaw but containing glycerol, Lane 5: markers. SigJ concentration used for each lane sample; 1 mM. B: ASEC gel filtration cumulative curve data o f sigJ: natively folded and refolded forms 
at various dilution levels from a starting, undiluted concentration, of; 1 mM. C: Standard curve generated for the ASEC gel filtration column used in Figure IB showing the differing apparent 
MW for both natively folded and refolded sigJ. A: Red numbering indicates the Mw protein marker sizes, 1: 200 kDa, 2: 116.3 kDa, 3: 97.4 kDa, 4: 66.3 kDa, 5: 55.4 kDa. 6: 36.5, 7: 31 kDa, 
8:21.5 kDa, 9: 14.4 kDa. 10: 6 kDa, 11:3.5 kDa, and 12:2.5 kDa.
8.4. Circular dichroism using sigJ.
To test the results obtained using the various secondary structure prediction 
programs that suggest sigJ contains a substantial element o f alpha helical 
secondary structure (as described in Chapter 6), the low resolution technique; 
circular dichroism was applied, as described in Section 2.3.6. Figure 8.3A shows 
the spectrum obtained o f natively folded sigJ that exhibits a broad minimum at 
222 nm. Arguably this result suggests that the soluble expressed sigJ contains a 
substantial component o f extended chain secondary structure, the signal for 
which dominates any present from helical contributions.
8.5. ID [JH]-NM R of sigJ.
ID [1H]-NMR analysis o f sigJ reveals chemical shift dispersion consistent with 
at least a significant component o f ordered, folded globular structure (circled 
blue and red in Figure 8.4). Preliminary estimation o f the translational diffusion 
time suggests that sigJ is monomeric (estimated molecular mass ~ 34 kDa, 
similar to the mass predicted from amino acid content) under these conditions 
(1.0 mM, pH 7.0).
Curiously the spectra o f natively expressed and refolded sigJ differed, and this 
was particularly evident in the up-field region o f the NMR spectrum that is 
typically populated by ring current-shifted resonances. A pH titration was also 
conducted (Figure 8.4A and B) on both the refolded and natively folded sigJ to 
determine the sensitivity o f the spectrum to pH variations. The spectra were 
essentially insensitive to the buffer pH in the range examined, and the 
characteristic differences in the spectra o f natively expressed and refolded sigJ 
persisted throughout.
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Figure 8.4: A: ID ['H]-NMR spectrum of natively folded sigJ pH 7.4, 1.0 mM, blue circled region; amide part o f sigJ, red region; methyl part of sigJ. B and C: Natively folded and refolded 
sigJ, respectively, at various pH conditions. All spectra obtained at 500 MHz, at 1 mM, pH 7.4 and 25 °C.
As a result o f  the differences in behaviour between the natively expressed and 
refolded sigJ it was concluded that the latter material, particularly in light o f its 
apparent aberrant gel filtration elution time, is not likely to be a physiologically 
relevant form o f the protein, and was not investigated further.
8.6. HSQC measurements of natively folded sigJ.
Using natively folded [15N]-sigJ, an HSQC spectrum was recorded as described 
in Section 2.3.7.3. The resulting spectrum, shown in Figure 8.5, exhibits some 
resolved features consistent with globular characteristics. However a region o f 
inhomogeneous, overlapping peak shapes with poor resolution dominates the 
centre o f the spectrum indicative o f a highly disordered and dynamic protein. In 
an effort to improve the spectrum, sigJ was cultured and purified in the presence 
o f deuterium rich media (in a manner identical to that used to generate isotope 
enriched [15N, 2H]-labelled TPxC60S) to form a [15N, 2H]-labelled sigJ sample. 
Surprisingly, the resulting spectrum o f the perdeuterated protein, plotted in red in 
Figure 8.5, was not improved in terms o f cross peak resolution compared to the 
protonated sample (blue contours). This behaviour contrasts with the results o f a 
comparable situation emerging from work in our laboratory. The protein shown 
in Figure 8.5B, is the enzyme dimethylarginine dimethylaminohydrolase 
(DDAH), obtained from Pseudomonas aeruginosa. PoDDAH is a 58 kDa 
homodimer responsible for the metabolism o f asymmetric methylarginine 
(AMAs) residues to citrulline and mono- or di-methylamines. What is shown in 
Figure 8.5B is the improvement in spectral quality from a non-deuterated [15N]- 
PtfDDAH protein to one that is highly deuterated. In this example as a result of 
the perdeuteration the line-width o f all cross peaks was substantially narrowed 
clearly facilitating the resolution o f cross peaks that strongly overlapped in the 
spectrum o f  the protonated protein, a result that facilitated the back-bone 
resonance assignment for the majority o f the cross peaks using triple resonance 
methods applied to a [2H ,13C ,15N]-isotope labelled sample o f PaDDAH. For sigJ 
the failure o f perdeuteration to improve the resolution o f the [15N]-HSQC 
spectrum indicated that dynamic effects may be dominant on the resonance line
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width. As a result o f this extensive line broadening the application o f triple 
resonance measurements sigJ sample was not pursued.
8.7. Limited Proteolysis -  Introduction.
As described in Chapter 6 , sigma factors appear to be comprised of loosely 
tethered globular domains, and there is scope that stable sub-domains could be 
isolated by controlled proteolysis o f the full length protein within the linker 
regions. For example, the ECF sigma factor a R is a global regulator o f redox 
homeostasis in the antibiotic-producing bacterium S. coelicolor and binds to the 
anti-sigma factor RsrA. Burton et al, (2002) utilized a combination o f limited 
proteolysis, surface-enhanced laser desorption ionization mass spectroscopy, and 
pull down assays to identify a -1 0  kDa N-terminal domain (aRN). The oRN 
domain encompasses the 0 2  region which is predicted to correspond to a folded 
globular domain. The crystal structure o f the complex between oRN and RsrA 
was subsequently solved to 2.4 A resolution. In a similar manner Campbell et al, 
(2002) utilized limited proteolysis to isolate a domain o f sigE from E. coli 
encompassing regions G\.2 , - 0 4  2 , which was subsequently sub-cloned and then 
crystallized and its high resolution structure solved. It appears reasonable that the 
0 4  region o f sigma factors, which is found to bind the -35 DNA element 
(reviewed in Gross et al, 1998; Craig et al, 1998; Colland et al, 1998; Burton et 
al, 2002; Campbell et al, 2002; Vassylyev et al, 2002 and Jain et al, 2004) is 
loosely tethered to the rest o f  the protein able to freely bind DNA. The 0 4  region 
is usually linked to region 0 2  via region <33 (Murakami et al, 2002) which in some 
sigma factors, including sigJ, is notably absent. There is a reasonable prospect 
then that the sigJ <34 (and possibly <3 2) domain might be accessible by limited 
proteolysis.
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Figure 8.5: A: 600 MHz HSQC spectral overlay of; [15N, 1 H]-sigJ -  blue spectrum and [15N, 2H]-sigJ -  red spectrum, both 1 mM and pH 7.4. B1 and B2: HSQC spectra of [ N, H]- 
PaDDAH and [l5N, 2H]-/>aDDAH, respectively, at 1 mM and pH 6.4.
8.7.1. Limited Proteolysis of sigJ.
By applying the principles outlined by Burton, et al (2002) a ‘range finding’ and 
‘time course’ limited proteolysis experiment was performed on purified sigJ, as 
detailed in Sections 2.7 and 2.8, respectively. The term ‘range finding’ is used 
here to refer to the process o f identifying the preferred protease and optimal 
protease concentration to use in subsequent limited proteolysis experiments. The 
selected protease must display several characteristic properties, in situ, to merit 
its continued use. These properties must include; a protein digestion pattern that 
is neither too aggressive, i.e. cleaving at recognition sites at an accelerated rate 
across the protein amino acid sequence thereby completely digesting and 
unwinding the protein, nor too passive, i.e. requiring prolonged incubation time 
to achieve full protein sequence coverage at all expected cleavable amino acid 
residues. With a large number o f potential proteases exhibiting a variety of 
amino acid selectivity for cleavage, choosing the right protease is essential. A 
theoretical peptide cleavage program (PeptideCutter: http://expasy.org/cgi- 
bin/peptidecutter/peptidecutter.pl) was first used to assess the number of 
potential fragments each o f the three proteases may produce upon addition to 
sigJ. This was based upon the selective residue cleavage sites for each protease 
and with the assumption that sigJ is a linear, unfolded protein with all cleavage 
sites accessible. Each protease has amino acid cleavage selectivity and therefore 
each o f the three proteases would produce markedly different digest patterns with 
sigJ. The three proteases assessed and the C-terminal cleavage amino acids are as 
follows; chymotrypsin (aromatic amino acid residues -  Tyr, Trp and Phe, Leu 
and Glu), trypsin (Lys and Arg) and elastase (uncharged non-aromatics -  Ser, 
Thr, Asn and Gin). The theoretical digest pattern for each protease, when applied 
to sigJ, is shown in Figure 8.6A. The theoretical protease cleavage program 
predicts that chymotrypsin could yield a total o f 19 fragments, with the top three 
largest peptide masses ranging from 2387-1489 kDa.
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Figure 8.6: A: Theoretical protease cleavage of linear, unfolded sigJ using elastase (red), chymotrypsin (blue) and trypsin 
(magenta). B: SDS-PAGE gel of; ‘range finding’ experiment, using the same three colour-coded proteases from A upon 
sigJ. Protease concentration: -j-: 0.01 mg/ml, *: 0 .1 mg/ml and, §: 1 mg/ml. Lanes; 6 and 10 are empty. White lines 
indicate seven distinct fragments reproduced in C. C: SDS-PAGE gel of; ‘time course’ experiment using chymotrypsin 
upon sigJ, lanes 3 - 4  correspond to the following incubation times: 5 mins, 10 mins, 20 mins, 30 mins, 1 hour and 2 hours. 
For B and C SDS-PAGE gels, lane 1: undigested sigJ and lane 2: protein mass ladder. Red (diagonal) numbering indicates 
the Mw protein marker sizes for gels in B and C, 1: 200 kDa, 2: 116.3 kDa, 3: 97.4 kDa, 4: 66.3 kDa, 5: 55.4 kDa. 6: 36.5, 
7: 31 kDa, 8: 21.5 kDa, 9: 14.4 kDa, 10: 6 kDa, 11: 3.5 kDa, and 12: 2.5 kDa.
The use o f trypsin predicts a potential total o f 34 fragments with a peptide mass 
range o f 2490-1473 kDa, for the top three largest fragments. Elastase is 
predicted by far the most proficient with a potential 47 fragments generated and 
achieving the largest peptide mass range o f 2500-1880 kDa for the top three 
largest possible peptide masses.
From the ‘range finding’ experiment (Figure 8.6B), elastase creates a well 
defined digest pattern at the lowest concentration (0.0.1 mg/mL) but proceeds to 
digest sigJ completely as the protease concentration increases, leaving coalesced 
small peptide fragments that are indefinable from one another. Trypsin has 
virtually no effect in digesting sigJ at the lowest concentration used but rapidly 
cleaves the protein at both 0.1 mg/mL and at 1 mg/mL leaving poorly resolved, 
indefinable bands on the SDS-PAGE gel. However, when chymotrypsin is used, 
little reaction is initially seen to occur at the 0.01 mg/mL concentration (Figure 
8.6B, lane 7) but at 0.1 mg/mL (Figure 8.6B, lane 8) the protease cleaves sigJ 
yielding a series o f well resolved, clearly defined bands. At the maximum 
protease concentration (Figure 8.6B, lane 9) 1 mg/mL, the reverse is true for the 
outcome -  at 1 mg/mL, chymotrypsin rapidly cleaves sigJ leaving behind a 
poorly resolved smear o f indefinable bands on the SDS-PAGE gel. It was clear 
from this ‘range finding’ experiment that the protease best used for the ‘time 
course’ experiment would be chymotrypsin, at 0.1 mg/mL. The presence o f such 
well defined bands might be indicative o f relatively stable folded modular 
components o f  sigJ that by virtue o f their 3D shape would have the effect of 
shielding the other potential proteolytic cleavage sites.
A ‘time course’ experiment is then implemented using the protease identified in 
the ‘range finding’ experiment using the process as described in Section 2.8. This 
is performed to assess the most effective time period o f protein/protease 
incubation needed to generate optimal amounts o f the desired digest pattern. A 
requirement o f this experiment is that over digestion o f the target protein must be 
avoided. This would ultimately render fragment identification difficult as a result 
fragment smearing. Figure 8.6C shows the ‘time course’ result at varying 
incubation times for sigJ in the presence o f chymotrypsin. The ideal time period 
for generating the maximum amount o f digested material, without cross-fragment 
contamination, was found to be 20 minutes. At this time period a total o f seven
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fragments can be visually identified from the SDS-PAGE gel (including the 
presumably intact/undigested sigJ fragment) that persists across the digest pattern 
in Figure 8.6B, lane 8 (highlighted by white lines), and reproduced in Figure 
8.6C. The molecular weights o f each o f the six digest fragments (not including 
intact sigJ) are estimated as ranging from between ~10 kDa and ~33 kDa. These 
seven fragments merit isolation and further detailed analysis by mass 
spectrometry-based methods. Limitations o f time and competing experimental 
imperatives mean that this extended analysis has not so far been completed to a 
satisfactory endpoint (preliminary attempts to characterise the fragments have 
yielded conflicting results, perhaps as a result o f contamination o f the fragment 
samples with undigested full length sigJ. Successful separation o f full length sigJ 
would provide additional information that can be used to design a series of 
isolated fragment-based expression constructs that could subsequently be 
expressed, purified and assessed using NMR-based experiments.
8.8. DNA binding.
As mentioned previously, the amino acid residues implicated in binding to the 
DNA promoter -10 element are located in a cleft-like feature o f the sigma factor. 
In this region many sigma factors contain a highly acidic stretch o f residues, 
often mostly disordered in nature. It is this acidic loop region that sterically 
inhibits DNA interaction and also repels the negatively charged DNA 
electrostatically making, primarily, DNA binding to <72 in the absence of core- 
RNAP impossible. However, not all sigma factors harbour this feature and based 
upon information from a collaborator at the St. Georges Hospital Biochemistry 
Research Department (SGH-BRD), another arm to the EU consortium on Mtb 
research, DNA binding to recombinant sigJ has been investigated.
The data obtained from SGH-BRD was from a discontinued avenue o f research, 
and as such demanded validation o f the claims that a sequence o f DNA (300 bp 
in length), upstream o f the sigF coding region in Mtb, was found to bind sigJ in 
the absence o f  core-RNAP. Data to support this claim was scarce however; 
Figure 8.7A displays the result o f a saturation binding curve o f the percentage of 
change in DNA fluorescence as a function o f protein concentration. From the
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data curve it can be seen that sigJ binds the 300 bp sigF DNA at the first instance 
at a concentration o f -1  pM and exponentially until a plateau at a sigJ 
concentration o f -45  pM, where -80%  o f the available DNA has bound to the 
protein. The starting concentration o f DNA used during this experiment was not 
provided.
With sigJ exhibiting very poor quality HSQC spectra as a result o f what is 
believed to be intrinsic structural disorder, DNA binding may help to quench this 
fluctuating motion by binding to the -10 and -35 DNA binding domains o f the 
protein and thereby ‘lock’ sigJ into a stable conformation. This expectation 
fuelled our interest to recapitulate the claim that sigJ could bind Mtb 
chromosomal DNA sequences in the absence o f core RNAP.
The 300 bp DNA template which was claimed to bind to sigJ was amplified from 
genomic Mtb DNA using PCR and specifically designed primers (described in 
Section 2.4.1). By isolating and purifying the desired 300 bp fragment, a 
modified reproduction o f the original binding experiment between sigJ and the 
DNA (Figure 8.7B) was performed using electrophoretic mobility shift assay 
(EMSA) as detailed in Section 2.5. The DNA concentrations used during these 
EMSA experiments ranged from 100 ng/reaction (19.2 pM) mixture to a diluted 
final concentration o f  2.5 ng/reaction (0.48 pM) mixture as used for the last 
EMSA binding experiment. NOTE: A final concentration o f 2.5 ng/reaction 
mixture is the minimum DNA concentration capable o f visualization under UV 
detection using the Novex® DNA pre-cast retardation gels and staining using 
ethidium bromide. Several rounds o f optimisation were required before the 
correct concentration ratio o f sigJ-DNA concentrations was obtained in 
producing the results shown. The initial result o f the EMSA binding experiment 
between sigJ and the 300 bp DNA fragment is shown in Figure 8.7B. The 
migration o f the 300 bp fragment is shown to be gradually retarded as sigJ 
concentration increases, with the first indication o f DNA migration inhibition 
evident at a sigJ concentration o f -0 .5  mM. By decreasing the concentration of 
DNA used in the EMSA binding experiments, while maintaining the same sigJ 
concentration throughout, an estimate into the binding specificity o f sigJ could be 
made. Figures 8.9C-E show that DNA at the lowest amounts measured (2.5 ng) 
in the presence o f sigJ (45 pM) provides a DNA retardation pattern that is
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consistently reproduced suggesting that indeed sigJ has the potential to interact 
and bind DNA.
However, with DNA binding specificity there are typically two modes o f affinity 
that can be ultimately proposed. These two possible modes include: the presence 
o f a sequence specific DNA feature, much like the DNA binding elements, -10 
and -35, that sigma factors are expected to locate to (with amino acid/nucleotide 
interaction based upon non-polar contacts to hydrogen bonds both with and 
without solvent molecules acting as bridges), or the entropically favorable 
structural features o f DNA molecules that allows them to orientate and associate 
with proteins through purely electrostatic interactions in a sequence independent 
(‘non-specific’) manner.
With sigJ exhibiting apparently concentration independent DNA binding, it must 
be questioned whether sigJ is binding to a specific DNA region located 
somewhere within the 300 bp DNA stretch. In an attempt to further test the 
DNA-binding characteristics o f sigJ, several DNA smaller constructs were made 
from the proposed 300 bp DNA fragment, as described in Chapter 2.4.1. The 
four DNA constructs isolate various sub-sections o f the initial 300 bp fragment 
while providing overlapping sections that would ultimately (if displaying 
differential affinity) single out a specific region o f DNA that could be implicated 
in binding exclusively to sigJ. The EMSA binding experiments o f sigJ with the 
four DNA constructs can be seen in Figure 8.8A-D.
The EMSA results indicate that DNA retardation is experienced with all four 
DNA constructs, with the initial indication o f DNA migration being slowed 
within a sigJ concentration o f -0 .4-0 .5  mM. The conclusion to this observation 
puts into doubt the premise that the binding o f DNA to sigJ is exclusively reliant 
upon a specific DNA sequence-specific recognition element.
To further examine the specific binding nature o f sigJ, a randomly chosen 300 bp 
DNA template obtained from the coding region for the protein HNS {Salmonella 
Typhimurium), was used in a control EMSA binding experiments with sigJ 
(Figure 8.9A-D).
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Figure 8.7: A: Saturation curve of sigJ in the presence o f 300 bp Mtb sigF DNA. B -  E: EMSA Novex*50 DNA precast retardation gels (6% agarose) of sigJ with 300 bp Mtb sigF DNA 
(varying concentration). DNA concentration for EMSA gel. B: 100 ng/lane, C: 60 ng/lane, D: 5 ng/lane, and E: 2.5 ng/lane. Lanes; 3 - 9 ,  contain sigJ at the following concentrations; 0.1 mM. 
0.3 mM, 0.4 mM, 0.5 mM, 0.6 mM, 0.8 mM and 1 mM. respectively. Lane 1 is 300 bp Mtb DNA with no sigJ present. Lane 2 is LMW ladder.
SigJ is shown to bind the 300 bp HNS DNA sequence with similar apparent 
affinity as that observed with the Mtb 300 bp DNA, with the first indication of 
DNA migration inhibition evident at a sigJ concentration of -0 .4-0 .5  mM and in 
some instances as with Figure 8.9C, at a much lower sigJ concentration. As a 
secondary control, the small protein lysozyme (a hydrolase whose function 
clearly does not involve binding to DNA) was used in place of sigJ in a DNA 
binding-specificity examination with the original 300 bp Mtb DNA. The result of 
using lysozyme instead o f sigJ indicates as expected, no DNA retardation (Figure 
8.9E).
8.8.1. DNA binding summary.
With these results, sigJ still remains an unambiguous DNA binding protein in the 
EMSA paradigm. The DNA structural element to which it binds could be very 
small, and as a result be present in any length o f DNA sequence used in 
subsequent EMSA binding experiments. By aligning the two DNA sequences 
used in these EMSA binding experiments it is observed that the sequences 
exhibit approximately 50 % sequence identity when optimally aligned at full 
length (it seems unlikely that there would be accidental shorter stretches of 
sequence identity) as shown in Figure 8.10. A major difference however is the 
differing extents o f the constituent nucleotide content for each o f the DNA 
sequences used. The Mtb DNA strand is dominated by a 63 % G-C content while 
in comparison the 300 bp S. Typ HNS DNA has less, having a 44 % G-C content. 
With 50% overall sequence identity it could be argued that both DNA sequences 
contain a homologous contiguous DNA stretch to which sigJ is binding. 
However, the DNA constructs made from the entire 300 bp Mtb sequence proved 
that regardless o f the region o f the DNA sequence used in the EMSA binding 
experiments, DNA migration was retarded regardless o f the construct used.
Therefore the DNA binding nature o f sigJ must be concluded as being DNA 
concentration independent and practically sequence non-specific, making sigJ 
capable o f binding DNA o f virtually any sequence length, regardless o f species 
source. In comparison to the sigJ/DNA saturation curve first obtained from SGH-
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BRD, where sigJ (within the range of 1-45 pM) was first observed to bind an 
indeterminate amount o f DNA, the EMSA experiments performed here at least 
verify that sigJ does indeed bind DNA in a similar manner.
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Figure 8.8: A -  D: EMSA Novex® DNA precast retardation gels (6% agarose) of sigJ with various length Mtb sigF DNA constructs. EMSA gel, A: PepA (200 bp), B: PepB (200bp), C: PepC 
(120 bp), and D: PepD (120 bp). Lanes; 3 - 9 ,  contain sigJ at the following concentrations; 0.1 mM, 0.3 mM, 0.4 mM, 0.5 mM, 0.6 mM, 0.8 mM and 1 mM, respectively. Lane 1 is 300 bp Mtb 
DNA with no sigJ present. Lane 2 is LMW ladder.
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Figure 8.9: A -  D: EMSA Novex® DNA precast retardation gels (6% agarose) of sigJ with 300 bp HNS (S. Typhimurium) (varying concentration). DNA concentration for EMSA gel, A: 100 
ng/lane. B: 60 ng/lane, C: 5 ng/lane, and D: 2.5 ng/lane. EMSA gel E: lysozyme plus 300 bp Mtb sigF DNA. Lanes; 3 - 9 ,  contain sigJ/lysozyme at the following concentrations; 0.1 mM, 0.3 
mM, 0.4 mM, 0.5 mM, 0.6 mM, 0.8 mM and 1 mM, respectively. Lane 1 is 300 bp Mtb DNA with no sigJ present. Lane 2 is LMW ladder.
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B
Ni£ttotKfe Campaubon 
SigJ300t)p(1 • 300rff)
s n m
N ucleotide N um ber M ol%
45
96
103
56
15.00
32.00
34.33
18.67
DNA molecule: S. typ HNS 300bp (1 - 300nt) 
Length = 300 base pairs
Molecular Weight = 91,211 kDa, single stranded 
Molecular Weight = 18,220 kDa, double stranded 
G+C content = 46.00%
A+T content = 54.00%
toS 300bp (1 -300rt)
N ucleotide N um ber M ol%
A 95 31.67
C 63 21.00
G 75 25.00
T 67 22.33
Figure 8.10: A: Global sequence alignment of 300 bp Mtb and S. typ HNS DNA. Nucleotides are colour coded to 
correspond to the block diagrams in B and C; Adenine (green), Cytosine (blue), Guanine (black) and Thymine (red). 
B: DNA content data o f 300 bp Mtb DNA. C: DNA content data of 300 bp S. typ HNS DNA.
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8.9. Discussion and concluding remarks.
The work in this Chapter indicates that natively folded recombinant Mtb sigJ is 
spectroscopically distinct from refolded sigJ isolated from inclusion bodies. The 
natively expressed sigJ is apparently monomeric and contains some globular 
folded component as witnessed by the appearance o f the ID and 2D NMR 
spectra. Nevertheless Mtb sigJ exhibits structural characteristics that initially 
made further NMR-based experimentation difficult, probably as a result o f its 
dynamic properties leading to line broadening. Because o f these difficulties, an 
investigation using various biochemical techniques was required to scratch the 
surface in trying to understand the structural and behavioural features that make 
sigJ essentially unique amongst the 13 currently known Mtb sigma factors. 
Preliminary limited proteolysis experiments revealed the potential to define 
relatively stable sub-fragments o f full length sigJ. The DNA binding specificity 
of sigJ was also confirmed as being essentially DNA concentration independent 
and potentially sequence non-specific, as identified by EMSA-based 
protein/DNA binding experiments.
Ideally the next step would be isolate some o f the peptide fragments obtained 
from the limited proteolysis o f sigJ, as a means to ascertain the amino acid 
sequence and to compare it to the location currently known for the two DNA 
binding domains along the sigJ amino acid sequence. Ultimately this would be 
the prelude to constructing a peptide sequence to match that o f the peptide 
isolated using limited proteolysis corresponding to one or both o f the DNA 
binding domains. Such a construct would then be available for structural probing 
using NMR and CD spectroscopy.
As for the DNA binding aspect o f sigJ it may also be o f interest to observe any 
effects that may occur upon addition o f large amounts o f DNA to a sigJ NMR 
sample and the subsequent HSQC measurements taken. Additionally it would be 
desirable to reconstitute sigJ-dependent action o f Mtb RNAP to screen for 
potential sequence-specific sigJ DNA recognition elements.
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Appendix
A.l: The standard genetic code.
Table A l.l:
First
Position
Second Position Third
Position
T C A G
TTT Phe TCT Ser TAT T yr TGT Cys T
T TTC Phe TCC Ser TAC T yr TGC C ys C
TTA Leu TCA Ser TAA Stop TGA Stop A
TTG Leu TCG Ser TAG Stop TGG Trp G
CTT Leu CCT Pro CAT H is CGT A rg T
C CTC Leu CCC Pro CAC H is CGC A rg C
CTA Leu CCA Pro CAA G in CGA A rg A
CTG Leu CCG Pro CAG G in CGG A rg G
ATT lie ACT T hr AAT A sn AGT Ser T
A ATC lie ACC Thr AAC A sn AGC Ser C
ATG He ACA T hr AAA L ys AGA A rg A
ATG M et ACG T hr AAG L ys AGG A rg G
GTT V al GCT A la GAT A sp GGT G ly T
G GTC V al GCC A la GAC A sp GGC G ly C
GTA V al GCA A la GAA G lu GGA G ly A
GTG V al GCG A la GAG G lu GGG G ly G
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A.2: Recombinant protein expression plasmid.
Shown below are diagrammatical representations o f  the plasmid vectors used in 
this project. Each includes the following features; open reading frames, 
promoters and unique restriction enzyme sites used for cloning.
For full-length TPxWt, TPxC60S and sigJ were each cloned separately into the 
same plasmid vector-type; [pET22b(+)J as shown in Figure A2.1.
TPxW t, TPxC60S and sigJ
Hind III-AW  AGCTT
Nde I -  CAVTATG
Bla I
His,
lac I
Figure A2.1: Plasmid vector [pET22b(+)] (Novagen®).
Refer to the Table, below, for nomenclature description.
Table A2.1: The nomenclature for plasmid vector [pET22b(+)] in Figure 
A2.1.
ORFs Promoters
Bla I: ampicillin resistance T7: T7 promoter
Lac I: Lac repressor N/A
His6: His-tag coding sequence N/A
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A.3: TPxWt nucleotide and amino acid sequence.
Mtb TPxWt: Met 1-Ala 165. Vector designation and size (base pairs): 
[pLEXTIJ46-l] and 5898 bp. Vector insert positioning (nucleotides): Nde I  
(5204) -H in d  III (5722).
Shown below is the nucleotide and amino acid sequence (displayed in bold 
underneath the triplet codon) for TPxWt as confirmed by MWG-Biotech™ 
sequencing services as described in Chapter 2.2.1.
atg gcg cag a t t acc ctg cgc ggc aac gcg a t t aac acc gtg ggc gaa
M A Q I T L R G N A I N T V G E
ctg ccg gcg gtg ggc age ccg gcg ccg gcg t t t acc ctg acc ggc ggc
L P A V 6 s P A P A F T L T G G
gat ctg ggc gtg a t t age age gat cag t t t cgc ggc aaa age gtg ctg
D L 6 V I s S D Q F R G K S V L
ctg aac a t t t t t ccg age gtg gat acc ccg gtg tgc gcg acc age gtg
L N I F P s V D T P V c A T s V
cgc acc t t t gat gaa cgc gcg gcg gcg age ggc gcg acc gtg ctg tgc
R T F D E R A A A s G A T V L C
gtg age aaa gat ctg ccg t t t gcg cag aaa cgc t t t tgc ggc gcg gaa
V S K D L P F A Q K R F c G A E
ggc acc gaa aac gtg atg ccg gcg age gcg t t t cgc gat age t t t ggc
6 T E N V M P A s A F R D S F G
gaa gat t a t ggc gtg acc a t t gcg gat ggc ccg atg gcg ggc ctg ctg
E D Y 6 V T I A D G P M A G L L
gcg cgc gcg a t t gtg gtg a t t ggc gcg gat ggc aac gtg gcg t a t acc
A R A I V V I G A D G N V A Y T
gaa ctg gtg ccg gaa a t t gcg cag gaa ccg aac t a t gaa gcg gcg ctg
E L V P E I A Q E P N Y E A A L
gcg gcg ctg ggc gcg
A A L 6 A
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A.4: TPxC50S nucleotide and amino acid sequence.
Mtb  TPxC60S: M etl-A lal65 . Vector designation and size (base pairs): 
[pLEXTIJ46-2] and 5898 bp. Vector insert positioning (nucleotides): Nde I  
(5204) -  H ind III  (5722).
Shown below is the nucleotide and amino acid sequence (displayed in bold 
underneath the triplet codon) for TPxC60S as confirmed by MWG-Biotech™ 
sequencing services as described in Chapter 2.2.1. The mutation C60S is 
highlighted in red.
a tg gcg cag a t t acc c tg cgc ggc aac gcg a t t aac acc g tg ggc gaa
M A Q I T L R G N A I N T V G E
ctg ccg gcg gtg ggc age ccg gcg ccg gcg t t t acc c tg acc ggc ggc
L P A V G s P A P A F T L T G G
gat c tg ggc gtg a t t age age gat cag t t t cgc ggc aaa age gtg c tg
D L G V I S S D Q F R G K S V L
c tg aac a t t t t t ccg age gtg gat acc ccg g tg age gcg acc age gtg
L N I F P S V D T P V S A T s V
cgc acc t t t gat gaa cgc gcg gcg gcg age ggc gcg acc gtg c tg tgc
R T F D E R A A A s G A T V L C
gtg age aaa gat c tg ccg t t t gcg cag aaa cgc t t t tgc ggc gcg gaa
V s K D L P F A Q K R F c G A E
ggc acc gaa aac gtg a tg ccg gcg age gcg t t t cgc g a t age t t t ggc
G T E N V M P A S A F R D S F G
gaa gat t a t ggc gtg acc a t t gcg gat ggc ccg a tg gcg ggc c tg ctg
E D Y G V T I A D G P M A G L L
gcg cgc gcg a t t gtg gtg a t t ggc gcg ga t ggc aac gtg gcg t a t acc
A R A I V V I G A D G N V A Y T
gaa ctg gtg ccg gaa a t t gcg cag gaa ccg aac t a t gaa gcg gcg ctg
E L V P E I A Q E P N Y E A A L
gcg gcg ctg ggc gcg
A A L G A
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A.5: Amino acid one and three letter codes.
A Ala Alanine
C Cys Cysteine
D Asp Aspartic acid (Aspartate)
E Glu Glutamic acid (Glutamate)
F Phe Phenylalanine
G Gly Glycine
H His Histidine
I He Isoleucine
K Lys Lysine
L Leu Leucine
M Met Methionine
N Asn Asparagine
P Pro Proline
Q Gin Glutamine
R Arg Arganine
S Ser Serine
T Thr Threonine
V Val Valine
W Trp Tryptophan
Y Tyr Tyrosine
Amino acid nomenclature used in this thesis:
X60: X = amino acid residue number 60.
C60S: Cysteine 60 mutated to Serine.
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A.6: Triple resonance chemical shift data for [2H, 1SN, 13C]-labelled 
TPxC60S at pH 7.4.
Table A6.1:
Residue N HN c„ CO c P Residue N HN c„ CO Cp
1 Met - - 56.875 175.515 42.658 81 Val 123.203 8.836 60.317 175.888 34.592
2 Ala 124.424 8.221 53.071 177.731 19.622 82 Ser 117.315 7.832 57.383 64.349 173.408
3 Gin 118.956 8.348 56.408 176.252 29.802 94 Gly 106.657 8.204 45.721 174.253 -
4 lie 121.487 8.109 61.823 176.535 39.337 95 Ala 122.147 8.008 53.218 177.766 20.240
5 Thr 118.127 8.177 62.371 174.491 70.307 96 Glu 119.544 8.580 58.120 177.682 29.665
6 Leu 124.514 8.203 55.446 177.039 42.774 97 Gly 110.296 8.523 45.560 174.518 -
7 Arg 121.398 8.258 56.568 176.844 31.141 98 Thr 114.895 7.712 61.596 174.718 70.344
8 Gly 109.636 8.409 45.41 173.887 - 99 Glu 124.353 8.800 57.834 176.939 30.786
9 Asn 118.655 8.259 52.264 174.514 39.692 100 Asn 114.517 8.682 54.423 172.561 38.698
10 Ala 123.655 8.162 52.791 177.564 20.098 101 Val 117.675 7.059 61.401 175.398 34.528
11 lie 118.732 8.039 60.305 174.735 40.089 102 Met 124.029 9.000 53.234 172.511 35.527
12 Asn 123.564 8.645 52.294 175.284 40.362 103 Pro - - 61.791 175.957 34.041
13 Thr 113.255 8.465 60.123 175.77 71.634 104 Ala 122.066 8.932 51.567 175.852 24.656
14 Val 116.643 8.388 62.719 175.672 32.937 105 Ser - 9.462 56.527 - 64.897
15 Gly 107.912 7.626 45.034 172.495 - 112 Gly 103.905 9.306 47.711 176.314 -
16 Glu 119.11 8.062 54.863 175.64 32.896 113 Glu 119.485 7.395 60.474 179.418 29.474
17 Leu 124.618 8.274 53.908 175.358 42.337 114 Asp 121.578 8.512 57.202 178.000 40.064
18 Pro - - 62.667 175.891 32.272 115 Tyr 116.416 8.201 59.823 173.34 38.08
19 Ala 124.061 8.075 52.239 179.174 19.499 116 Gly 105.147 6.92 46.725 174.312 -
20 Val 123.498 8.488 65.282 178.164 31.798 117 Val 104.723 7.877 60.552 175.573 33.492
21 Gly 115.789 9.356 44.686 173.241 - 118 Thr 120.02 7.232 64.944 174.127 68.899
22 Ser 117.082 7.836 57.107 - - 119 He 129.165 9.334 64.018 178.255 37.733
23 Pro - - 63.470 177.636 32.149 120 Ala 130.572 9.068 54.388 176.631 21.184
24 Ala 128.43 8.501 50.906 175.672 18.671 121 Asp 113.084 7.374 53.302 175.308 43.592
25 Pro - - 62.972 176.921 31.556 122 Gly 105.368 8.415 45.443 173.691 -
26 Ala 127.159 8.566 52.625 177.979 19.168 123 Pro - - 65.747 178.269 32.899
27 Phe 111.748 8.091 56.625 174.251 43.507 124 Met 112.607 8.861 55.337 173.958 32.986
28 Thr 115.52 9.193 61.101 173.09 71.839 125 Ala 120.636 7.360 54.059 178.052 18.366
29 Leu 121.855 9.006 53.385 176.343 48.421 126 Gly 108.475 8.667 45.527 175.735 -
30 Thr 116.136 8.69 63.368 175.710 70.477 127 Leu 118.664 8.147 54.495 175.329 42.337
31 Gly 114.907 8.908 44.173 175.917 - 128 Leu 116.358 7.632 54.388 - 41.010
32 Gly 105.591 8.821 47.721 176.973 - 129 Ala 120.427 8.268 51.496 175.516 19.822
33 Asp 117.17 7.991 52.635 178.588 40.293 130 Arg 114.927 7.457 54.885 176.067 29.369
34 Leu 112.295 8.105 57.603 175.944 38.033 131 Ala 129.162 8.186 51.685 174.657 23.358
35 Gly 106.696 8.209 44.190 173.534 - 132 He 117.115 8.688 60.165 175.354 42.822
36 Val 120.399 8.430 63.111 176.966 34.172 133 Val 124.382 8.593 61.633 174.489 36.741
37 He 129.707 8.729 61.014 174.698 40.634 134 Val 126.22 9.287 61.609 175.041 34.658
38 Ser 120.269 8.442 55.507 175.751 66.001 135 lie 131.241 9.788 61.478 175.885 40.412
39 Ser 119.562 8.215 62.021 174.211 60.876 136 Gly 111.033 8.731 44.566 174.803 -
40 Asp 121.727 8.057 56.91 178.101 40.58 137 Ala 123.598 8.645 54.951 177.763 18.587
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41 Gin 117.553 7.629 57.268 176.584 28.637 138 Asp 114.423 7.944 53.452 176.573 40.188
42 Phe 117.092 7.204 56.402 174.318 39.585 139 Gly 108.337 8.349 45.180 173.894 -
43 Arg 120.154 6.914 58.293 178.366 29.962 140 Asn 118.35 8.057 51.622 176.135 39.586
44 Gly 114.257 8.977 45.805 173.581 - 141 Val 122.874 8.983 65.254 176.309 31.749
45 Lys 120.48 8.302 54.858 174.519 35.596 142 Ala 132.312 9.641 52.815 177.096 27.907
46 Ser 115.802 8.423 58.577 174.281 64.81 143 Tyr 117.84 7.552 58.99 173.328 41.707
47 Val 121.775 9.012 60.568 173.421 36.796 144 Thr 118.308 7.699 60.054 172.486 72.777
48 Leu 128.563 9.072 54.49 173.872 44.594 145 Glu 118.861 8.460 57.217 173.511 33.611
49 Leu 125.855 9.440 54.097 172.965 42.248 146 Leu 129.806 8.579 53.859 176.242 44.128
50 Asn 127.504 9.177 51.327 173.397 39.008 147 Val 128.136 8.145 60.887 175.337 32.036
51 lie 125.327 8.711 63.392 175.606 39.937 148 Pro - - 64.918 176.27 33.002
52 Phe 124.701 9.297 56.262 175.083 44.08 149 Glu 116.144 7.00 55.289 176.841 32.542
53 Ser - - 60.563 175.597 63.640 150 lie 120.719 8.313 63.081 176.085 38.888
64 Val 121.133 7.731 65.165 176.839 32.421 151 Ala 122.050 8.339 52.978 176.968 18.780
65 Arg 120.457 7.856 58.885 178.221 30.440 152 Gin 118.350 7.373 55.456 175.175 30.666
66 Thr 112.969 7.901 64.347 178.260 58.199 153 Glu 122.110 8.421 54.348 174.83 31.043
67 Phe 122.076 7.773 60.756 176.054 38.983 154 Pro - - 61.881 177.176 32.716
68 Asp 118.866 8.346 57.630 178.525 40.473 155 Asn 120.319 10.256 51.868 174.99 36.920
69 GIu 117.72 8.070 59.559 180.034 30.319 156 Tyr 124.352 7.394 61.166 177.513 38.176
70 Arg 120.059 8.044 59.073 179.671 31.123 157 Glu 116.424 8.331 59.926 - 29.282
71 Ala 122.43 8.446 55.425 180.339 17.976 158 Ala 122.462 7.475 54.619 - 121.821
72 Ala 122.50 8.201 54.893 181.476 18.406 159 Ala 120.821 7.189 54.823 - 18.955
73 Ala 121.08 7.902 54.584 179.082 18.609 160 Leu 114.77 8.047 57.573 180.371 41.406
74 Ser 111.793 7.383 59.713 174.691 65.026 161 Ala 122.081 7.965 54.883 180.97 17.918
75 Gly 109.46 7.803 45.211 174.223 - 162 Ala 119.969 7.232 54.145 178.605 18.838
76 Ala 122.929 7.470 51.726 176.953 20.914 163 Leu 116.177 7.336 55.347 177.307 43.514
77 Thr 117.218 7.895 63.269 172.899 70.979 164 Gly 107.435 7.704 45.661 173.47 -
78 Val 127.74 8.834 61.585 174.041 34.083 165 Ala 128.391 7.670 - 172.127 21.634
79 Leu 125.667 8.722 52.590 175.877 44.027
275 -
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A.7: Spin systems identified from unassigned cross peaks found in the TPxC60S HSQC spectrum.
Ca,/ and Caj.j chemical shifts are presented for all the triple resonance experiments performed.
Table A7.1:
2D NMR (*H, 15N) and Triple Resonance Experiments (*H, 13C)
(Spectral co-ordinates o f nuclei presented in ppm. All first co-ordinates set = Ca,„ second co-ordinate set = Caj-i)
Spin
System
HSQC HNCA HN(CO)CA HNCB HN(CO)CB HNCO HN(CA)CO
1 8.616/131.982 8.604/50.901
8.614/55.824
8.630/18.899 8.630/177.376
(previous)
8.615/177.185
(weak)
2 7.823/123.415 7.817/61.448 7.810/41.938 7.834/174.181 7.824/175.830
3 7.669/122.723 7.655/55.858 - 7.684/176.264 7.694/177.630
7.684/176.245
4 8.198/122.104 8.186/52.083 8.178/52.004 
8.191/53.787
8.190/42.703 8.198/176.046 8.195/176.185
- L
LZ
~
5 8.109/ 120.010 8.097/63.438 8.102/63.436
8.098/61.216
6 8.560/119.692 8.527/50.942 8.526/50.845
8.536/60.453
7 7.332/119.366 7.307/54.184
8 9.155/118.380 9.137/57.562
9 7.174/117.740 7.166/52.200
7.164/56.924
10 8.227/117.253 8.235/52.788
11 8.073/116.204 8.061/55.516
8.110/31.216
8.109/33.284
7.161/18.256
8. 125/ 176.802
8.557/177.026
7.327/173.704
9.160/174.493
7.196/176.571
8. 119/ 176.790
8.118/176.180
8.558/176.890
8.560/174.209
7.198/178.543
8.239/176.636
8.099/173.336
-278 
-
12 8.281/115.748 8.280/64.778
13 7.328/114.376 7.323/55.251 7.331/52.229
7.326/52.184
14 5.724/112.085
15 7.033/107.438 7.023/55.759
16 8.964/114.025 8.964/54.204 8.963/54.127
8.963/59.386
17 7.239/117.523 7.229/58.992
18 7.406/118.640 7.404/61.284
8.275/51.812 - 8.291/176.654
7.342/178.600
5.745/178.342
7.048/178.296
8.969/63.580 - 8.982/176.282
7.250/175.736
7.349/175.748
7.052/174.537
8.976/174.110
A.8: Triple resonance chemical shift data for [2H, 1SN, 13C]-labelled 
TPxC60S at pH 6.0.
Table A8.1:
Residue N HN Ca CO Residue N HN C„ CO
1 Met - - - - 81 Val 123.281 8.830 - -
2 Ala 125.325 8.354 55.302 174.295 82 Ser 113.420 7.780 60.384 175.773
3 Gin 120.010 8.400 52.110 177.408 94 Gly 106.051 7.856 - 174.447
4 lie 122.190 8.270 55.471 175.861 95 Ala 121.850 7.990 - -
5 Thr 118.352 8.343 60.703 176.224 96 Glu 120.256 8.645 52.437 178.005
6 Leu 124.689 8.351 61.395 174.234 97 Gly 110.502 8.555 57.501 177.627
7 Arg 121.350 8.280 54.641 176.916 98 Thr 115.824 7.718 45.174 174.538
8 Gly 109.018 8.403 55.873 176.783 99 Glu 125.289 8.752 61.326 174.521
9 Asn 118.608 8.256 45.044 173.844 100 Asn 114.321 8.599 57.234 176.808
10 Ala 123.650 8.187 52.764 174.604 101 Val 117.269 7.062 53.928 172.491
11 lie 118.746 8.110 52.175 177.463 102 Met 123.899 9.021 60.723 175.337
12 Asn 123.444 8.705 59.527 174.671 103 Pro - - - -
13 Thr 112.992 8.484 51.775 175.340 104 Ala 122.439 8.961 61.203 176.099
14 Val 116.497 8.416 59.509 175.906 105 Ser 114.243 9.496 50.916 175.712
15 Gly 107.932 7.611 61.960 175.692 112 Gly 103.954 9.342 61.397 175.888
16 Glu 118.845 8.110 44.662 177.457 113 Glu 119.457 7.392 47.383 176.278
17 Leu 124.972 8.243 54.148 175.546 114 Asp 121.525 8.491 59.715 179.345
18 Pro - - - - 115 Tyr 116.452 8.219 56.557 177.988
19 Ala 124.081 8.083 62.013 175.854 116 Gly 105.169 6.916 59.289 173.318
20 Val 123.429 8.489 51.565 179.143 117 Val 104.895 7.851 46.341 174.222
21 Gly 115.823 9.368 64.497 178.131 118 Thr 119.960 7.233 59.737 175.574
22 Ser 117.112 7.855 44.325 173.221 119 He 129.187 9.347 64.390 174.079
23 Pro - - - - 120 Ala 130.588 9.082 63.259 178.190
24 Ala 128.408 8.497 62.796 177.614 121 Asp 113.167 7.380 53.687 176.595
25 Pro - - - - 122 Gly 105.296 8.414 52.756 175.261
26 Ala 127.130 8.563 62.322 176.891 123 Pro - - - -
27 Phe 111.625 8.088 51.957 177.919 124 Met 112.634 8.861 65.110 178.240
28 Thr 115.366 9.166 56.098 174.238 125 Ala 120.661 7.364 54.641 173.935
29 Leu 122.320 9.039 - 173.134 126 Gly 108.448 8.663 53.376 178.042
30 Thr 116.165 8.679 52.820 176.289 127 Leu 118.711 8.162 45.152 175.666
31 Gly 114.934 8.917 62.735 175.712 128 Leu 116.433 7.675 53.869 175.389
32 Gly 105.555 8.829 - 175.871 129 Ala 120.288 8.266 53.611 174.723
33 Asp 117.213 7.996 47.356 173.784 130 Arg 114.973 7.432 50.810 174.579
34 Leu 112.486 8.105 52.156 176.971 131 Ala 128.952 8.167 54.272 176.097
35 Gly 106.663 8.203 56.974 175.891 132 He 117.372 8.699 51.022 174.626
36 Val 120.416 8.432 43.817 173.520 133 Val 124.282 8.590 59.176 175.360
37 He 129.627 8.744 62.249 176.951 134 Val 126.321 9.300 60.825 174.473
38 Ser 120.422 8.464 60.265 174.675 135 He 131.332 9.835 60.896 174.990
39 Ser 119.622 8.230 55.009 175.687 136 Gly 111.048 8.744 60.693 175.938
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40 Asp 121.711 8.051 61.483 177.104 137 Ala 123.515 8.671 44.215 175.482
41 Gin 117.490 7.614 56.289 178.028 138 Asp 114.409 7.940 54.289 177.768
42 Phe 117.056 7.182 56.644 176.592 139 Gly 108.348 8.359 52.948 177.215
43 Arg 120.079 6.905 55.743 174.321 140 Asn 118.264 8.059 44.821 173.867
44 Gly 114.171 8.977 57.606 178.333 141 Val 122.905 9.011 51.128 176.116
45 Lys 120.224 8.277 45.431 173.568 142 Ala 132.335 9.651 64.428 176.290
46 Ser 115.982 8.470 54.184 174.614 143 Tyr 117.846 7.560 52.187 177.122
47 Val 122.060 9.032 58.112 174.279 144 Thr 118.241 7.699 58.464 173.306
48 Leu 128.468 9.130 59.788 173.468 145 Glu 118.573 8.476 59.376 172.477
49 Leu 125.775 9.463 53.829 173.855 146 Leu 129.928 8.572 56.624 173.524
50 Asn 127.348 9.216 53.519 173.048 147 Val 128.319 8.194 53.260 176.114
51 lie 125.307 8.716 50.825 174.071 148 Pro 116.279 - - -
52 Phe 124.719 9.324 62.622 - 149 Glu 121.005 6.984 64.201 176.140
64 Val 121.692 7.660 60.601 - 150 lie 121.934 8.347 54.501 176.803
65 Arg 119.349 7.731 65.396 - 151 Ala 118.561 8.364 62.308 176.037
66 Thr 113.884 8.045 59.001 - 152 Gin 121.971 7.395 52.288 176.869
67 Phe 122.474 7.632 65.450 176.319 153 Glu 120.102 8.401 54.705 175.115
68 Asp 118.185 8.421 60.395 - 154 Pro - - - -
69 Glu 118.319 8.287 56.137 - 155 Asn 125.296 10.252 61.186 173.536
70 Arg 121.077 7.998 59.040 179.837 156 Tyr 122.417 7.454 51.448 176.229
71 Ala 122.340 8.337 58.634 179.581 157 Glu 116.560 8.383 59.921 177.851
72 Ala 121.869 8.235 54.670 180.247 158 Ala 120.703 7.513 59.270 179.474
73 Ala 121.651 8.003 53.949 171.821 159 Ala 114.783 7.148 53.964 180.045
74 Ser 112.180 7.356 53.975 179.105 160 Leu 121.931 8.044 54.179 178.803
75 Gly 108.770 7.813 59.152 174.424 161 Ala 120.063 7.964 57.073 180.403
76 Ala 122.953 7.269 44.544 174.214 162 Ala 116.064 7.231 54.218 180.941
77 Thr 117.597 8.004 51.076 177.068 163 Leu 107.534 7.310 53.523 178.642
78 Val 127.868 8.865 56.675 172.986 164 Gly 128.353 7.702 54.710 177.319
79 Leu 125.477 8.743 56.700 174.540 165 Ala 123.281 7.673 45.318 173.478
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A.9: SigJ nucleotide and amino acid sequence.
Mtb SigJ: Metl-Asn312. Vector designation and size (base pairs): [pLEXT-01] 
and 6045 bp. Vector insert positioning (nucleotides): Nde I  (5204) -  Hind III 
(5978).
Shown below is the nucleotide and amino acid sequence (displayed in bold 
underneath the triplet codon) for sigJ as confirmed by MWG-Biotech™ 
sequencing services as described in Chapter 2.2.1.
a tg gaa gtg age gaa t t t gaa gcg ctg cgc cag cat ctg atg age gtg
M E V S E F E A L R Q H L M S V
gcg t a t cgc ctg acc ggc acc gtg gcg gat gcg gaa gat a t t gtg cag
A Y R L T G T V A D A E D I V Q
gaa gcg tgg ctg cgc tgg gat age ccg gat acc gtg a t t gcg gat ccg
E A w L R w D S P D T V I A D P
cgc gcg tgg ctg acc acc gtg gtg age cgc ctg ggc ctg gat aaa ctg
R A w L T T V V S R L G L D K L
cgc age gcg gcg cat cgc cgc gaa acc t a t acc ggc acc tgg ctg ccg
R S A A H R R E T Y T G T w L P
gaa ccg gtg gtg acc ggc ctg gat gcg acc gat ccg ctg gcg gcg gtg
E P V V T G L D A T D P L A A V
gtg gcg gcg gaa gat gcg cgc t t t gcg gcg atg gtg gtg ctg gaa cgc
V A A E D A R F A A M V V L E R
ctg cgc ccg gat cag cgc gtg gcg t t t gtg ctg cat gat ggc t t t gcg
E R L R P D Q R V A F V L H D G
gtg ccg t t t gcg gaa gtg gcg gaa gtg ctg ggc acc age gaa gcg gcg
F A V p F A E V A E V L G T s E
gcg cgc cag ctg gcg age cgc gcg cgc aaa gcg gtg acc gcg cag ccg
A A A R Q L A s R A R K A V T A
gcg ctg a t t age ggc gat ccg gat ccg gcg cat aac gaa gtg gtg ggc
Q P A L i s G D P D P A H N E V
cgc ctg atg gcg gcg atg gcg gcg ggc gat ctg gat acc gtg gtg age
V G R L M A A M A A G D L D T V
ctg ctg cat ccg gat gtg acc t t t acc ggc gat age aac ggc aaa gcg
V S L L H p D V T F T G D s N G
ccg acc gcg gtg cgc gcg gtg cgc ggc age gat aaa gtg gtg cgc t t t
K A p T A V R A V R G S D K V V
a t t ctg ggc ctg gtg cag cgc t a t ggc ccg ggc ctg t t t ggc gcg aac
R F i L G L V Q R Y G P G L F G
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gcg
Q
gtg
P
cgc
R
t t t
F
ggc
6
ctg  gtg aac ggc gaa ctg  ggc gcg t a t  acc gcg ggc ctg 
L A L V N G E L G A Y T A  
gat ggc t a t  cgc gcg a tg  gcg ccg cgc a t t  acc gcg a t t  
G V D G Y R A M A P R I T  
gat ggc aaa gtg tgc gcg c tg  tgg gat a t t  gcg aac ccg 
D G K V C A L W D I A N P  
acc ggc age ccg c tg  aaa gaa cgc cgc gcg cag ccg acc 
T G S P L K E R R A Q P T  
cgc cat cat cgc aac 
R H H R N
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